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Internalisation of nano- and microparticles, particularly by macrophages, is a fundamental 
process impacting the efficacy of particulate delivery systems. A greater understanding of how 
particle properties such as size, hydrophobicity, surface chemistry, surface charge, and shape 
influence this process will therefore lead to the design of more effective drug delivery systems 
and improved clinical outcomes. Recently, there has been a number of studies focussing on 
how the shape of nanoparticles affects their internalisation, however few studies focus on 
microparticle delivery systems which are especially useful in the field of inhaled drug delivery. 
This work aimed to explore the influence of microparticle shape, size, and surface chemistry 
in order to strengthen the knowledge in this area and assist in the design of microparticle 
delivery systems.  
In this work, microfabrication techniques have been applied to produce a range of 
microparticles of diverse shape in order to assess their internalisation by RAW 264.7 
macrophages. Additionally, surface modification of different sized spherical particles with 
zwitterionic surface chemistry has been achieved to explore how these properties impact 
cellular internalisation.  
Silicon oxide microparticles of spherical, hexahedral, and truncated pyramid shapes were 
fluorescently labelled using covalent silane linker chemistry to allow their detection by confocal 
microscopy and imaging flow cytometry. Each particle shape was shown to be internalised by 
macrophages and to follow identical uptake pathways resulting in each particle shape residing 
in the phagolysosome after internalisation. Truncated pyramids were internalised by a lower 
percentage of macrophages than spherical particles, however in macrophages stimulated with 
lipopolysaccharide prior to particle administration, no differences in uptake of different shapes 
were observed.  
A wider range of microparticle shapes including hexahedrons, bars, cubes, and circular disks 
were microfabricated using polycrystalline silicon and a label-free method used to detect 
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particle uptake by light scattering using imaging flow cytometry. The percentage of cells 
internalising particles was shown to be dependent on particle shape and in particular, 
differences in uptake between hexahedral and circular disk shaped particles indicate that 
points of high curvature may act to increase internalisation. The effect of these polycrystalline 
silicon microparticle shapes on cellular metabolism, membrane permeability, and release of 
lysosomal enzymes was then explored revealing no differences in response to different 
particle shapes across a range of concentrations.   
Spherical silicon oxide particles (diameter 0.5, 1, 3 μm) modified either with amine or 
zwitterionic surface chemistry were applied to cells by equivalent total mass, number, and 
surface area. Particle uptake was highly dependent on particle dose, dose metric, and particle 
size, however no difference in particle uptake was seen between the different surface 
chemistries studied. Additionally, uptake of particles was assessed in the presence of 
dipalmitoyl phosphorylcholine, a major component of lung surfactant, which resulted in 
reduced uptake of smaller (0.5, 1 μm) particles but had no effect on the uptake of larger (3 






I would like to thank my supervisors, Lluïsa Pérez-García, and Snow Stolnik for their support 
and motivation throughout this project. Many thanks to my industrial supervisors Richard Kaye 
and Emanuela Cingolani for their advice and insight and to Frankie Rawson for his 
constructive feedback over the years. I would like to acknowledge financial support from the 
EPSRC grant EP/L01646X/1 and GSK through the CDT in Advanced Therapeutics and 
Nanomedicines.  
I would like to thank our collaborators, the group of J. A. Plaza, in particular Marta Duch, who 
have been so helpful in providing materials which have been essential for the work. I thank 
Rob Cavanagh for his tutelage and guidance in cell culture, David Onion for his expertise in 
flow cytometry, and Robert Markus for his skill in microscopy.  
I would like to express my gratitude to my office and CDT colleagues, and members of Lluïsa’s 
group for providing an environment in which it has been a pleasure to work.  
I would like to thank my parents for their boundless support and encouragement and finally, 







Table of Contents 
Abstract................................................................................................................................. iii 
Acknowledgements ............................................................................................................... v 
Table of Contents .................................................................................................................. vi 
List of figures ....................................................................................................................... xii 
List of tables ........................................................................................................................ xvi 
List of abbreviations ........................................................................................................... xvii 
1. Introduction ....................................................................................................................... 1 
1.1 Particulate carriers for drug delivery ............................................................................ 1 
1.2 Particle entry to the cell: Endocytosis .......................................................................... 2 
1.2.1 Clathrin-mediated endocytosis .............................................................................. 3 
1.2.2 Caveolae-mediated endocytosis ........................................................................... 4 
1.2.3 Clathrin- and caveolin-independent mechanisms of endocytosis ........................... 5 
1.2.4 Macropinocytosis .................................................................................................. 5 
1.2.5 Phagocytosis ......................................................................................................... 6 
1.2.6 Measures of particle uptake .................................................................................. 9 
1.3 Particle properties affecting cellular uptake ................................................................ 10 
1.3.1 The effect of particle size on cellular uptake ........................................................ 10 
1.3.2 The effect of particle hydrophobicity on particle uptake ....................................... 12 
1.3.3 The effect of particle surface charge on particle uptake....................................... 13 
1.3.4 The effect of particle surface chemistry on cellular uptake .................................. 14 
1.3.5 Protein corona formation on nano and microparticles .......................................... 15 
1.4 Particle shape ............................................................................................................ 17 
vii 
 
1.4.1 Methods for making nano and microparticles of different shapes ........................ 17 
1.4.1.1 Bottom-up methods ...................................................................................... 18 
1.4.1.2 Top-down methods ....................................................................................... 23 
1.4.2 The effect of nano and microparticle shape on cellular uptake ............................ 29 
1.4.2.1 Studies on the effect nanoparticle shape on cellular uptake .......................... 29 
1.4.2.2 Studies on the effect of microparticle shape on cellular uptake ..................... 30 
1.4.2.3 Other effects of particle shape ...................................................................... 32 
1.4.2.4 Microparticles for lung delivery ..................................................................... 32 
1.5 Aims and objectives ................................................................................................... 33 
2. Materials and General Methods ...................................................................................... 36 
2.1 Materials .................................................................................................................... 36 
2.1.1 Plasticware and glassware .................................................................................. 36 
2.1.2 Materials for cells culture ..................................................................................... 36 
2.1.3 Chemicals ........................................................................................................... 37 
2.2 General Methods ....................................................................................................... 37 
2.2.1 Routine cell culture methods ............................................................................... 37 
2.2.1.1 Culture of RAW 264.7 cells ........................................................................... 37 
2.2.1.2 Cell counting ................................................................................................. 38 
2.2.1.3 Cell freezing.................................................................................................. 38 
2.2.1.4 Cell revival .................................................................................................... 39 
2.2.1.5 Particokinetics .............................................................................................. 39 
2.2.2 Statistical analysis ............................................................................................... 39 
viii 
 
3. Interactions of silicon oxide microparticles of different shape by RAW 264.7 macrophages
 ........................................................................................................................................... 40 
3.1 Introduction ................................................................................................................ 40 
3.1.1 Methods of functionalising silicon oxide particles with fluorescent dyes ............... 40 
3.1.2 Methods of analysing particle internalisation ....................................................... 41 
3.1.3 Studies of the uptake of silicon oxide particles of different morphologies ............ 43 
3.2 Materials and Methods .............................................................................................. 44 
3.2.1 Materials ............................................................................................................. 44 
3.2.2 Methods .............................................................................................................. 44 
3.2.2.1 Non-covalent labelling of silicon oxide particles anchored on silicon wafers . 45 
3.2.2.2 Covalent labelling of silicon oxide particles anchored on silicon wafers ........ 46 
3.2.2.3 Covalent labelling of silicon oxide particles in suspension ............................ 47 
3.2.2.4 Determination of fluorophore release from particles in PBS at 37°C ............. 48 
3.2.2.5 Acquisition of brightfield and fluorescent images .......................................... 49 
3.2.2.6 Water contact angle measurements ............................................................. 49 
3.2.2.7 Removal of silicon oxide particles from silicon wafer ..................................... 49 
3.2.2.8 Determination of trypan blue quenching efficiency ........................................ 50 
3.2.2.9 Qualitative particle uptake of silicon oxide particles by RAW 264.7 macrophages 
assessed by confocal microscopy ............................................................................ 50 
3.2.2.10 Quantitative uptake of silicon oxide particles by RAW 264.7 cells assessed by 
flow cytometry .......................................................................................................... 52 
3.3 Results and Discussion ............................................................................................. 54 
3.3.1 Characterisation of fabricated particles ............................................................... 54 
3.3.2 Functionalisation of silicon oxide particles for fluorescent labelling ...................... 55 
ix 
 
3.3.2.1 Non-covalent labelling of silicon oxide particles was achieved using a 
complexation in solution method .............................................................................. 56 
3.3.2.2 Covalent labelling using silane linkers .......................................................... 62 
3.3.2.3 Comparison of fluorophore release from non-covalent and covalently labelled 
particles .................................................................................................................... 68 
3.3.3 Characterisation of fluorescently labelled particles .............................................. 70 
3.3.3.1 Measurement of median fluorescence intensity (MFI) and % coverage of 
fluorophore ............................................................................................................... 70 
3.3.3.2 Measurement of trypan blue quenching efficiency ........................................ 74 
3.3.4 Particle interaction with RAW 264.7 cells ............................................................ 74 
3.3.4.1 Qualitative determination of microparticle uptake .......................................... 74 
3.3.4.2 Intracellular localisation of Spheres, hexahedrons, and Pyramids ................. 77 
3.3.4.3 Comparison of image analysis and trypan blue (TB) quenching methods ..... 81 
3.3.4.4 Effect of LPS stimulation on particle uptake .................................................. 84 
3.3.4.5 Effect of particle shape on uptake by RAW 264.7 macrophages ................... 88 
3.4 Conclusions ............................................................................................................... 91 
4. Interaction of polysilicon microparticles with RAW 264.7 macrophages ........................... 92 
4.1 Introduction ................................................................................................................ 92 
4.1.1 Polysilicon and silicon microparticles ................................................................... 93 
4.2 Materials and Methods .............................................................................................. 97 
4.2.1 Materials ............................................................................................................. 97 
4.2.2 Methods .............................................................................................................. 97 
4.2.2.1 Fabrication and Scanning electron microscopy (SEM) characterisation of 
polysilicon particles .................................................................................................. 97 
x 
 
4.2.2.2 Labelling of polysilicon particles with AUTES and RBITC ............................. 98 
4.2.2.3 Label free detection of polysilicon particles by light scattering ...................... 99 
4.2.2.4 Quantification of polysilicon particle uptake by RAW 264.7 cells by flow 
cytometry .................................................................................................................. 99 
4.2.2.5 MTS, LDH and glucuronidase assays ......................................................... 102 
4.3 Results .................................................................................................................... 106 
4.3.1 Functionalisation of polysilicon particles with AUTES and RBITC ..................... 106 
4.3.2 Assessment of particle side scattering .............................................................. 109 
4.3.3 Polysilicon particle association with RAW 264.7 macrophages ......................... 112 
4.3.4 Effect of particle shape on metabolic activity, toxicity, and lysosomal enzyme release
 .................................................................................................................................. 121 
4.3.4.1 MTS assay ................................................................................................. 121 
4.3.4.2 LDH assay .................................................................................................. 124 
4.3.4.3 Release of lysosomal enzyme glucuronidase ............................................. 126 
4.4 Discussion ............................................................................................................... 129 
4.5 Conclusions ............................................................................................................. 133 
5. Effect of silicon oxide particle size and surface modification with zwitterion on interaction 
with macrophages ............................................................................................................. 135 
5.1 Introduction .............................................................................................................. 135 
5.2 Materials and Methods ............................................................................................ 138 
5.2.1 Materials ........................................................................................................... 138 
5.2.2 Methods ............................................................................................................ 138 
5.2.2.1 Modification of silicon oxide spheres with AUTES, RBITC, and MDSA ....... 138 
5.2.2.2 XPS characterisation of modified particles .................................................. 139 
xi 
 
5.2.2.3 Zeta potential measurements ..................................................................... 140 
5.2.2.4 Water contact angle measurements ........................................................... 140 
5.2.2.5 Acquisition of brightfield and fluorescent images ........................................ 140 
5.2.2.6 Quantitative uptake of silicon oxide spheres by RAW 264.7 cells ............... 141 
5.3 Results and Discussion ........................................................................................... 143 
5.3.1 Characterisation of modified silicon oxide particles ........................................... 143 
5.3.1.1 XPS characterisation .................................................................................. 143 
5.3.1.2 Zeta potential measurements ..................................................................... 147 
5.3.1.3 Water contact angle θ (°) measurements .................................................... 149 
5.3.1.4 Fluorescence of modified particles .............................................................. 151 
5.3.2 Uptake of silicon oxide particles by RAW 264.7 macrophages .......................... 153 
5.3.2.1 Effect of particle size on uptake .................................................................. 153 
5.3.2.2 Effect of zwitterion surface chemistry on particle uptake ............................. 163 
5.4 Conclusions ............................................................................................................. 170 
6. General discussion and Future work ............................................................................. 172 
7. References ................................................................................................................... 180 
Appendix I – Supporting information from chapter 3 .......................................................... 205 
Appendix II - Supporting information for chapter 4 ............................................................ 216 





List of figures  
Figure 1.1: Schematic representation of the different endocytic mechanisms ....................... 3 
Figure 1.2: Particle properties affecting cellular uptake ....................................................... 10 
Figure 1.3: Gold nanoparticles of different morphology ....................................................... 19 
Figure 1.4: Particles fabricated using soft templates ........................................................... 21 
Figure 1.5: Hollow silica particles fabricated using a hematite template .............................. 21 
Figure 1.6: The film stretching method ................................................................................ 24 
Figure 1.7: Photolithographic production of polysilicon particles .......................................... 24 
Figure 1.8: Porous silicon microparticles fabricated using photolithography ........................ 25 
Figure 1.9: Colloidal alphabet soup ..................................................................................... 27 
Figure 1.10: Particle replication in non-wetting templates (PRINT) ...................................... 28 
Figure 1.11: Schematic summarising key aspects of the project ......................................... 35 
Figure 3.1 SEM images of fabricated SiO2 microparticles ................................................... 55 
Figure 3.2: Images of surfaces after functionalisation using the step-by-step method ......... 58 
Figure 3.3: Effect of solvent on particle functionalisation ..................................................... 60 
Figure 3.4: Particle functionalisation using complexation in solution method ....................... 61 
Figure 3.5: Chemical structures of silanes ........................................................................... 63 
Figure 3.6: Fluorescence of covalently labelled particles ..................................................... 67 
Figure 3.7 images of particles before and after incubation in PBS 37°C for 2 hours ............ 70 
Figure 3.8: % reduction in fluorescence intensity after incubation in PBS at 37°C for 2 hours
 ........................................................................................................................................... 70 
Figure 3.9: Fluorescently labelled particles in suspension ................................................... 72 
Figure 3.10: CLSM images of RAW 264.7 cells with internalised microparticle shapes ....... 76 
Figure 3.11: Intracellular localisation of particles after phagocytosis. .................................. 80 
Figure 3.12: Comparison of image analysis and TB quenching methods for quantifying particle 
internalisation ...................................................................................................................... 83 
Figure 3.13: Light microscopy images of RAW 264.7 cells .................................................. 85 
xiii 
 
Figure 3.14: Effect of LPS stimulation on particle uptake .................................................... 87 
Figure 3.15: The effect of LPS stimulation on particle association, internalisation, and surface-
binding ................................................................................................................................ 88 
Figure 3.16: The effect of particle shape on cellular uptake ................................................ 89 
Figure 4.1: SEM images of the polysilicon particles used in this chapter ............................. 95 
Figure 4.2: Distinction between polysilicon particle-associated and unassociated cells using 
scattering intensity ............................................................................................................ 101 
Figure 4.3: Distinction between cells with internal particles and cells with external particles
 ......................................................................................................................................... 102 
Figure 4.4: Effect of AUTES deposition solvent on particle labelling with RBITC ............... 107 
Figure 4.5: Scattering intensity histograms of RAW 264.7 cells and each particle shape .. 110 
Figure 4.6: Summary of MSI values for RAW 264.7 cells and each particle shape ............ 112 
Figure 4.7: Side scattering intensity histograms of RAW 264.7 cells incubated with polysilicon 
particles ............................................................................................................................ 114 
Figure 4.8: Cell images from imaging flow cytometry across the range of scattering intensities 
for cells unassociated and associated with polysilicon particles ........................................ 115 
Figure 4.9: Cellular association, internalisation and surface binding of polysilicon particles with 
RAW 264.7 cells ............................................................................................................... 117 
Figure 4.10: Particle factors affecting cellular association, internalisation, and surface-binding
 ......................................................................................................................................... 119 
Figure 4.11: Effect of particle shape on number of internalised (A) and surface-bound (B) 
particles per cell. ............................................................................................................... 120 
Figure 4.12: Effect of increasing polysilicon particle dose on RAW 264.7 metabolic activity
 ......................................................................................................................................... 123 
Figure 4.13: Effect of increasing polysilicon particle dose on RAW 264.7 LDH release ..... 125 
Figure 4.14: Effect of increasing polysilicon particle dose on RAW 264.7 lysosomal 
glucuronidase release ....................................................................................................... 128 
xiv 
 
Figure 5.1: Widescan XPS spectra of silicon oxide particles with modified surface chemistry.
 ......................................................................................................................................... 146 
Figure 5.2: Zeta potential measurements of silicon oxide particles with different surface 
chemistry .......................................................................................................................... 148 
Figure 5.3: Water contact angle measurements of modified particles ................................ 151 
Figure 5.4: Representative brightfield and fluorescence images of silicon oxide particles . 152 
Figure 5.5: Effect of particle size on the percentage of cells with internalised particles ..... 154 
Figure 5.6: Effect of DPPC on the % of cells with internalised particles ............................. 158 
Figure 5.7: Effect of particle size on the number of internalised particles per cell that 
internalised particles ......................................................................................................... 160 
Figure 5.8: Effect of particle size on the % dose internalised ............................................. 162 
Figure 5.9: Effect of zwitterion surface chemistry on the % of cells with internalised particles.
 ......................................................................................................................................... 164 
Figure 5.10: Effect of zwitterion surface chemistry on the number of internalised particles per 
cell that internalised particles ............................................................................................ 167 
Figure 5.11: Effect of zwitterion surface chemistry on the % dose internalised .................. 169 
Figure S3.1: 1H NMR of 1-Octadecyl 1H Imidazole ........................................................... 205 
Figure S3.2: 1H NMR of 1.2Br ........................................................................................... 206 
Figure S3.3: Brightfield, fluorescence, and surface plots of surfaces washed with water instead 
of DMSO after imidazolium treatment in DMSO ................................................................ 206 
Figure S3.4: Fluorescence intensity histograms of RBITC labelled particles before and after 
trypan blue quenching ....................................................................................................... 207 
Figure S3.5: Calibration of particle labelling. ..................................................................... 208 
Figure S3.6: Effect of temperature on phagocytosis .......................................................... 209 
Figure S3.7: Gating of single cell population ..................................................................... 210 
Figure S3.8 Gating of in-focus cell population ................................................................... 211 
Figure S3.9: Gating of cells associated with particles ........................................................ 212 
Figure S3.10: Cell masks used to identify cells with internal and surface-bound particles . 213 
xv 
 
Figure S3.11: Histogram of internalisation score defining whether particles are internalised or 
surface-bound ................................................................................................................... 213 
Figure S3.12: Distinction between trypan blue stained and unstained cells ....................... 214 
Figure S3.13: Distinction between cells with surface-bound and internalised particles using 
the trypan blue quenching method .................................................................................... 215 
Figure S4.1: Cell images from imaging flow cytometry of cells with internal and external 
particles. ........................................................................................................................... 216 
Figure S5.1: High resolution XPS spectra of S peaks from MDSA modified particles ........ 218 





List of tables 
Table 3.1: Dimensions of fabricated Hexahedrons, Truncated pyramids, and Spheres ....... 55 
Table 3.2: Water contact angles θ (°) after treatment with PFP, GOPTS, APTMS, and AUTES
 ........................................................................................................................................... 65 
Table 3.3: Particle MFI and estimation of surface labelling .................................................. 73 
Table 3.4: Quenching efficiency of trypan blue .................................................................... 74 
Table 4.1: Particle shapes and their dimensions ................................................................. 96 
Table 5.1: Surface composition (Atomic %) of silicon oxide particles with modified surface 
chemistry .......................................................................................................................... 147 
Table 5.2: Summary of particle characteristics .................................................................. 152 





List of abbreviations 
 
AFM Atomic force microscopy 
APs   Assembly Proteins 
APTES  (3-aminopropyl) triethoxysilane 
APTMS  (3-aminopropyl)) trimethoxysilane 
ATP Adenosine triphosphate 
ATPP   5-(4-aminophenyl)-10,15,20-(triphenyl)porphyrin 
AUTES  (11-aminoundecyl) triethoxysilane 
CNM   Centro Nacional de Microelectrònica 
COPD   Chronic obstructive pulmonary disease 
CTAB   Cetyltrimethylammonium bromide 
DAPI   4’,6-diamidine-2’-phenylindole dihydrochloride 
DCM   Dichloromethane 
DMEM   Dulbecco’s Modified Eagle Medium 
DMSO   Dimethylsulfoxide 
DPI Dry powder inhaler 
DPPC Dipalmitoylphosphatidylcholine 
EBL   Electron beam lithography 
EtOH   Ethanol 
FBS   Foetal bovine serum 
FITC   fluorescein isothiocyanate 
GEEC   GPI-AP enriched early endosomal compartments 
GOPTS  (3-glycidoxypropyl)trimethoxysilane 
xviii 
 
GPI   Glycosylphosphatidyl inositol 
HBSS   Hank’s balanced salt solution 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HUVECs  Human umbilical vein endothelial cells 
ICP-AES  Inductively coupled plasma atomic emission spectroscopy 
ICP-MS  Inductively coupled mass spectrometry 
IFN   Interferon 
IgG   Immunoglobulin G 
IL   Interleukin 
LAMP   Lysosome associated membrane glycoprotein 
LDH   Lactate dehydrogenase 
LDL   Low-density lipoprotein 
LPS   Lipopolysaccharide  
LSCM   Laser scanning confocal microscopy 
MDSA N-(3-sulfopropyl)-N-methacroyloxyethyl-N,N-dimethylammonium 
betaine 
MFI   Median Fluorescence Intensity 
MMPs   Matric metalloproteinases 
MSI Median scattering intensity 
MTS 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium 
MUG   4-methyl umbelliferyl-β-D-glucuronide hydrate 
PAMPs  Pathogen-associated molecular patterns 
PBS   Phosphate buffered saline 
PCL   Polycaprolactone 
PDMS   Polydimethyl siloxane 
xix 
 
PEG   Poly(ethylene glycol) 
PES Phenazine ethosulphate 
PFP   10-(pentafluorophenoxycarbonyl)decyltrimethoxysilane 
PFPE   Perfluoropolyether 
PLGA   Poly(lactic-co-glycolic) acid 
PRINT   Particle replication in non-wetting templates 
PVA   Polyvinyl acetate 
PVP   Polyvinyl pyrollidone 
RBITC   Rhodamine B isothiocyanate 
RES   Reticuloendothelial system 
RILP   Rab interacting lysosomal protein 
RNS   Reactive nitrogen species 
ROS   Reactive oxygen species 
SAM   Self-assembled monolayer 
SEM   Scanning electron microscopy 
TB   Trypan blue 
TCPP   5,10,15,20-(tetra-4carboxyphenyl)porphyrin 
TEM   Transmission electron microscopy 
TEOS   Tetraethyl orthosilicate 
TLRs   Toll-like receptors 
TNF   Tumour necrosis factor  
TX-100  Triton X-100 
UFO   Unidentified flying object 
WGA   Wheat germ agglutinin 




1.1 Particulate carriers for drug delivery 
Nano and micro-particulate carriers of therapeutic molecules offer a number of advantages for 
the purposes of drug delivery. Over recent years the amount of research in this area has risen 
drastically, although there still remain many hurdles to increasing the number of approved 
pharmaceutical products 1. By using particulate drug delivery systems the effectiveness of 
medicines can be improved through improved drug solubility/stability, passive/active targeting, 
intracellular delivery, and controlled drug release 2. The range of delivery systems studied 
include micelles, dendrimers, liposomes, polymeric nano/microparticles, lipid nanoparticles, 
inorganic particles, crystalline particles, and hydrogels 3.   
The first major success story in this field was Doxil®, a pegylated liposomal formulation of 
doxorubicin used for the treatment of a number of cancers including Kaposi’s sarcoma, 
metastatic breast cancer, recurrent ovarian cancer, and multiple myeloma 4. By using a 
liposomal carrier with  prolonged circulation time, Doxil® achieves higher tumour accumulation 
due to passive accumulation and reduced side effects compared to free doxorubicin 5.   
Since then a number of particle formulations have come on to the market mainly for the 
treatment of cancer (Abraxane®, Onivyde®, Depocyt®, Daunoxome®, Eligard®) 6. However, 
other therapeutic areas include multiple sclerosis (Copaxone®), analgesia (DepoDur®), 
macular degeneration (Visudyne®), menopausal therapy (Estrasorb®), and infection (Abelcet®, 
AmBisome®)  6-11.  In the inhalation field, dry powder inhalers most commonly make use of 
microparticles with diameters between 0.5 and 5 μm, as these have been shown to be most 
effective at depositing deep into the lung 12. Techniques such as spray drying have made 
possible the control of particle size, density, porosity, and surface energy and have resulted 
in particles with increased drug loading and higher deposition for example, tobramycin 
pulmospheres™ for the treatment of pseudomonal infections 13.  
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Most recently, lipid nanoparticle formulations containing RNA have been developed as 
vaccines against COVID-19 14-15.  Here the lipid nanoparticle acts to increase efficiency of 
RNA uptake by cells after intramuscular delivery 14, 16.  
When administered particulate carriers come into contact with different cell types, they interact 
with the cellular membrane and can be internalised by endocytosis 17. A number of particle 
factors (size, charge, surface chemistry, hydrophobicity, shape) contribute to this interaction 
and ultimately, understanding of how each of these factors affect particle-cell interactions will 
lead to the design of more effective drug delivery systems. 
 
1.2 Particle entry to the cell: Endocytosis 
Endocytosis describes the mechanism of internalisation of part of the cells plasma membrane 
in order to form a distinct intracellular compartment. It is a key cellular process which underlies 
much of a cells regular function, for example by regulating the sensitivity of the cell to a specific 
ligand. When a ligand binds to its specific receptor on the plasma membrane, the receptor is 
endocytosed thereby limiting the cellular response to further stimulation by the ligand 18. 
Pathogens such as viruses can exploit routes of endocytosis in order to gain entry into cells 
and thereby replicate 19 and it is the goal of many researchers to deliver therapeutic 
nanoparticles via these same mechanisms. Endocytosis can occur through a number of 
distinct routes which are normally described by the specific proteins involved and can be 
subdivided into phagocytosis (occurring only in specialised cell types) and pinocytosis 
(occurring in all cells) (figure 1.1). Pinocytosis mechanisms are further subdivided to include 
macropinocytosis, clathrin mediated endocytosis, caveolin-mediated endocytosis, and 






Figure 1.1: Schematic representation of the different endocytic mechanisms from ref 21.   
 
1.2.1 Clathrin-mediated endocytosis 
Upon binding of certain receptors, for example low-density lipoprotein (LDL) and transferrin 
receptors 22-23, clustering of a number of receptors results in the formation of coated pits 24. 
The coated pits are formed by the assembly of clathrin, a triskelion shaped protein consisting 
of three heavy and three light chains, into polyhedral lattices 25. Clathrin assembly is mediated 
by assembly proteins (APs) particularly AP2, and the formation of the polyhedral coat provides 
the driving force required for membrane invagination 26. Subsequent recruitment of dynamin 
into helical rings that form a collar at the neck of the invaginated pit, promotes scission of the 
newly formed vesicle 27. It has also been suggested that the helical structure could act as a 
spring that pushes the newly formed vesicle towards the cytosol 28. After scission from the 
membrane, the chaperone protein HSC70 disrupts clathrin-clathrin interaction in the lattice 
and dephosphorylation of phosphatidylinositol (4,5) bisphosphonate cause depolymerisation 
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and subsequent disassembly of the clathrin coat 29. The vesicle can then fuse with other 
internalised uncoated vesicles or be trafficked towards early endosomal compartments 24.  
Clathrin-mediated endocytosis has been identified as a route of entry into the cell for a number 
of nanoparticles including PLGA 30, silica 31, and chitosan 32 particles. The internalisation 
pathway depends on particle properties such as size, surface chemistry, and charge 33-34. It 
has been shown that positively charged particles are more dependent on clathrin-mediated 
uptake than negatively charged particles 35, however, the internalization pathway also 
depends on cell type. Studies have shown an upper size limit for clathrin-mediated 
endocytosis to be ~ 200 nm 33 therefore it is important to consider this when designing targeted 
nanomedicines.  
 
1.2.2 Caveolae-mediated endocytosis 
Caveolae were first described as flask shaped invaginations in the cell membrane and later 
caveolins, membrane proteins that bind directly to cholesterol, 36 were identified as the protein 
surrounding these invaginations 37. Ligands that bind to folate receptors 38 as well as albumin 
39, and cholesterol 40 have been shown to trigger internalisation of caveolae and so 
modifications of nanoparticles with such ligands have been explored 41-43. The caveolae reside 
at the plasma membrane for extended periods of time 44, binding of ligands triggers tyrosine 
kinase dependent signalling cascades that culminate in the recruitment of dynamin and 
subsequent budding of vesicles away from the plasma membrane 45. After budding, transport 
is dependent on the type of ligand that is to be internalised, for example, the virus SV-40 is 
transported to the endoplasmic reticulum, where it resides until transport to the nucleus 46 
whereas caveolae are responsible for the transcytosis of proteins such as albumin 47. The 
avoidance of fusion with lysosomal compartments mean that internalised material avoids 
degradation, an attractive property for the delivery of sensitive therapeutics such as RNA.  
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Typically caveolae are 60-80 nm in diameter 48 however, internalisation of nanoparticles up to 
100 nm by caveolae-mediated endocytosis has been shown 49.  In comparison with clathrin-
mediated endocytosis, caveolia-mediated endocytosis is slow, however, it plays a much 
bigger role in transcytosis 50 and so is likely to be an important route for the transport of 
nanoparticles across biological barriers. Indeed, researchers have sought to make use of this 
to promote transport of nanoparticles across the blood-brain barrier 51.   
 
1.2.3 Clathrin- and caveolin-independent mechanisms of endocytosis 
Glycosylphosphatidyl inositol (GPI) linked proteins can also be internalised through pathways 
that are independent of clathrin and caveolin 52. One mechanism is cholesterol-dependent and 
gives rise to GPI-AP enriched early endosomal compartments (GEEC) 52. Activation of cdc42 
on the plasma membrane leads to actin polymerisation and the generation of endosomal 
invaginations in a dynamin independent manner 53. GEECs are acidic in nature and undergo 
fusion with sorting endosomes 54. Another such endocytic pathway is via flotillins, membrane 
associated proteins which are thought to have a number of functions including structural, 
sensing, and endocytic roles 55. Flotillins 1 and 2 form microdomains on the cytoplasmic side 
of the cell membrane 56 and have been shown to bud and are thought to be responsible for 
the internalisation of cholera toxin 57. The importance of these pathways as they pertain to 
nanoparticle delivery is not yet clear as there are no studies that point to them being major 
uptake pathways compared to clathrin and caveolin dependent mechanisms 17.  
 
1.2.4 Macropinocytosis  
Macropinocytosis is a process, stimulated by growth factor activation of receptor tyrosine 
kinases, which leads to the engulfment of fluid into inhomogeneous vacuoles with sizes 
between 0.5 and 10 μm known as macropinosomes 58. Actin drives the extension of the 
plasma membrane as membrane ruffles, which form a cup-like structure that subsequently 
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seals forming a nascent macropinosome 59. After internalisation, the macropinosome interacts 
with the endosomal pathway, eventually fusing with lysosomes to form an acidic 
macropinolysosome 59. Nano- and microparticles that are in close proximity to the cell can 
therefore be taken up by this non-specific mechanism, and because macropinocytosis takes 
place in almost all cell types, it therefore represents a common pathway for nano and 
microparticle internalisation 60. In addition, the rate of macropinocytosis is known to be higher 
in immune and cancer cells and so this pathway is of particular interest in vaccines and cancer 
therapy 60.  
 
1.2.5 Phagocytosis 
Phagocytosis is a process for internalising larger (diameter >500nm) particles and only takes 
place in specialised cells such as macrophages, neutrophils, monocytes, osteoclasts, 
eosinophils, and dendritic cells 61. These cells are responsible for the removal of pathogens, 
foreign particles, and cellular debris as part of the immune response. The process of 
phagocytosis can be considered to take place in three main stages; particle recognition, 
particle internalisation, and phagosome maturation 62.  
Particle recognition 
On the surface of phagocytic cells exist a diverse array of receptors to enable the recognition 
and binding of foreign particles. Pattern recognition receptors bind pathogen-associated 
molecular patterns (PAMPs) located on the surface of pathogens, for example bacterial and 
fungal particles, and are also involved in binding unopsonized particles 63. These include 
Scavenger receptors (A and B-type) 64, and lectins, including mannose and dectin receptors 
65-66. On the other hand, opsonic receptors such as Fc receptors 67 and complement receptors 
68 bind particles that have been exposed to opsonins (immunoglobulins and complement 
components respectively) which adsorb onto the particles, enabling their recognition by 
macrophages 69. Additionally, in response to external stimuli, for example binding of LPS to 
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toll-like receptor 4 (TLR4), expression of certain receptors 70 and their affinity towards specific 
ligands 71 is increased thus modulating the macrophage response to different particle types.  
Particle internalisation 
Particle binding to each receptor type triggers signal transduction pathways unique to the type 
of receptor bound. Fc and complement receptor signalling pathways have been well studied 
whereas the exact mechanisms of scavenger receptor-mediated phagocytosis have not yet 
been fully elucidated due to their structural heterogeneity and functional overlap 72.  
Upon binding of Fc receptors by a particle opsonised with IgG, tyrosine residues present on 
the cytoplasmic Fc receptor domains, are phosphorylated by tyrosine kinases which are then 
able to act as a docking site for the tyrosine kinase SYK 73. SYK phosphorylation drives the 
activation of LAT and Gab2, which triggers secondary messengers such as phospholipase C 
to activate protein kinase C triggering calcium release and VAV activation of Rho, RAC, and 
Cdc42 GTPases. These drive actin polymerisation via WASP and Scar activation of the actin 
nucleation ARP2/3 complex 73. Actin polymerisation causes the extension of pseudopods 
surrounding the particle as a cup.  
Unlike in the case of Fc receptor mediated phagocytosis, complement receptor mediated 
phagocytosis does not require tyrosine kinases 74. It has been suggested that the formation of 
pseudopodia surrounding the particle does not occur, instead, the particle appears to sink into 
the cell membrane 75. However, this is disputed, as other studies have reported an 
internalisation mechanism involving membrane ruffles 76. Upon receptor binding, Rho is 
activated through an as yet undefined mechanism, which leads to Rho kinase and mDia1 
activation and actin polymerisation via the Arp2/3 complex 77. mDia1 also interacts with CLIP-
170 which binds directly to the microtubule cytoskeleton 78. Complement receptor mediated 
phagocytosis therefore proceeds through a cooperation of both actin and microtubules.   
The process of sealing the phagocytic cup is less well understood but is known to involve PI3-
kinase. When PI3-kinase inhibitors are used, the extension of pseudopods surrounding the 
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particle proceeds but phagosome closure is inhibited 79.  Myosin IC has also been implicated 
in the constriction of the cup in a purse-string-like mechanism that pulls the particle towards 
the cell 80. Recently, it has been demonstrated that dynamin 2 plays a role in the scission of 
the nascent phagosome from the plasma membrane 81.  
Phagosome maturation 
The process of phagosome maturation describes the alteration of the phagosomal membrane 
and contents towards a phagolysosome which contains an environment designed to 
breakdown internalised particles. In early phagosome formation, Rab5 promotes fusion of the 
phagosome with early endosomes, which slightly lowers the luminal pH to 6.1-6.5 82. At the 
same time recycling of the phagosomal membrane to the plasma membrane and trans-golgi 
network occurs, so the size of the phagosome remains unaltered. This process continues to 
occur throughout the maturation process 83. Accumulation of Rab 7 promotes late phagosome 
formation by recruitment of Rab interacting lysosomal protein (RILP) which mediates 
centripetal movement of the phagosome to bring it in contact with SNARE proteins such as 
VAMP 7/8 which promote fusion with endosomes and lysosomes 84. During this stage the pH 
of the lumen is further decreased to pH 5.5-6 due to V-ATPases which, coupled with the 
presence of newly acquired proteases, increases the degradative capacity of the late 
phagosome 85. Fusion of lysosomes with the late phagosomes marks the final stage of the 
process by formation of the phagolysosome. LAMP proteins are now present in the membrane 
and the environment inside the lumen is optimal for the breakdown of internalised protein, in 
particular by cathepsins 86. Reactive oxygen species (ROS) are generated by NADPH-oxidase 
through generation of O2- which can undergo dismutation to H2O2 which in turn can generate 
hydroxyl radicals and singlet oxygen 87. Similarly, reactive nitrogen species (RNS) such as NO  
are generated by nitric oxide synthase and are further converted to species such as NO2, 
ONOO-, N2O3, and HNO 88. These highly toxic species serve the purpose of destroying 




1.2.6 Measures of particle uptake 
 
There are a number of methods that have been used in the literature to determine particle 
uptake by cells including qualitative and qualitative methods, these are discussed in detail in 
chapter 3. Particle internalisation is expressed in different ways depending on the method 
used, for example when using flow cytometry, often the percentage of cells which are above 
a certain fluorescence threshold is reported 89. On the other hand, the amount of material 
internalised per cell (mass, number of particles etc.) has been determined using methods such 
as inductively coupled plasma mass spectrometry (ICP-MS) 90. Alternatively, the amount of 
particles not taken up by cells has been used to infer particle uptake 91. Each is a valid measure 
of uptake, however, the measure used should be taken into consideration when comparing 
the results of different studies, as this can affect the interpretation of results. It is also important 
to ensure that particles that are attached to the cell surface, but not internalised are 
distinguished from those that have been internalised. This may require extensive washing or 
trypsinisation to remove the adhered particles, or alternatively quenching of extracellular 
fluorescence 92. This is not always carried out and so what is reported is cellular association 




1.3 Particle properties affecting cellular uptake  
Properties of particles that have been shown to affect cellular uptake include particle size, 
shape, surface chemistry, charge, and mechanical properties (figure 1.2). Development of the 
research in this area provides opportunities to rationally design drug delivery systems based 
on the desired therapeutic outcome. This section reviews studies investigating the effects of 
particle properties on cellular uptake.  
 
 
Figure 1.2: Particle properties affecting cellular uptake. Schematic representation depicting modifications that can 
be made to particulate delivery systems in order to modulate cellular uptake from ref 93 
 
1.3.1 The effect of particle size on cellular uptake 
A number of studies have specifically investigated the effects of modulating the size of 
nano/microparticles on cellular internalisation. Wang et al. studied the uptake of gold 
nanoparticles (diameters 13, 45, 70, 110 nm) into CL1-0 (a lung cancer cell line) and HeLa 
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cells 94. In both cell lines they found that 45 nm particles were internalised to the greatest 
extent. Differences in internalisation between different sized particles were explained by 
consideration of a) binding energy between ligands and receptors and b) thermodynamic 
driving force of membrane wrapping. For nanoparticles <40 nm in diameter, binding of a single 
particle does not produce sufficient free energy to trigger internalisation and so particles below 
this size enter cells only when clustered together, this reduces their uptake compared to 
particles >50 nm in diameter 94.  For larger particles, >80 nm in diameter, endocytosis occurred 
rarely. This was attributed to the depletion of free receptors limiting the ligand-receptor binding 
energy and resulting in partial wrapping of the particles 94. In a study by Lu et al. the uptake of 
mesoporous silica nanoparticles (diameters 30, 50, 110, 170, 280 nm) by HeLa cells was 
assessed 95. In agreement with Wang et al. it was demonstrated that nanoparticles of 50nm 
diameter had the highest internalisation. Other studies by Osaki et al. (glycosylated quantum 
dots in HeLa cells) 96, Jiang et al. 97 (gold nanoparticles in SK-BR-3 cells), and Chithrani et al. 
(gold nanoparticles in HeLa cells)  98 also concurred that 50 nm particles are taken up most 
efficiently by cells.  
In contrast to the above, Xu et al. demonstrated that, in Caco-2 and HT-29 cell lines, particles 
of diameter 100 nm were taken up to the greatest extent 99. Kulkarni and Feng also showed 
that 100 nm particles were taken up most by Caco-2 and MDCK cells 100. It is possible that the 
optimum particle size for uptake is cell-line dependent and so this factor should be taken into 
consideration when considering particle size modulation for a particular application. 
He et al. measured the uptake of different sized polymeric nanoparticles across a range of 
different cell lines including LO2 (hepatocyte), HEK-293 (kidney), 786-O (kidney), HFL-1 (lung 
fibroblast), A549 (lung epithelial), SMMC-7721 (hepatocarcinoma) as well as freshly harvested 
murine macrophages 101.  It was shown that larger particles (300 and 500 nm) were taken up 
by the murine macrophages to a greater extent than smaller (150 nm) particles, however in 
the non-phagocytic cell lines the opposite was the case, with smaller particles being taken up 
more than larger particles. This suggests that, as a result of their specialised capacity for 
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engulfing particles, the optimum particle size for internalisation into macrophages may be 
different from other cell types. This is potentially useful for drug delivery because often it is 
desirable for an administered particle to avoid macrophage clearance while having enhanced 
uptake into the desired cell type.  
On the other hand, in a study by dos Santos et al. which compared the effect of polystyrene 
particle size on cellular uptake in cell lines including HeLa (epithelial), A549 (lung epithelial), 
1321N1 (brain astrocytoma), HCMEC D3 (brain endothelial), and RAW 264.7 (macrophage) 
cell lines, it was shown that, although differences in the amount of particles taken up by cells 
did arise, (in the order RAW 264.7 > HCMEC D3 > 1321N1 > A549 > Hela) the optimum 
particle size for maximum uptake was the same in all cell lines (40 nm) 102.  
A number of studies comparing effect of particle size on internalisation into macrophages have 
demonstrated that the optimum particle size for phagocytosis is 1-2 μm 103-107. In one such 
study, an important distinction is made between the number of particles and the total volume 
of particles ingested per cell 107. Although there was a higher number of 430 nm particles 
internalised than 1.9 μm particles, the total volume of particles inside the cells was higher for 
the larger particles which equates to a higher intracellular dose in the context of drug delivery. 
As discussed earlier, the endocytic pathways have varying size limits, so larger particles will 
be able to make use of fewer endocytic pathways. For example, in cells without phagocytic 
capacity, the only mechanism through which micron-sized particles may enter the cell is by 
macropinocytosis, whereas 50 nm particles can make use of each of the clathrin/caveolin-
dependent and independent mechanisms.  
 
1.3.2 The effect of particle hydrophobicity on particle uptake  
Another factor shown to modulate particle uptake is hydrophobicity. Tabata and Ikada 
investigated the effect of hydrocarbon chain length on the uptake of cellulose microspheres 
on uptake by mouse peritoneal macrophages 108. It was shown that the number of particles 
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taken up per cell was increased with increasing chain length up to a maximum of 8 carbons. 
Increasing the chain length further resulted in a decrease of particle uptake. The contact angle 
of particles with maximum uptake was 50-60°.  
In a similar study by Lorenz et al. the effect of hydrophobicity on the uptake of 
poly(methacrylate) nanoparticles by HeLa, Jurkat, Kg1A, and mesenchymal stem cells was 
examined 109. In all cell lines, particle uptake increased with increasing hydrophobicity.  
Studies generally indicate that more hydrophobic particles tend to elicit higher uptake by cells, 
although the reason for this is not clear. Hydrophilic polymers have commonly been used in 
order to decrease particle uptake 110 and so it may be that hydrophobic particles display 
enhanced interaction with the lipophilic cell membrane. Alternatively, it has been suggested 
that hydrophobic particles alter the composition of the protein corona, resulting in increased 
uptake 111. The effect of protein corona is discussed in section 1.3.5.   
 
1.3.3 The effect of particle surface charge on particle uptake 
It is difficult to study the effect of particle surface charge in isolation owing to the fact that 
surface chemistry also plays a role in particle uptake, and this must be modified to alter the 
surface charge. Nonetheless, by studying particle uptake across a range of particle types and 
surface chemistries, the effect of surface charge on uptake has been elucidated.  
He et al. studied the uptake of chitosan-based nanoparticles with zeta potential values 
between -40 and +35 mV by murine macrophages 101. It was shown that regardless of the sign 
of the charge, a higher magnitude of the zeta potential increased particle uptake. Additionally, 
positively charged particles appeared to be taken up by a higher percentage of cells than 
negatively charged particles.  
Gratton et al. compared the internalization of 1μm microparticles with amines on the particle 
surface (ζ potential = +23 mV) against the same particles after blocking the amines with acetic 
anhydride (ζ potential = -19 mV) 112. In each of the cell lines tested (HeLa, 3T3, OVCAR-3, 
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MCF-7, RAW 264.7) microparticles with positive zeta potential were internalised by a higher 
percentage of cells with the exception of RAW 264.7 cells.  
The majority of studies have shown that positively charged particles are internalised by cells 
favourably compared to negatively charged particles 35, 113-115. On the other hand, some studies 
have shown the opposite effect 116. It has been suggested that positively charged particles 
associated with cells to a higher extent, due to their electrostatic interaction with the negatively 
charged cell membrane. However, as pointed out by Forest et al., this fails to take into account 
the protein corona and its effects on the biological identity of the particle and how this affects 
uptake 117.  
 
1.3.4 The effect of particle surface chemistry on cellular uptake  
The effect of particle surface chemistry has been studied with a particular focus on enhancing 
particle uptake through the use of targeting ligands. The range of targeting ligands is diverse 
and includes small molecules (e.g. folic acid 118, biotin 119, mannose 120, sialic acid 121), proteins 
and peptides (e.g. concanavalin A 122, wheat germ agglutinin 123, RGD peptides 124,  transferrin 
125, endothelial growth factor 126) and antibodies (e.g. Herceptin 127, rituximab 128). On the other 
hand there is also a need to avoid uptake and subsequent clearance of particles by the 
reticuloendothelial system (RES) 129. Few surface chemistries have been identified that are 
able to achieve this goal, however poly(ethylene glycol) (PEG) coatings have been used 
extensively for this purpose 130. Other stealth chemistries that have been studied include 
poly(oxazolines) 131, betaines 132, and polyglycerols 133. A delicate balance of targeting and 
stealth properties must be struck in order to actively target the site of action and prolong 
residence time simultaneously 134. One way in which this problem has been addressed is by 
attaching PEG by a linker which degrades in response to a stimulus at the site of action. The 
active targeting groups can then be exposed in order to enhance particle uptake by the desired 
cells. Guo et al. have employed this strategy in the case of tumours that over express matrix 
metalloproteinases (MMPs) 135.  
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1.3.5 Protein corona formation on nano and microparticles 
When nano and microparticles are exposed to biological fluids, adsorption of proteins takes 
place, resulting in the formation of the so-called protein corona 136. The particle is surrounded 
by a tightly bound layer of adsorbed proteins referred to as the hard corona, which in turn is 
surrounded by a more loosely bound layer of proteins referred to as the soft corona 137. 
Exchange of adsorbed proteins takes place between the protein corona and the biological 
milieu. The identity of the proteins that adsorb on to the surface of the particle is dependent 
on particle properties  such as size, surface chemistry, hydrophilicity, and charge, and the 
composition of the biological medium 138. Upon initial immersion in biological fluids, more 
abundant proteins adsorb first, these are later exchanged with proteins that have more affinity 
to the particle surface 139.  
Recently, there has been much interest in the relationship between how particle properties 
determine the make-up of the protein corona and how the resulting protein corona affects 
particle-cell interactions.  
Tenzer et al studied the effect of surface chemistry modifications on protein adsorption using 
silica nanoparticles with carboxylic acid or amine groups on their surface 140. It was found that, 
as the incubation time of the particles in human plasma increased, the profiles of protein 
corona changed depending on the surface chemistry. The same result was observed when 
comparing bare silica and polystyrene nanoparticles. Silica particles displayed an abundance 
of apolipoprotein E and A-I which have been associated with enhanced particle uptake into 
cells 141-142.  Curiously, negatively charged proteins represented the majority of bound proteins 
to all particle types irrespective of particle type and surface charge. This indicates that overall 
protein charge may be less important than the interaction of individual binding domains within 
the protein structure for corona formation 140.  
In another such study, Ashby et al. utilized iron oxide nanoparticles with surface modifications 
of increasing hydrophobicity to study the impact on corona constituents 143. It was shown that 
the profile of adsorbing proteins changed with varying surface hydrophobicity and moreover, 
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a wider variety of proteins adsorbed on to more hydrophobic particles. Proteins with more 
hydrophobic binding domains were found to bind hydrophobic particles more favourably. The 
effect of particle size was also examined with larger particles (25 nm) adsorbing higher 
quantities of protein due to their higher surface area and displaying a different protein profile 
to smaller particles (15 nm) of the same surface chemistry. 
However, another important consideration is the ability of the nanoparticle surface to denature 
the protein structure upon binding, resulting in a loss of functionality. The effect of gold 
nanoparticle surface charge on cytochrome C structure has been studied 144. It was found that 
particles with a neutral surface charge did not have any significant effect on protein structure. 
However, when adsorbed onto positively and negatively charged particles, changes in protein 
structure took place. In the case of positively charged particles, the change in protein structure 
was significant enough to result in a loss of redox activity.  
The orientation of the protein is also a factor in determining its functionality when adsorbed on 
to the particles surface. Wang et al. studied the orientation of transferrin when adsorbing onto 
gold nanoparticles modified with surface ligands of different chirality 145. The binding of 
transferrin to the transferrin receptor was then shown to be dependent on its orientation. This 
is therefore a key consideration when designing nano/microparticles with targeting ligands, it 
is not simply enough to display the ligand on the particle surface, but it must also present to 
the receptor in the correct manner. In a study by Jain et al. the orientation and conformation 
of cytochrome C on the surface of gold nanoparticles was modulated by controlling the 
underlying surface chemistry 146. This affected the apoptosis inducing capability of the particles 
by altering the availability of the heme ring to interact with apoptosis initiating protein (APAF-
1).  
It is thought that the mechanism through which PEGylation of nanoparticles extends their 
residence time in the body, is by the reducing the formation of the protein corona which 
reduces interaction with immune cells 147. It is not the total prevention of corona formation, but 
the prevention of binding of certain proteins that promote particle uptake 148. Recently, 
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zwitterionic coatings have been explored for their similar ability to reduce protein adsorption 
and thus offer an alternative coating to pegylation 149-150.  
 
1.4 Particle shape  
The advent of novel methods for fabricating particles of various morphologies has resulted in 
increased interest in assessing the impact of particle shape on cellular interactions. The 
majority of studies assessing the effect of particle shape have utilised particles with nano-
sized dimensions owing to their potential use in systemic drug delivery as opposed to micron 
sized particles which tend to be cleared faster from the body 151. Below, methods for 
manufacturing nano and microparticles as well as studies on the effect nanoparticle and 
microparticle shapes on cellular uptake are discussed. 
 
1.4.1 Methods for making nano and microparticles of different shapes 
There are a wide variety of methods for fabricating nano and microparticles of different shape. 
These can broadly be divided into bottom-up methods whereby the starting material is on the 
atomic length scale and is then built up until they are of nano/microscale dimensions and top-
down methods whereby bulk material is reduced in size until it is of nano/microscale 
dimensions 152. Both methods have their own advantages and disadvantages for example 
bottom-up approaches are often more easily scaled up, however they can lack the precision 
in terms of polydispersity of top-down approaches. On the other hand, top-down approaches 
tend to lose this precision when nanometre-sized (<100 nm) features are required 152.  In the 
following sections an overview is given of some of the methods used to make nano and 




1.4.1.1 Bottom-up methods 
Synthesis of Gold and Silver nanoparticles 
The synthesis of spherical gold nanoparticles occurs via a seed-mediated growth mechanism. 
Typically a solution of chloroauric acid (HAuCl4) is mixed with a reducing agent such as sodium 
citrate or sodium borohydride which converts the gold from an oxidation state of +3 to 0 (atomic 
gold) 153. The aggregation of gold atoms causes the formation of the initial seeds (~1.5nm) 
and subsequent reaction with AuCl3 causes the growth of seeds into larger nanoparticles (10-
200nm) 153. For synthesis of citrate stabilised nanoparticles (known as the Turkevich 
synthesis) the final size of the gold nanoparticles can be determined by the ratio of gold to 
citrate 154.  In this case the citric acid acts as both a reducing agent and a stabilising agent 
preventing aggregation of the nanoparticles 155. In a method devised by Brust et al, a two-
phase system is used whereby sodium borohydride is used as the reducing agent, 
tetraoctylammonium bromide as a phase transfer agent, and dodecanethiol as a stabilising 
agent 156.  This method allows for the production of highly stable nanoparticles (1-5nm) which 
can be further functionalised for the desired application.  
The synthesis of different shaped gold nanoparticles makes use of the same seed-mediated 
growth mechanism as spherical particles, however after the initial growth of the gold seeds 
different reducing agents and surfactants are added to direct the growth of the nanoparticles 
towards the desired shape 157. In particular, the addition of silver nitrate along with surfactants 
to the gold seeds has been shown to aid in the growth of anisotropic particles. It is thought 
that different amounts of deposition of silver ions onto the different facets of the gold seed 
crystal helps to slow/inhibit crystal growth along facets with higher coating thus resulting in 
anisotropic particles 157.  
Lui and Guyott-Sionnest demonstrated that by the addition of cetyltrimethylammonium 
bromide (CTAB), silver nitrate, and L-ascorbic acid to gold seeds it was possible to form highly 
uniform populations of nano rods or bipyramidal particles depending on whether the seeds 
were synthesised using CTAB or sodium citrate 158. By maintaining the same concentration of 
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silver nitrate and varying the concentration of gold seeds the aspect ratio of the gold nanorods 
can be controlled. Using a similar procedure Sau and Murphy were able to synthesise gold 
cubes, hexagons, triangles, tetrapods and stars by changing the ratio of reactants, some of 
these are shown in figure 1.3 159. It is important to note that due to the use of surfactants during 
nanoparticle synthesis, the surface chemistry of the different particles produced using these 
methods is likely to be different and so this should be considered when comparing different 




Figure 1.3: Gold nanoparticles of different morphology. TEM images of A) mixture of rods, hexagons and triangles 
B) hexagonal particles, C) Cubes, D) Triangles. Adapted from reference 159, Scale bars = 100 nm 
 
In the case of silver nanoparticles, the formation of nanoparticles of different morphology can 
be achieved using similar methods to those described above 160. Another common method 
(which can also be used to form gold nanoparticles of different morphology) is the so called 
polyol method 161. In this method ethylene glycol or similar compounds are used as the 
20 
 
reducing agent and solvent for silver nitrate and a polymer such as poly(vinyl pyrollidone) is 
used as a stabiliser. Shape control is brought about by deposition of the stabiliser on different 
facets of the seed crystal which can be altered by the addition of various ions 162. In particular, 
sulphide ions have proven to enhance the reduction of silver nitrate ions and has been used 
to aid in scaling up the process 163. Due to the high dependence of crystal shape on the ions 
present in the reaction mixture, it is very important to use starting materials of high purity. 
Similarly to gold, silver nanoparticles of myriad different shapes including rods, cubes, wires, 
bars, pyramids, prisms, as well as branched structures have been synthesised 164-170.  
 
 
Synthesis of silicon oxide nanoparticles  
The most common method for making spherical silicon oxide nanoparticles is the Stöber 
method 171. The process involves the hydrolysis and condensation of alkoxysilicate precursors 
such as tetraethyl orthosilicate (TEOS) in alcohol/water solutions under different conditions 
171. As the condensation reaction proceeds Si-O-Si bonds are formed and this results in the 
formation of silicon oxide nanoparticles. Depending on the pH of the solution the particles will 
aggregate into a gel-like network (low pH) or remain as dispersed nano/microparticles (high 
pH) 172. High pH reaction mixtures are obtained by the addition of ammonia (NH3) and by 
varying the concentration of NH3 and other parameters such as temperature and rate of 
reactant addition, it is possible to control the size of the particles 173.  
By the addition of surfactants such as cetrimonium bromide into the Stöber process it is 
possible to synthesise silica nanoparticles that possess pores that are of tailorable size 
(between 2 and 50nm) and are thus termed mesoporous silica particles 174.  During this 
process the surfactant acts as a micellar template and is subsequently removed from the 
particles by heating at high temperatures (>500°C) 175. This surfactant template method can 
be used to make rod-shaped silica nanoparticles and can be thought of as a soft-template 
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method 176. Other soft templates used, include bacteria, viruses, and lipid nanotubes 177-179. 
Figure 1.4 shows particles that have been fabricated using biological soft templates.  
 
Figure 1.4: Particles fabricated using soft templates. SEM images of  g) Cocci templated particles h) E.Coli 
templated particles i) Mildew fungus templated particles. Adapted from reference 178 
 
In contrast to soft templates are hard template methods where a silica shell is grown onto an 
pre-fabricated solid nanoparticle of the desired morphology, thereafter the template can then 
be removed by means such as selective etching, resulting in hollow silica particles 180. 
Alternatively, the template particle can remain at the core of the silica particle and thus, 
depending on the core material, the particle will have added properties for example magnetism 
in the case of an iron core 181. Hard template methods have employed starting materials such 
as calcium carbonate, aluminium oxide, gold, and haematite 182-185. Therefore, the particle 
morphologies that can be made using this method are those of the template particles including 
silica rods, cubes, ellipsoids, sheets, octahedrons and dodecahedrons 186-190. Figure 1.5 
shows hollow silica particles fabricated using a hematite template that was subsequently 
removed.  
 
Figure 1.5: Hollow silica particles fabricated using a hematite template. TEM images of c) pseudocubes g) ellipsoids 




Curiously, nature has its own way to make silica nano/microparticles with incredibly diverse 
morphology in the form of diatoms, single-celled algae existing in the oceans and waterways 
that possess a cell wall made of silica 191. Diatoms themselves have been used as the template 
for nanoparticle synthesis and for drug delivery applications 192-194. 
 
Synthesis of polymeric nanoparticles  
Polymeric nanoparticles represent a promising avenue for developing novel therapeutics and 
as such have been the focus of many researchers. Resulting from this are numerous methods 
of polymer nanoparticle synthesis including solvent evaporation, nanoprecipitation, 
emulsification, salting out, dialysis, and spray drying 195-200. 
These methods utilise either natural polymers such as chitosan, gelatin, or alginate or 
synthetic polymers such as poly(lactide co-glycolic acid) (PLGA), poly(ethylene glycol) (PEG) 
and combinations thereof 201-204.  By using block co-polymers with opposing polarities and 
different block lengths it is possible to obtain polymers that self-assemble into nanoparticles 
of different shapes 205. Shapes such as rods (of varying length), vesicles, discs and toroids 
have been prepared by self-assembly 206-208. Self-assembly of polymeric particles tends to 
result in less uniform particle populations than the inorganic methods detailed above. 
Additionally, due to their structure being inherently dependent on their environment, the 
particles shape may be less stable and can change depending upon the conditions. As a tool 
for drug delivery, this property could be advantageous, for example shape-switching particles 





1.4.1.2 Top-down methods 
Film-stretching method 
Originally developed by Nagy and Keller, the film stretching method utilises pre-fabricated 
polymer spheres which are deposited onto a heated PVA film and stretched 210. Polystyrene 
latex spheres were stretched in this way resulting in a uniform population of ellipsoidal 
microparticles 211. The group of Mitragotri developed this method further by stretching in 
different directions and by altering the heating/stretching sequence to produce microparticles 
shaped like barrels, bullets, pills, pulleys, ribbons and disks (figure 1.6) 212.  Other polymers 
such as PLGA and polycaprolactone (PCL) have been applied to this method with the 
advantages of being biodegradable and that drugs/fluorophores can be encapsulated into the 
particles during the initial synthesis steps 213. As with polymeric particles synthesised using 
bottom-up methods, the stimuli responsive properties of polymers have been utilised to 




Figure 1.6: The film stretching method. Left: the film stretching method adapted from 211. Right: SEM images of 
polystyrene particles fabricated by stretching a) barrels b) bullets c) pills d) pulleys e) biconvex lenses adapted 
from reference 212 
 
Photolithography 
Originally developed for use in the microelectronics industry, photolithography enables the 
patterning of micro/nanoscale topographies on to silicon wafers 214. Computing power is limited 
by the number of transistors that can fit onto a single chip and over the past 50 years this 
number has doubled every two years following Moore’s law 215. This has been enabled by the 
advancement in photolithographic techniques that have allowed smaller and smaller features 
to be patterned on to silicon wafers. The technique works by deposition of layers of materials 
for example gold, copper or silicon oxide onto the silicon wafer and subsequent patterning 
using a photomask and photoresist (figure 1.7). Through selective etching processes, 
unwanted elements are removed and the final wafer possesses the micro/nanoscale pattern 
on its surface. 
 
 
Figure 1.7: Photolithographic production of polysilicon particles a) Silicon wafer b) thermal growth of a sacrificial 
oxide layer c) deposition of a polysilicon device layer d) spin coating of wafer with photomask e) photolithographic 
step f) etching of device layer g) removal of photomask h) removal of sacrificial oxide layer i) particles are released 





In order to fabricate particles using this technique, a sacrificial material layer which is present 
beneath the particle pattern can be etched away to release the particles from the wafer 217. 
Control of particle shape in the X- and Y- dimensions is achieved by design of the photomask 
made by electron beam lithography (EBL) with feature sizes which can be in the range of 50-
100 nm depending on the wavelength of light and photomask material required during the 
patterning process 218. In the Z-dimension there is no direct control of shape in this way and 
so particles typically have flat top and bottom surfaces, however thickness of the particles can 
be controlled by controlling the thickness of the deposited material layer 219. There are 
however, exceptions to this as shown by the group of Ferrari who fabricated bowl-shaped 
porous silicon microparticles with tailorable pore size by using a series of chemical etchings 
to form a hemispherical shape (figure 1.8) 220. 
 
 
Figure 1.8: Porous silicon microparticles fabricated using photolithography: SEM images of a) bowl-shaped 





The group of Jose A. Plaza have fabricated polycrystalline silicon “barcode” particles whereby 
the morphology of each particle is coded for use in single-cell tracking 221. Additionally the 
same group fabricated silicon oxide microparticles of varying aspect ratios and branching 
structures 222.  
Precise control over morphology, resulting in uniform particle populations, is an attractive 
feature of this technique from a drug delivery perspective, moreover this technique is scalable. 
However, there are a few limitations to consider. Firstly, the lowest size of the particles that 
can be produced using this technique is somewhat larger (typically on the order of a few 
microns) than those produced by bottom up methods which could limit the potential 
applications. Secondly, the type of materials used are predominately silicon based (silicon, 
silicon oxide, silicon nitride) the biocompatibility of which requires thorough assessment 223. 
Additionally, due to the specialised nature of this technique and the need for a clean room 
facility, this technique is not widely available.  
 
Soft lithography 
In order to circumnavigate some of the issues pertaining to hard lithography, lithographic 
methods utilising soft materials such as polymers and hydrogels have been developed. By 
using the same layer by layer deposition and photomask patterning methods, soft particles of 
various morphologies have been produced. Patterning can be achieved either by direct 
patterning of the soft substrate, or by the fabrication of a template using hard lithography and 
subsequent formation of particles by moulding also known as nanoimprint lithography. Li et al. 
used direct patterning of polyvinyl pyrollidone (PVP) cross-linked with PEG triacrylate to 
produce microparticles (<10 μm) of different shapes and sizes incorporating fluorescent 
dextrans 224. It was demonstrated that particles could be fabricated comprising multiple 
polymer layers each incorporating a different fluorescent dextran. Using a similar method 
Hahgooie et al. fabricated disks, rings, crosses and s-shaped particles all less than 10 μm in 
size  225. The diversity of shapes that can be produced is exemplified in a paper by Hernandez 
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and Mason who fabricated what they termed “colloidal alphabet soup” comprising 
microparticles ~5 μm in size in the shape of the letters of the alphabet (figure 1.9) 226. 
 
Figure 1.9: Colloidal alphabet soup: SEM images of a) Letters of the alphabet b) square doughnuts c) crosses d) 
triangular prisms e) pentagonal prisms. Scale bars = 3μm. Adapted from  ref 226. 
 
Nanoimprint lithography can be considered as a more scalable alternative to direct 
photolithography owing to the fact that many polymer moulds can be fabricated from a single 
template. One problem is that the technique often results in particles that are stuck together 
via a residual layer which can be difficult to remove fully 227. The group of DeSimone overcame 
this challenge in a methodology they term particle-replication in non-wetting templates 
(PRINT) (figure 1.10) 228. By using a non-wetting perfluoropolyether (PFPE) as the material for 
the mould, an increase in the achieved printing resolution was demonstrated in comparison to 
polydimethyl siloxane (PDMS) moulds which have been used previously 229. This is due to the 
low surface energy of the PFPE mould which prevents the polymer solution from sticking to 
the non-void parts of the mould 230. Solidification of the particles can occur via U.V crosslinking 
or by solvent evaporation and particles are subsequently removed by adherence to a 
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dissolvable PVP sheet and peeling away of the mould. Using this method, a diverse array of 
particle shapes have been fabricated with sizes as low as 55x60 nm 230-232.  
 
Figure 1.10: Particle replication in non-wetting templates (PRINT) Left: The PRINT process adapted from reference 
232. Right: SEM images of PLGA PRINT particles; A) 80 x 320 nm cylinders B) 200 x 200 nm cylinders C) 200 x 
600 nm cylinders D) 1 μm “sphere approximates” E) 2 μm cubes F) 3 μm doughnuts. Adapted from ref 230  
 
A potential issue with these polymerisation methodologies it that monomers left over from the 
fabrication process are often toxic to cells and so care must be taken to remove these before 
use in biological systems 233. Additionally, curing of the polymers using ionising radiation could 






1.4.2 The effect of nano and microparticle shape on cellular uptake  
1.4.2.1 Studies on the effect nanoparticle shape on cellular uptake 
Chithrani et al. studied the internalisation of gold nanoparticles of varying aspect ratio by HeLa 
cells 98. Particles were synthesised as either rods (14 x 40 nm, 14 x 74 nm) or spheres 
(diameter 14 nm or 74 nm) and the number of particles per cell calculated by inductively 
coupled plasma atomic emission spectroscopy (ICP-AES). It was shown that the 
administration of particles with an aspect ratio of 1 (spheres), regardless of size, resulted in a 
higher number of particles per cell. In a further study by Chithrani and Chan spherical gold 
nanoparticles (diameter 50 nm) displayed increased uptake compared with a range of rod-
shaped particles (20x30 nm, 14x50 nm, 7x42 nm) 234. Uptake of each nanoparticle shape was 
by clathrin-mediated endocytosis, however the exact mechanism through which rod-shaped 
particles displayed reduced uptake was not elucidated. Similarly Qiu et al. observed that the 
uptake of gold nanoparticles (diameter 30 nm) by MCF-7 cells decreased with increasing 
aspect ratio 235.  
Yu et al. studied the association of unmodified and amine-modified silicon oxide spheres 
(diameter 115 nm), mesoporous silica spheres (diameter 120 nm) and mesoporous silica rods 
of aspect ratio 2, 4, and 8 (diameter ~100 nm) by RAW 264.7 macrophages and A549 
epithelial cells. The cellular association of the different particle shapes was assessed using 
inductively coupled mass spectrometry (ICP-MS). Amine-modified particles exhibited higher 
association in both cell lines. No difference in cellular association was observed between the 
different mesoporous particle shapes in RAW 264.7 cells. In A549 cells similar results were 
seen as in RAW 264.7 cells apart from amine-modified aspect ratio 8 rods which showed 
significantly higher association than the other amine-modified mesoporous particles 236. 
In a similar study by Herd et al. the association of silica “worms” (232 x 1348 nm) and spheres 
(diameter 178 nm) by RAW 264.7 was examined by flow cytometry and showed that spheres 
exhibited a higher cellular association than worms 237. Furthermore, inhibitor studies 
demonstrated that the primary uptake mechanism was different for worms and spheres. The 
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uptake of worms was primarily inhibited by colchicine indicating active uptake by phagocytosis 
as the primary uptake mechanism. In contrast, the uptake of spheres was primarily inhibited 
by chlorpromazine indicating that clathrin-mediated endocytosis was the major mechanism of 
uptake 237. In contrast to the above study, Huang et al. found that rod shaped mesoporous 
silica particles (110 x 240 nm and 110 x 450 nm) had higher association with A375 epithelial 
cells than spherical particles (d = 100 nm) 238.  
The disparate uptake of nanoparticles of different shapes seems to result from their utilisation 
of different uptake pathways which is largely dependent on overall particle size, however 
despite this, particles of different shapes, internalised by the same endocytic mechanism have 
shown differences in uptake 98. Theoretical studies have suggested that differences in the 
efficiency of membrane wrapping of different shaped particles also plays a significant role 239.  
 
1.4.2.2 Studies on the effect of microparticle shape on cellular uptake  
Champion and Mitragotri used the film stretching method to fabricate a wide array of particle 
shapes (oblate and prolate ellipsoids, elliptical disks, rectangular disks and UFO-shaped 
particles) across a range of volumes and assessed whether or not uptake occurred in 
macrophages by direct observation 240. Whether or not particle internalization occurred was 
expressed in terms of the particle shape and the angle of particle contact with the cell 
membrane. Internalisation occurred only when the initial point of contact was with the major 
axis (the smaller axis of an anisotropic particle) of each particle shape. Although this study 
gives insight into the reason why particles of different shapes may or may not be internalised 
in discrete circumstances it did not assess the overall differences in internalisation between 
particle shapes. Inspired by this study, worm-like particles with high aspect ratio (AR=20) were 
designed that showed reduced internalisation by macrophages in comparison with spheres of 
equivalent volume 241.   
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In a study by the same group, comparing the uptake of spheres, prolate ellipsoids and oblate 
ellipsoids by macrophages, there was no difference observed between particle shapes derived 
from 3.6μm diameter spheres 242. However, in particles derived from 0.5 μm and 1 μm spheres, 
oblate ellipsoids and spheres showed higher uptake than prolate ellipsoids. A further study 
comparing internalisation of spheres (diameter 5 μm) and disks (0.1x1x3μm) by human 
umbilical vein endothelial cells (HUVECS) showed that spherical particles were internalised to 
a greater extent than disks at earlier time points (0.5-3 hr), however at later time points (5+ hr) 
the two particle shapes displayed equivalent internalisation 243.  
Lu et al. studied the internalisation of CdTe-quantum dot microcomposites of spherical 
(diameter 1.85 μm), rod (2.5x1.2x1.0 μm), and needle (8.5x0.3 μm) morphologies by RAW 
264.7 cells 244. Spheres were internalised by a higher proportion of cells than both rod and 
needle-shaped particles with needle shaped particles hardly being internalised by any cells. 
Kozlovskaya et al. compared uptake of hydrogel capsules of spherical (diameter 1.8 μm) and 
discoidal (3.6x1.2x0.59 μm) microparticles by J774A.1, HMVEC, and 4T1 cells 245. In all cell 
lines, more spheres were taken up per cell than discoidal particles.  
In general, reports on the effects of nano and microparticle shape on cellular uptake are very 
mixed and the interpretation of published studies is further complicated by the effects of other 
particle properties and different cell types. For example, the synthesis of nanoparticles of 
different shapes often involves the use of surfactants which, if not removed before uptake 
experiments, will have a large impact on the results. It is therefore challenging to study these 
effects; however, particle shape has been demonstrated to influence uptake and so by 
extending the current knowledge on how particle shape influences cellular uptake, the design 
of more effective medicines can be achieved. The majority of studies published thus far 
compare spherical and rod-shaped particles, therefore the study of a more diverse array of 
particle shapes is warranted.  
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1.4.2.3 Other effects of particle shape 
Particle shape has also been shown to be an important determinant in the biodistribution of 
particles after administration to the body.  Particular attention has been paid to the movement 
of micron-sized particles of different shapes in flow 246. The hydrodynamics of non-spherical 
microparticles in blood often result in their margination towards the blood vessel walls, leading 
researchers to explore their use in vascular targeting 247-248. Differences in biodistribution 
between spheres, disks, cylinders, and hemispherical particles has been demonstrated by 
Decuzzi et al. 249. This opens another avenue for consideration in the targeting of different 
areas of the body using different particle shapes.  
1.4.2.4 Microparticles for lung delivery 
The majority of studies have focused on the effect of particle shape in particles in the nano-
size range. However, the use of micron-sized particulate carriers is of particular interest in the 
field of pulmonary delivery. Particle size has been shown to be a crucial parameter in 
determining where in the lung the particles are deposited following inhalation. Particles that 
are too large deposit at the back of the throat and are swallowed, whereas particles that are 
too small are exhaled 250. Inhaled particles are often between 1 and 5 μm in size as these 
deposit into the lower airways 251. However, disparities between healthy and diseased lungs 
have been shown whereby higher deposition takes place in the central airways than in 
peripheral airways in patients with asthma and chronic obstructive pulmonary disease (COPD)  
252-253.  
In the small airways, where airflow is low relative to the upper airways, sedimentation by 
gravity is the predominant mechanism of particle deposition for particles between 0.5-3 μm  
254. Below this size, diffusion is the dominant mechanism of deposition and particles that do 
not deposit are exhaled.  
Pulmonary delivery of therapeutics can be useful for both local and systemic delivery. In order 
for systemic delivery to occur, inhaled particles must reach the alveoli where drug molecules 
must then dissolve and cross the alveolar epithelium into the blood stream 255.  
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However, particulate matter in the alveoli is removed by macrophages. Particles are 
phagocytosed and then macrophages containing particles are cleared either by migration to 
the lymphatic system or by movement towards the ciliated region in the lung whereby they are 
transported towards the nasopharynx and swallowed 256. Depending on the clinical scenario it 
may be beneficial either to enhance or avoid the removal of a therapeutic carrier particle by 
macrophages in the lung. For example, in the development of COPD, there is often a 
disturbance in the balance between M1 and M2 phenotypes and so targeting them in order to 
modulate this balance may be beneficial 257. On the other hand, in cases such as asthma and 
pulmonary hypertension, a long residence time resulting in prolonged release of the 
therapeutic could result in less frequent dosing and higher compliance, making avoidance of 
particle uptake desirable 258. This strategy has been pursued for the sustained systemic 
release of insulin delivered to the lung 259. 
The control of microparticle shape to either reduce or enhance macrophage uptake could 
therefore be a strategy to enhance the effectiveness of inhaled therapeutics. Although it might 
be considered that the production of particles with defined shape might be difficult to achieve 
on an industrial scale, it has been demonstrated that methods such as PRINT are scalable 
and is being investigated by Liquidia Inc. to produce inhalable microparticles of controlled 
shape 260.  
 
1.5 Aims and objectives  
 
This work aimed to understand the uptake of polycrystalline silicon (polysilicon) and silicon 
oxide microparticles with different shapes, size, and surface chemistry by RAW 264.7 
macrophages (figure 1.11). A variety of microparticle shapes were microfabricated by 
collaborators at the Centro Nacional de Microelectrònica (CNM) using lithographic methods. 
These particles were then functionalised by surface modification with fluorescent molecules 
34 
 
to enable detection of intracellular particles by flow cytometry. Additionally, spherical silicon 
oxide microparticles of a range of sizes were purchased and functionalised using a zwitterionic 
surface chemistry and uptake by RAW 264.7 macrophages assessed.  
The experimental work is summarised as follows: 
- In chapter 3 silicon oxide particles are functionalised with fluorescent molecules using 
covalent and non-covalent methods and the suitability of each labelling method for use 
in cellular uptake studies assessed. Uptake of silicon oxide spheres, hexahedrons, and 
truncated pyramids is then assessed using qualitative and quantitative methods.  
 
- In chapter 4 a label-free method of detecting polysilicon microparticles of hexahedral, 
cuboidal, bar-shaped and circular disk morphologies is used to assess particle uptake 
by RAW 264.7 cells. The effect of each particle morphology on cellular metabolism, 
toxicity, and lysosomal enzyme release is studied. 
 
- In chapter 5 spherical silicon oxide particles (0.5, 1, 3 μm) are functionalised with 
zwitterionic surface chemistry, and their uptake by RAW 264.7 macrophages 
measured with emphasis on dosing metric, lipopolysaccharide (LPS) stimulation, and 









2. Materials and General Methods 
 
2.1 Materials  
2.1.1 Plasticware and glassware 
 
Tissue culture treated 75 cm2 (T-75) cell culture flasks, sterile pipettes, and 12, 24, 96, well 
polystyrene plates (black/clear) were purchased from Corning life sciences (Holland). 15 mL 
sterile centrifuge tubes (falcon tubes) were obtained from Greiner (USA). Haemocytometer 
(Neubauer chamber) for counting of cells and particles was obtained from Scientific Laboratory 
Supplies (UK).  
 
2.1.2 Materials for cells culture 
Dulbecco’s Modified Eagle Medium (DMEM, D546), FBS (F7524), L-glutamine (G7513), 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES H0887), Penicillin/Streptomycin,  
Hank’s Balanced Salt Solution (HBSS, H8264), 4’,6-diamidine-2’-phenylindole dihydrochloride 
(DAPI), fluoroshield™ (F6182), LDH assay kit, 4-methyl umbelliferyl-β-D-glucuronide hydrate 
(MUG) were purchased from Sigma-Aldrich. RAW 264.7 cells were obtained from the 
American Type Culture Collection, ATCC (USA). 
Corning® biocoat™ 20mm collagen coated coverslips 10553322, Lipopolysaccharide (LPS), 
CD107a (LAMP-1) monoclonal antibody Alexafluor 488, and Accutase were purchased from 
Fisher Scientific. Phallodin Ifluor 488 (ab176753) was purchased from Stratech Scientific. 
Formaldehyde 4% and Dimethylsulfoxide (DMSO) were purchased from VWR. CellTiter 96® 
AQueous One solution cell proliferation assay (MTS reagent) was purchased from Promega 





1H-imidazole, 1-bromooctadecane, Fluoromount™ F4680, Rhodamine B isothiocyanate 
(RBITC, 283924), 3-aminopropyl trimethoxysilane (APTMS, 281778), Triton X-100 (TX-100), 
N-(3-sulfopropyl)-N-methacroyloxyethyl-N,N-dimethylammonium betaine (MDSA, 537284), 
and Silicon oxide spheres (0.5, 1, 3 μm) were purchased from Sigma-Aldrich. H2SO4 (98%), 
NH4OH (20%) and (3-glycidoxypropyl)trimethoxysilane (GOPTS) 97% were purchased from 
Fisher Scientific. 5-(4-aminophenyl)-10,15,20-(triphenyl)porphyrin (ATPP) and 5,10,15,20-
(tetra-4carboxyphenyl)porphyrin (TCPP) were purchased from Porphychem (France). 10-
(pentafluorophenoxycarbonyl)decyltrimethoxysilane (PFP, 15468785) was purchased from 
Alfa Aesar. 11-aminoundecyltriethoxysilane (AUTES, S25045) was purchased from 
Fluorochem (UK). 1,3-bis(bromomethyl)benzene, H2O2 (35%), and dimethylsulfoxide (DMSO) 
were purchased from VWR. BDP-630 NHS ester was purchased from Lumiprobe.  
 
2.2 General Methods 
2.2.1 Routine cell culture methods 
 
2.2.1.1 Culture of RAW 264.7 cells 
RAW 264.7 macrophages were cultured in T-75 cell culture flasks. 15 mL high glucose DMEM 
supplemented with 10% FBS, 1% L-glutamine, and 1% penicillin/streptomycin was used as 
the culture media. Cells were incubated at 37°C with 5% CO2 in 95% humidity. Cell culture 
media was removed by aspiration and replaced with 15mL pre-warmed fresh media every 48 
hours.  
Cells were harvested by gentle scraping once they reached 60-80% confluency. Successful 
detachment of cells by scraping was confirmed by examination under a microscope. Detached 
cells in media were transferred by pipette into a 15 mL falcon tube. Falcon tubes containing 
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cells were centrifuged at 1200 RPM (300G) for 5 minutes to cause the cells to form a pellet. 
The supernatant was removed by aspiration and replaced with 6 mL fresh (pre-warmed at 
37°C) media. The cells were suspended in the fresh media by pipetting up and down to 
disperse the pellet. At this point cells would either be counted for seeding in well plates for 
experiments or if undergoing routine passaging would be split into new T-75 culture flasks 
containing 15mL fresh pre-warmed media. Typical passaging ratios from 6 mL cell suspension 
were 1:3 and 1:6. Cells were passaged between P13 and P30 after which cells were disposed 
of and fresh P13 cells were revived from storage 261.  
 
2.2.1.2 Cell counting 
A haemocytometer was used to count the number of cells for each experiment. 10 μL detached 
cell suspension in fresh pre-warmed media was transferred to a 200 μL microcentrifuge tube. 
To this, trypan blue solution (0.4%, 10 μL) was added and mixed by pipetting the solution up 
and down. 10 μL of this mixture was transferred onto the haemocytometer and cells counted 
under the microscope. Cells were counted from the four corners of the haemocytometer and 
the sum divided by four to give an average. This result was then multiplied by 2 to account for 
the dilution by adding the trypan blue solution and then multiplied by 10,000 to give the number 
of cells per 1 mL.  
 
2.2.1.3 Cell freezing 
After detachment of cells and centrifugation following the procedure in section 2.2.1.1 cells 
were suspended in 1mL cell culture media containing 10% DMSO. This cell suspension was 
then transferred by pipette to a 1 mL cryovial. Cryovials were labelled with the date, cell type, 
and passage number and then placed in a Mr Frosty™ (Thermoscientific) freezing container 
containing isopropanol. The Mr Frosty™ container was placed in a -80°C freezer overnight 
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after which time cryovials were transferred into liquid nitrogen containers for long-term storage. 
Each cryovial contained a whole flask of cells.  
 
2.2.1.4 Cell revival 
After removal of a cryovial containing cells from liquid nitrogen storage, the cryovial was placed 
in a water bath at 37°C until partially defrosted. As soon as the cell suspension had partially 
defrosted it was transferred to a 15 mL falcon tube and 10 mL pre-warmed media added. The 
suspension was centrifuged at 1200 RPM (300G) for 5 minutes and the supernatant removed. 
The pellet was suspended in 15 mL fresh pre-warmed media and this cell suspension 
transferred to a fresh T-75 cell culture flask and stored in an incubator at 37°C, 95% humidity, 
5% CO2.  
2.2.1.5 Particokinetics 
For all experiments whereby particles were applied to cells, particles were applied as 
suspensions to wells which contained RAW 264.7 cells adhered to the bottom of the well. The 
density of silicon oxide (2.20 g/cm3) and polysilicon (2.33 g/cm3) resulted in sedimentation of 
particles to the bottom of the well to initiate contact with the cells. Stated particle doses are 
the doses administered to each well.  
2.2.2 Statistical analysis  
Statistical analysis was performed using GraphPad Prism 7 whereby P<0.05 was considered 
statistically significant (*). Further statistical significance was denoted as follows P<0.01 (**), 
P<0.001(***), P<0.0001(****). Appropriate statistical tests and ad hoc analyses were selected 
and are detailed in each figure caption. Data is presented as mean ± SEM for independent 
experiments and mean ± standard deviation for dependent experiments. The number of 





3. Interactions of silicon oxide microparticles of different shape 
by RAW 264.7 macrophages 
 
3.1 Introduction 
In this chapter, silicon oxide microparticles of hexahedral and truncated pyramid 
morphologies, fabricated using lithography, are compared with silicon oxide microspheres 
acquired from a commercial supplier to assess their interactions with RAW 264.7 
macrophages. Initially, different methods of functionalising the microparticles with fluorescent 
molecules are compared and then the interaction of functionalised particles with RAW 264.7 
macrophages is assessed.  
 
3.1.1 Methods of functionalising silicon oxide particles with fluorescent dyes 
By far the most common method to functionalise the surface of silicon oxide particles is by the 
use of alkoxysilane molecules. Alkoxy groups hydrolyse in the presence of small amounts of 
water to form silanols that form hydrogen bonds with the hydroxyl groups on the surface of the 
silicon oxide.  Through loss of water molecules these bonds are made covalent and a self-
assembled monolayer (SAM) is formed on the silicon dioxide surface. A wide number of 
alkoxysilane molecules are available with numerous different functional groups for example 
amines, epoxides, thiols, azides, and acrylates. Therefore, this method offers a convenient 
way to impart useful surface chemistries for further functionalisation to silicon oxide particles. 
Commonly (3-amino-propyl) triethoxysilane (APTES) has been used to modify the surface of 
silicon oxide particles so that amine-reactive groups such as NHS esters or isothiocyanates 
can be used to further conjugate the surface with fluorophores, drug molecules or targeting 
moieties 262-266.  
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Functionalisation of the particle surface with fluorophores allows the visualisation of the silicon 
oxide particles by fluorescent microscopy. Alternatively, fluorescent dye molecules can be 
encapsulated into the internal structure of the particles during synthesis, known as fluorescent 
doping methods. Fluorophores can be linked to the internal structure of the silica either 
covalently (by alkoxysilanes) or non-covalently by electrostatic interaction 267-268. This method 
has the advantage that the dye molecules are encapsulated within the silica rather than 
present at the surface meaning that the dye has minimal effect on the particle surface 
properties and additionally does not have the chance to interact with receptors on the cell 
surface. Non-covalent doping methods can result in dye leakage from the particles 269 and so 
covalent doping methods are typically favoured.  
Previously, members of our group have described a novel method for non-covalently 
immobilising fluorophore onto the surface of polycrystalline silicon microparticles. This method 
utilises a gemini imidazolium surfactant that physisorbs onto the particle surface. The 
surfactant serves as a host to immobilise porphyrin dye molecules onto the surface of the 
particles.  
This method could also allow for non-covalent binding of drug molecules and other surface 
chemistries to the particle surface therefore this methodology is explored here to fluorescently 
label silicon oxide particles in contrast with covalent methods in order to serve as a proof of 
concept for further development. 
 
3.1.2 Methods of analysing particle internalisation 
There are numerous methods available to researchers to assess the internalisation of particles 
into cells in vitro each with its own advantages and disadvantages. These methods can be 
divided into quantitative (flow cytometry, plate reader methods, inductively coupled mass 
spectrometry (ICP-MS) and qualitative (semi-quantitative) methods such as 
confocal/fluorescence/light microscopy and scanning electron microscopy 270. 
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Qualitative methods rely on high-resolution imaging to allow visualisation of particle 
internalisation events and are useful in providing descriptive information about the sample. 
However, often these methods are time-consuming and expensive which therefore leads to a 
reduction in the number of samples that can be assessed, thus decreasing the reliability of the 
quantitative information that can be obtained. Furthermore, due to the selection of which cells 
are imaged by the researcher, these methods can be subject to unconscious sampling bias 
that can reduce the validity of the obtained results 271.  
On the other hand, quantitative methods are able to assess high numbers of cells in order to 
give highly reliable information about the sample, but lack the sensitivity in discriminating 
between internalised and surface-bound particles 272. For example, assessment of cells by 
flow cytometry or plate reader methods will give information about the proportion of cells that 
are associated with fluorescent particles, but not the location of particles with respect to the 
cells. Further methodological steps can be used, for example by quenching extracellular 
fluorescence or by staining surface-bound particles with a secondary fluorophore to 
discriminate between cells with internal and cells with surface-bound particles. However, these 
methods are very system-specific, requiring efficient quenching/labelling and therefore are not 
suitable as a general method.  
Imaging flow cytometry is a recently developed method that aims to overcome some of these 
limitations by combining the spatial resolution of microscopy with the high-throughput nature 
of flow cytometry. It has been used by a number of groups to assess the internalisation of 
particles. However a study by Fei et al. 273 reported that it is not able to suitably distinguish 
between internal and surface-bound particles without the addition of a secondary fluorescent 
label. 
In contrast, a study by Vranic et al 274 showed similar results between trypan blue quenching 
of fluorescein isothiocyanate (FITC)-labelled silica nanoparticles and imaging flow cytometry 
image analysis. Owing to the conflicting reports it is necessary to assess the validity of this 
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method for the particles used in this chapter, a comparison with a well-established trypan blue 
quenching method is performed. 
 
3.1.3 Studies of the uptake of silicon oxide particles of different morphologies 
Studies of silicon oxide particles of different shapes have primarily been focussed on 
respirable silica dusts in order to understand how the particle morphology affected toxicity in 
macrophages 275-277. Recently, an increased number of studies have begun to examine silicon 
oxide particle morphology as a tool for enhancing control over drug delivery for example by 
increasing/decreasing uptake by cells 236-238, 278-281.  
It is difficult to make clear comparisons between these studies because the effects of particle 
shape are difficult to study in isolation. Differences in particle size, surface chemistry, and cell 
type are ever present and have been shown to play important roles in particle internalisation 
93, 95, 282. Additionally, cellular association is often used as a proxy for internalisation.  
The majority of studies examining the effect of silicon oxide particle shape utilise particles that 
are in the nano size range 236-238, 278-280, 283. However, there are few studies that look at silicon 
oxide particles in the micron size range (>1 μm) and so in this chapter silicon oxide particles 
with dimensions in the micron range are used to study the effects of particle shape on 
internalisation. Our group has functionalised hexahedral-shaped silicon oxide microparticles 
for intracellular pH sensing 284 and demonstrated the versatility of particle shapes that can be 
fabricated using photolithography 222. However, the effect of silicon oxide microparticle shape 






3.2 Materials and Methods 
 
3.2.1 Materials  
1H-imidazole, 1-bromooctadecane, Fluoromount™ F4680, rhodamine B isothiocyanate 
(RBITC, 283924), 3-aminopropyl trimethoxysilane (APTMS, 281778), and silicon oxide 
spheres (diameter 3 μm) were purchased from Sigma-Aldrich. H2SO4 (98%), NH4OH (20%) 
and (3-glycidoxypropyl)trimethoxysilane (GOPTS) 97% were purchased from Fisher Scientific. 
5-(4-aminophenyl)-10,15,20-(triphenyl)porphyrin (ATPP) and 5,10,15,20-(tetra-
4carboxyphenyl)porphyrin (TCPP) were purchased from Porphychem (France). 10-
(pentafluorophenoxycarbonyl)decyltrimethoxysilane (PFP, 15468785) was purchased from 
Alfa Aesar. 11-aminoundecyltriethoxysilane (AUTES, S25045) was purchased from 
Fluorochem (UK). 1,3-bis(bromomethyl)benzene and H2O2 (35%) were purchased from VWR. 
BDP-630 NHS ester was purchased from Lumiprobe.  
Silicon oxide hexahedrons and truncated pyramids were fabricated by collaborators at the 
Centro Nacional de Microelectrònica (CNM) in Barcelona according to ref 222 . Briefly, a P-type 
silicon wafer (100) was wet oxidised (100°C) to produce a 1 μm or 3 μm thick silicon oxide 
layer. A photoresist (HIPR 6512) was spun to produce a 1.2 μm thick layer and subsequently 
exposed to UV light through a photomask. The photomask was developed by baking at 200°C 
for 30 minutes and the exposed silicon oxide degraded by dry etching with a C2F6/CHF3 
mixture in a Drytek quad 484 RIE. Definition of the anchors underneath the particles was 
achieved by quasi-isotropic etching in SF6/C4F8 atmosphere in an A-60E DRIE and photoresist 
removed by plasma cleaning (TEPLA 300E).  
 




3.2.2.1 Non-covalent labelling of silicon oxide particles anchored on silicon wafers 
 
Synthesis of imidazolium amphiphile 1.2Br  
1-octadecyl-1H-imidazole was synthesised according to reference 285 (3.77 g, 80.05 %) 1H 
NMR (400 Hz, CDCl3, 25°C, TMS): δ 0.9 (t, 3H, CH3), 1.28 (d, 30H, (CH2)15), 1.79 (t, 2H, CH2), 
3.94 (t, 2H, CH2), 6.92 (s, H, Im-H), 7.08 (t, H, Im-H), 7.48 (s, H, Im-H).  
1.2Br was synthesised according to reference 285 (1.37 g, 80.20%) 1H NMR (400 Hz, CDCl3, 
25°C, TMS): δ 0.81 (t, 6H, CH3), 1.18 (m, 60H, CH2), 1.83 (t, 4H, CH2), 4.21 (t, 4H, CH2), 5.56 
(s, 4H, Ch2), 7.11 (s, 2H, Ar-H), 7.2 (s, 2H, Im-H), 7.50 (d, H, Ar-H), 7.98 (m, 1H, Ar-H), 8.04 
(m, 2H, Im-H), 10.46 (s, 2H, Im-H). 
Surface activation of silicon oxide particles anchored on silicon wafers 
Silicon wafers possessing silicon oxide microparticles attached to the surface by supporting 
anchors were cut using a diamond scribe into ~5x5 mm pieces. Pieces of wafer were 
transferred to a 10 mL glass vial (4 wafer pieces per vial) with the silicon oxide particle pattern 
facing up. Acidic piranha solution (1 mL) was prepared by adding H2O2 (35%, 300 μL) 
dropwise to H2SO4 (98%, 700 μL) and this solution transferred into the vial containing the 
wafer pieces. This solution was freshly prepared each time to avoid loss of activity. After 1 
hour the acidic piranha solution was removed, the surfaces rinsed with MilliQ water (3x 1mL), 
dried under a nitrogen stream and added to a fresh 10 mL glass vial.  
Basic piranha solution was prepared by adding NH4OH (20%, 150 μL) to MilliQ water (700 
μL), to this mixture H2O2 (35%, 150 μL) was added dropwise. Basic piranha solution was 
transferred to the vial containing the wafer pieces for 30 minutes. This solution was freshly 
prepared each time to avoid loss of activity. The basic piranha solution was removed and the 
wafer pieces washed with MilliQ water (3x 1 mL) and dried under a stream of nitrogen before 




Step-by step method for non-covalent immobilisation of 1.2Br and labelling with TCPP on 
silicon oxide particles anchored on silicon wafers  
1.2Br solution (2 mM, 2 mL) in either DMSO, DCM, acetone or MeOH was added to the 
surfaces immediately after surface activation to avoid surfaces being contaminated. After 24 
hours the 1.2Br solution was removed and the surfaces washed with milliQ water (3 x 1 mL), 
dried in a stream of nitrogen and transferred to a fresh 10 mL glass vial. TCPP (sodium salt) 
(2.5 mM) in milliQ water 1mL was added to the surfaces which were protected from light and 
left overnight. TCCP solution was removed and the surfaces washed with milliQ water (3x1 
mL) and dried in a stream of nitrogen. One wafer piece was used per condition to serve as a 
proof of concept, multiple areas of each surface were examined for fluorescence.  
 
Solution method for non-covalent labelling with 1.2Br and ATPP 
1.2Br solution (2mM) in EtOH (1 mL) was mixed with a solution of ATPP (2 mM) in acetone (1 
mL) and 1 mL of the resulting solution added to a 10 mL vial containing freshly activated wafer 
pieces. The wafer pieces were left submerged in this solution overnight after which time the 
solution was removed and the surfaces washed with 3 x 1 mL milliQ water and dried with a 
nitrogen stream.  
 
3.2.2.2 Covalent labelling of silicon oxide particles anchored on silicon wafers 
Covalent labelling with PFP/GOPTS and ATPP 
Freshly activated wafer pieces were placed in a 10 mL glass vial and submerged in a 2% v/v 
solution of either PFP or GOPTS in acetone (1 mL) for 30 minutes at room temperature. The 
silane solutions were removed and the wafer pieces washed with acetone (3x 1mL), dried with 
a nitrogen air stream and placed in a fresh 10 mL glass vial. ATPP solution (4mM) in acetone 
(1 mL) was then added to the wafer pieces which were protected from light and left overnight. 
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The ATPP solution was removed and the wafer pieces washed with acetone (3 x 1mL) before 
being dried with a nitrogen stream.  
 
Covalent labelling with APTMS/AUTES and RBITC/BDP 630 
Freshly activated wafer pieces were placed in a 10 mL glass vial with the silicon oxide particle 
facing up and submerged in either 2% v/v APTMS solution in acetone (1 mL) for 30 minutes 
or 0.1% v/v AUTES solution in EtOH (1 mL) for 2 hours. Silane solutions were removed and 
the wafer pieces washed with 3 x 1mL of the corresponding solvent (acetone for APTMS 
treated wafer pieces, EtOH for AUTES treated wafer pieces) before being dried with a nitrogen 
air stream and placed in a fresh 10 mL glass vial. RBITC solution in EtOH (1 mL) was then 
added to the wafer pieces which were protected from light and left overnight. For experiments 
in section 3.3.2.2 comparing the covalent labelling methods, a 200 μM solution of RBITC in 
EtOH (1 mL) was used, for all subsequent experiments 30 μM RBITC solution in EtOH (1 mL) 
was used. Alternatively BDP 630 NHS ester (30 μM) in Na2HPO4/NaH2PO4 buffer pH 8 (700 
μL) was added to the wafer pieces, protected from light and left overnight. Wafer pieces were 
washed with 3x 1 mL EtOH (RBITC labelled wafer pieces) or milliQ water (BDP 630 labelled 
wafer pieces) and dried with a stream of nitrogen before removal of particles by peeling. 
 
3.2.2.3 Covalent labelling of silicon oxide particles in suspension 
Surface activation of silicon oxide particles in suspension 
1 mg (20 μL) silicon oxide spheres as received (stock concentration 5% w/v) were transferred 
to a 1.5 mL microcentrifuge tube and centrifuged at 5700 RPM (6175 G) for 10 minutes and 
the supernatant removed. Particles were suspended in acidic piranha solution (700 μL) for 1 
hour with shaking to prevent particles from falling out of suspension. Particles were centrifuged 
at 5700 rpm (6175 G) for 10 minutes and the acidic piranha solution removed. Particles were 
washed by resuspension in 700 μL milliQ water and then centrifuged 5700 rpm (6175 G) for 
48 
 
10 minutes. This washing process was repeated 3x and then the supernatant removed. 
Particles were suspended in basic piranha solution (700 μL) and left shaking for 30 minutes. 
Particles were centrifuged at 5700 rpm (6175 G) for 10 minutes and the basic piranha solution 
removed. Particles were washed using the same resuspension in 700 μL milliQ water and 
centrifugation steps used to wash the particles after removal of the acidic piranha solution.  
Covalent labelling with AUTES and RBITC/BDP 630 
Freshly activated silicon oxide particles were suspended in 0.1% v/v AUTES in EtOH (700 μL) 
and left to shake for 2 hours. Particles were centrifuged at 5700 RPM (6175 G) for 10 minutes 
and the silane solution removed. Particles were washed by resuspension in 700 μL EtOH and 
centrifugation at 5700 RPM (6175 G) for 10 minutes before removal of the supernatant. This 
washing process was repeated 3x and then the supernatant removed. Particles were 
suspended in RBITC (30 μM) in EtOH (700 μL) or BDP 630 NHS ester (30 μM) in 
Na2HPO4/NaH2PO4 buffer pH 8 (700 μL) and left on a shaker overnight while protected from 
light. Particles were washed with EtOH 3x 700 μL (RBITC labelled particles) or milliQ water 
3x 700 μL (BDP 630 labelled particles) by repeated suspension and centrifugation as above. 
Particles were stored in 700 μL EtOH at 4°C. 
 
3.2.2.4 Determination of fluorophore release from particles in PBS at 37°C 
Wafer pieces possessing particles labelled non-covalently using 1.2Br-ATPP or ATPP alone 
and covalently using AUTES-RBITC were placed in microcentrifuge tubes containing warm 
PBS (700 μL) and incubated at 37°C for 2 hours with shaking. The fluorescence intensity of 
the particles was assessed before and after incubation using fluorescence microscopy. 
Fluorophore release was measured from 3 wafer pieces per sample by imaging 5 areas of 




3.2.2.5 Acquisition of brightfield and fluorescent images 
Brightfield and fluorescence images were acquired using a Nikon Eclipse TiU fluorescence 
microscope. Images of wafer pieces were acquired by placing the wafer piece on a glass slide 
with the silicon oxide side face-down. Images of particles in suspension were acquired by 
pipetting 15 μL particle suspension onto a glass slide and then covering with a coverslip. For 
fluorescence imaging of TCPP and ATPP-labelled samples ex =425 nm and em >620 nm. 
For fluorescence imaging of RBITC labelled samples ex = 550 nm and em >590 nm. Images 
were processed using imageJ® to produce fluorescent surface plots. For fluorescence 
imaging of BDP 630 labelled particles ex =630 nm and em >670 nm.  
3.2.2.6 Water contact angle measurements 
Water contact angle measurements were acquired using a KSV CAM 200 optical contact 
meter. Surfaces were placed with the silicon oxide particle face upwards and the water contact 
angle measured. Measurements were taken in triplicate (3 wafer pieces per sample).  
 
3.2.2.7 Removal of silicon oxide particles from silicon wafer 
A drop of fluoromount™ aqueous mounting medium was placed onto each of the wafer pieces 
and spread using a micropipette tip to ensure complete coverage. This was then left to air dry 
(~20 minutes). After drying the mounting medium was peeled away from the wafer piece 
surface using tweezers and placed in a 1 mL microcentrifuge tube. MilliQ water (1mL) was 
added and the microcentrifuge tube and sonicated to aid dissolution of the mounting medium. 
After complete dissolution had occurred the microcentrifuge tube was centrifuged for 10 
minutes at 5700 RPM (6175 G) resulting in a pellet forming. The supernatant was removed 
and the cycle of centrifugation and washing with milliQ water (1 mL) repeated x2 times. 




3.2.2.8 Determination of trypan blue quenching efficiency 
MFI of particles was measured by imaging flow cytometry using a 50 μL suspension containing 
RBITC-labelled particles in 1% HEPES in HBSS. MFI was measured with and without the 
addition of trypan blue solution (0.4%, 10 μL) immediately before sample analysis. Flow 
cytometer settings were kept the same for each sample, details can be found in section 
3.2.2.10.  
 
3.2.2.9 Qualitative particle uptake of silicon oxide particles by RAW 264.7 macrophages 
assessed by confocal microscopy 
 
Preparation of particle suspensions 
BDP 630 labelled particles were centrifuged at 5700 RPM (6175 G) for 10 minutes. From this 
point onwards all work took place inside a sterile cell culture hood to maintain the sterility of 
the particles. Stock particle suspensions were prepared by removal of the EtOH and the 
addition of 1 mL buffer comprising 1% HEPES in HBSS. The number of particles per mL was 
calculated by counting particles on a haemocytometer. A volume of each particle stock 
solution containing 1,500,000 particles  was transferred into fresh microcentrifuge tubes and 
the volume made up to 1 mL with fresh 1% HEPES in HBSS buffer.  
 
Preparation of RAW 264.7 cells 
RAW 264.7 cells grown to 60-80% confluency were harvested by scraping and counted as 
described in section 2.2.1. 300,000 cells per well in 1 mL culture media were seeded onto 
collagen coated glass coverslips inside clear polystyrene 6-well plates and incubated at 37°C, 
5% CO2 95% humidity overnight to allow cell attachment. Culture media was then removed 
and the cells washed with 1 mL pre-warmed (37°C) PBS. The PBS was removed by aspiration 
and 1 mL per well pre-warmed particle suspensions each containing 1,500,000 particles 
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added to each well. Cells were kept in an incubator for 4 hours after which time the particle 
suspensions were removed by aspiration and the cells washed with 3x 1mL pre-warmed PBS. 
Cells were fixed by the addition of 1 mL per well of 4% formaldehyde in PBS for 15 minutes 
and then washed with 3x 1mL PBS. Permeabilisation of cells was achieved by adding 1 mL 
per well 0.1% Triton X-100 in PBS for 3 minutes. Cells were washed with PBS (3x 1 mL) and 
the PBS removed. 
 
Immunofluorescence staining and preparation of confocal slides 
Actin staining was performed by addition of 1 mL per well pre-warmed Ifluor 488 phalloidin 
solution in PBS (1 μL ifluor488 stock solution in 1 mL PBS) for 30 minutes at room temperature 
while protected from light. Staining solution was then removed and the cells washed with PBS 
(3x 1 mL). Alternatively, LAMP-1 staining was achieved by the addition of 1 mL per well of 
alexafluor 488 labelled CD107a antibody (5 μg per mL in PBS) for 45 minutes while protected 
from light. Cells were washed with PBS (3x 1 mL). Nuclear staining was achieved by addition 
of 1 mL per well prewarmed 300 nM DAPI solution in PBS for 5 minutes at room temperature. 
DAPI solution was then removed by aspiration and the cells washed with PBS (3 x 1 mL).  
Coverslips were removed from the well plate and rinsed with deionised water to prevent salt 
crystal formation and mounted onto glass slides with a drop of fluoroshield™ mounting 
medium. Slides were sealed using nail varnish and stored protected from light at 4°C. Confocal 
images were obtained within one week of slide preparation.  
 
Confocal microscopy  
Confocal microscopy was performed using a Zeiss Elyra PS 1 LSM780 inverted confocal 
microscope with a Zeiss 63x water immersion objective. Excitation/emission wavelengths for 
each fluorophore are as follows: DAPI (ex:360 em:450) Ifluor 488 (ex:480 em:520) 
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Alexafluor 488 (ex:480 em:520) BDP 630 (ex:630 em:650) Images were processed using 
imageJ®. 
 
3.2.2.10 Quantitative uptake of silicon oxide particles by RAW 264.7 cells assessed by flow 
cytometry 
 Preparation of particles 
RBITC modified particles were centrifuged at 5700 RPM (6175 G) for 10 minutes. From this 
point forwards all work was performed inside a sterile cell culture hood to maintain sterility. 
The EtOH supernatant was removed and the particles suspended in 1 mL buffer comprising 
1% HEPES in HBSS. Particles were counted using a haemocytometer to give the 
concentration of particles per mL of the stock suspensions. For each experiment the required 
volume of particle stock suspension was transferred to a fresh microcentrifuge tube and made 
up to 1 mL with 1% HEPES in HBSS buffer.  
 
Preparation of cells  
RAW 264.7 cells were harvested once they reach 60-80% confluency by scraping as 
described in chapter 2. 100,000 cells in culture media were seeded per well into a 12 well 
plate and incubated overnight at 37°C, 5% CO2, 95% humidity. In experiments where RAW 
264.7 cells were stimulated with LPS, culture media was used without 1% 
penicillin/streptomycin and was supplemented with 100 ng per mL LPS.  
Culture media was removed by aspiration and the cells washed with 1 mL pre-warmed (37°C) 
PBS. PBS was removed and 1 mL pre-warmed particle suspensions applied at ratios of 5 or 
10 particles per cell. Cells were incubated for 4 hours after which time the particle suspensions 
were removed and the cells washed with warm HBSS (3 x 1 mL). Cells were prepared for flow 




Preparation of fixed cells for flow cytometry: Image analysis method   
HBSS was removed from each well by aspiration and 250 μL accutase added to each well 
and the cells placed in an incubator for 5 minutes to detach cells. 250 μL HBSS was then 
added to each well and the total volume of each well transferred to fresh microcentrifuge tubes. 
Samples were centrifuged at 250 G for 5 minutes and the supernatants removed. The cells 
were suspended in 250 μL 4% formaldehyde in PBS for 20 minutes before being centrifuged 
for 5 minutes (250 G) and the supernatant removed. Fixed cells were suspended in 50 μL 
HBSS and stored at 4°C until analysis by flow cytometry. Samples were always analysed 
within 1 week of sample preparation.  
 
Preparation of cells for flow cytometry: Trypan blue quenching method 
HBSS was removed from each well by aspiration and 250 μL accutase added to each well 
and the cells placed in an incubator for 5 minutes to detach cells. 250 μL HBSS was then 
added to each well and the total volume of each well transferred to fresh microcentrifuge tubes. 
Samples were centrifuged at 250 G for 5 minutes and the supernatants removed. Cells were 
suspended in 50 μL HBSS and kept on ice until analysis by flow cytometry. All samples were 
analysed within 2 hours of sample preparation. Immediately before analysis of each sample 
10 μL 0.4% trypan blue solution was added to quench surface-bound particle fluorescence. 
  
Flow cytometry 
All flow cytometry was performed using an Amnis imagestreamX MKII imaging flow cytometer 
in standard configuration with 40X magnification. Illumination settings: Brightfield LED 32.01 
mW, 561 nm laser 200 mW, 785 nm laser 2 mW. Data was acquired using INSPIRE software 
with a minimum of 500 cells per sample (typically > 1000 per sample). Data was analysed 




3.3 Results and Discussion 
 
3.3.1 Characterisation of fabricated particles 
 
Silicon oxide microparticles anchored on to silicon wafers fabricated using photolithography 
by collaborators at the CNM and were characterised by SEM imaging (figure 3.1). The method 
involves growing a thermal layer of silicon oxide on top of a silicon wafer, a photomask is then 
used to selectively etch the particles that have a morphology which is defined by A) the 
photomask and B) the thickness of the original silicon oxide layer 222. After fabrication, particles 
remain anchored to the silicon wafer by a thin silicon support, which can subsequently be 
removed to release the particles into suspension. Particle shapes were selected so as to 
examine particle morphologies that had not yet been studied in the literature. 
The images show highly uniform particle populations for both hexahedrons (figure 3.1Ai-iii) 
and truncated pyramids (figure 3.1Bi-iii). Figure 3.1 Aiii shows a hexahedral particle removed 
from its silicon support, a ~200nm piece of the support remains attached to the particle. 
Uniformity of particle size and shape is essential to ensure that any effects of particle shape 
on cellular uptake in later experiments are not caused by polydispersity. Particle dimensions 
were measured using imageJ® and the results are displayed in table 3.1.  
Both hexahedrons and pyramids have a wider base than at the top of the particles and some 
curvature can be observed on the particle edges which is particularly evident in the truncated 
pyramids. For the calculation of particle volume and surface area this curvature was not taken 
into account and flat edges assumed. Silicon oxide spheres, acquired from a commercial 




Figure 3.1 SEM images of fabricated SiO2 microparticles Ai-iii) Hexahedrons Bi-iii) Truncated Pyramids 
 












Hexahedrons 1.1 3.4 3.1 35.1 11.6 
Truncated pyramids 3.2 2.8 1.8 40.5 17.2 
Spheres - - - 28.3 14.1 
 
 
3.3.2 Functionalisation of silicon oxide particles for fluorescent labelling 
As silicon oxide is transparent, in order to detect the microparticles within cells it was first 
necessary to label them with a fluorescent molecule. To achieve this, different methods were 
explored to modify silicon oxide hexahedrons while they were still attached to silicon wafer 
pieces. The functionalised particles could then be removed from their supports into 
suspension. This section applies a non-covalent functionalisation method previously used in 
the group to label polycrystalline silicon microparticles and well-established covalent linker 




3.3.2.1 Non-covalent labelling of silicon oxide particles was achieved using a complexation in 
solution method  
 
Previously, members of the group had used a step-by-step deposition method to first deposit 
1.2Br onto polysilicon particle surfaces and subsequently add the salt of a fluorescent 
porphyrin molecule 5,10,15,20-(tetra-4-carboxyphenyl)porphyrin (TCPP) 286. After activation 
of the particle surface, 1.2Br is immobilised on the particle surface. TCCP is then introduced 
which forms a complex with the immobilised 1.2Br (Scheme 3.1).  
 
Scheme 3.1: Step-by-step deposition of 1.2Br on to silicon oxide hexahedrons surface and subsequent 
complexation with TCPP.  
 
This method was applied to silicon oxide microparticles anchored to a silicon wafer, the results 
are shown in figure 3.2.  Successful activation of surface was confirmed by measuring water 
contact angle, activated surfaces had a water contact angle < 10° indicating hydrophilic nature 
due to hydroxyl groups present on the surface.  
As can be seen in the fluorescence images and fluorescence surface plot, poor labelling of 
the particles was achieved using this method (figure 3.2A). The particles can barely be 
distinguished from the background and there was very little difference in fluorescence 
compared to the control surface which had been immersed in TCPP solution without prior 
modification with 1.2Br (figure 3.2B) The presence of 1.2Br did not improve the fluorescent 
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labelling compared to the control as can be seen from the values in the fluorescence line plots 
(figure 3.2Aiv/Biv).  It was thought that the washing procedure used (washing the surfaces 
with DMSO) was causing the removal of 1.2Br from the particle surface and so this was further 
investigated. Changing to washing with water as well as removal of the washing procedure 






Figure 3.2: Images of surfaces after functionalisation using the step-by-step method. i) brightfield ii) fluorescence 
iii) fluorescence surface plots iv) fluorescence line plots of surfaces treated with  A) 1.2Br and TCPP B) TCPP 





The effect of other solvents used to immobilise 1.2Br (DCM, Acetone, Methanol) was 
investigated and the corresponding fluorescence images shown in figure 3.3. The 
fluorescence images and surface plots show that the solvent did affect the immobilisation of 
1.2Br on the surface. In the case of DCM the fluorescently labelled particles can be seen on 
the wafer (figure 3.3A), however the particles are not evenly labelled. Bright spots of 
fluorescence can be seen unevenly distributed across the surface of the particles. Note also 
that there are some areas without fluorescent particles. This is a result of accidental particle 
removal during the handling of the wafer pieces (surface damage).  
Likewise, immobilisation in acetone (figure 3.3B) resulted in unevenly labelled particles as well 
as highly fluorescent patches which are likely aggregates of TCPP. The fluorescence line plot 
(figure 3.3 Biv) suggests consistent functionalisation of particles, however, the presence of 
aggregates (which could not be removed by sonication) seemed also to increase the 
fluorescence of nearby particles, this is most likely an artefact.  
When methanol was used there was no evidence of particle labelling (figure 3.3C), only the 




Figure 3.3: Effect of solvent on particle functionalisation. i) Brightfield,ii) fluorescence, iii) fluorescence surface plots, iv) fluorescence line plots showing particle functionalisation 




None of the functionalised sample met the quality required, in terms of uniformity of labelling 
for cell studies. A new method was investigated by which the 1.2Br fluorophore complex was 
formed first in solution before being deposited on the activated particle surface as shown in 
figure 3.4A. For this method 5-(4-aminophenyl)-10,15,20-(triphenyl)porphyrin (ATPP) 
dissolved in acetone was used in place of TCPP, 1.2Br was dissolved in ethanol. The results 
are shown in figure 3.4B-C.  
 
 
Figure 3.4: Particle functionalisation using complexation in solution method. A) Scheme showing complexation in 
solution method, B) particles modified using 1.2Br and ATPP C) control particles immersed in ATPP overnight. i) 
Brightfield images ii) fluorescence images, iii) fluorescence surface plots, iv) fluorescence intensity profiles. Yellow 




The images show that the particles were fluorescently labelled by ATPP both in the presence 
of, and in the absence of 1.2Br. This indicates that ATPP adsorbs on to the surface of silicon 
oxide particles most likely as a result of the electrostatic interaction of the amino groups of the 
ATPP and the hydroxyl groups of the silicon oxide surface. The particles appear evenly 
labelled across their surfaces and the fluorescence surface plot shows that the fluorescence 
values are consistent between different particles. Particles labelled in the presence of 1.2Br 
had a higher MFI (5757 ± 259, n=502) compared with particles labelled in the absence of 1.2Br 
(1498 ± 65, n=488) which indicates that the presence 1.2Br increases the amount of ATPP 
binding to the particles surface.  
This method of fluorescent labelling showed much more even functionalisation than using the 
step-by-step method and so was taken forward to compare with the well-established covalent 
linking methods.  
 
3.3.2.2 Covalent labelling using silane linkers  
Covalent labelling methods have been used by a vast number of groups in order to label silica 
particles with fluorescent molecules or other molecules of interest 287. There are a wide variety 
of silanes that are available to purchase which have different terminal functional groups for 
this purpose. The use of four silane linkers were explored, PFP, GOPTS, APTMS, and 




Figure 3.5: Chemical structures of silanes: 10-(pentafluorophenoxycarbonyl)decyltrimethoxysilane (PFP), (3-
glycidoxypropyl)trimethoxysilane  (GOPTS),  3-aminopropyl trimethoxysilane  (APTMS), 11-
aminoundecyltriethoxysilane (AUTES).  
 
 
PFP and GOPTS contain reactive functional groups which undergo nucleophilic 
substitution/addition reactions (scheme 3.2 A, B) 288. As such, they react with molecules that 
contain primary amine groups to form amide and amino alcohol groups respectively. On the 
other hand, APTMS and AUTES are both amine terminated silanes which offer stable terminal 
groups that can be coupled with amine reactive fluorophores such as rhodamine B 





Scheme 3.2: Labelling of particle surfaces functionalised with silane linkers A) PFP and ATPP B) GOPTS and 





After activation using acidic and basic piranha treatment, silanes were deposited on particles 
attached to wafers and their water contact angles measured. The results are shown in table 
3.2. The increase in contact angle from hydrophilic (<10°) to hydrophobic (>40°) is consistent 
with the presence of hydrocarbon chains of the silanes and thus indicates successful 
deposition of each of the silanes. GOPTS, APTMS, and AUTES displayed comparable water 
contact angles to those previously published 289-291. Only one study has measured the contact 
angle of a surface after modification with PFP 288. A water contact angle of 88° was measured 
which is significantly higher than measured in this study, however a different deposition time, 
solvent, and substrate (polycrystalline silicon) were used.  
GOPTS and APTMS exhibit lower contact angles than PFP and AUTES, this is likely due to 
the length of the hydrocarbon chains. Longer chains are more hydrophobic and so produce 
higher contact angles 292-293. It would be expected that PFP would have a higher contact angle 
than AUTES owing to the highly hydrophobic pentafluorophenyl group, a possible explanation 
for the lack of difference could be that due to the instability of PFP, some reaction with 
atmospheric water might have taken place and so the surface is more hydrophilic.  
 
 
Table 3.2: Water contact angles θ (°) after treatment with PFP, GOPTS, APTMS, and AUTES 
 
Surface treatment 
Water contact angle ± 
s.d 
Activation < 10° 
PFP 59.0° ± 3 
GOPTS 38.9° ± 4 
APTMS 37.7° ± 11 





After immobilisation of each of the silanes on particle surfaces, ATPP solution was added to 
PFP and GOPTS- modified surfaces and RBITC was added to APTMS and AUTES-modified 
surfaces as shown in scheme 3.2. Fluorescence microscopy images showed that each of the 
silanes had been successfully immobilised onto the particle surface and had subsequently 
been labelled (figure 3.6).  
In each case uniformity of labelling on the surface of the particles was very consistent and 
comparable to the complexation-in-solution method. This is important for cell studies as an 
uneven distribution of fluorophore on the particle surface will cause a difference in interaction 
between the particle and cell and thus interfere with the results.  
All of the covalent linkers demonstrated suitable labelling in these microparticles to be used 
for cell work. Although these linkers have been used for labelling silicon oxide particles in the 
literature, it was necessary to test each of them in these novel microfabricated particles. 
AUTES was chosen as the linker for subsequent experiments because it has been 
demonstrated that linkers with longer carbon chains (undecyl) form stable monolayers that are 




Figure 3.6: Fluorescence of covalently labelled particles. A) PFP and ATPP, B) GOPTS and ATPP, C) APTMS and RBITC, and  D) AUTES and RBITC  i) Brightfield, ii) 
fluorescence iii) fluorescence surface plots, and iv) fluorescence intensity profiles. Yellow lines represent the location from which fluorescence line plots were taken.
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3.3.2.3 Comparison of fluorophore release from non-covalent and covalently labelled particles  
 
In order to be suitable for uptake experiments, it was necessary to determine that both non-
covalently labelled and covalently labelled particles would not release fluorophore in buffer 
conditions at 37°C. Wafer pieces possessing particles labelled non-covalently using 1.2Br-
ATPP or ATPP alone and covalently using AUTES-RBITC were incubated in PBS at 37°C for 
2 hours. The fluorescence intensity of the particles was assessed before and after incubation 
using fluorescence microscopy (figure 3.7). Median fluorescence intensity values were 
calculated by imaging 5 areas of each wafer piece and measuring the fluorescence intensity 
of 500 particles per area. After incubation 1.2Br-ATPP labelled particles showed a 19.9% 
reduction in fluorescence intensity indicating that ATPP was released into the buffer (figure 
3.8). This was also the case with particles that were non-covalently labelled with ATPP alone 
which showed a 53.1% reduction in fluorescence intensity. However, as expected no such 
decrease was seen with covalently labelled AUTES-RBITC particles which showed no 
significant change in fluorescence intensity.  
The release of ATPP from non-covalently labelled particles could cause erroneous results and 








Figure 3.7 images of particles before and after incubation in PBS 37°C for 2 hours. Fluorescence images, 
fluorescence surface plots, and fluorescence intensity profiles of particles before (i) and after (ii) incubation in PBS 
for 2 hours at 37°C. A) Particles labelled with ATTP in the presence of 1.2 Br, B) particles labelled with ATPP in 
absence of 1.2Br, C) Particles labelled with AUTES and RBITC. 
 
 
Figure 3.8: % reduction in fluorescence intensity after incubation in PBS at 37°C for 2 hours  
 
3.3.3 Characterisation of fluorescently labelled particles  
 
3.3.3.1 Measurement of median fluorescence intensity (MFI) and % coverage of fluorophore 
 
Silicon oxide spheres, hexahedrons, and pyramids were fluorescently labelled using AUTES 
and RBITC. For the spheres this process was performed while the spheres were in suspension 























































































wafers by a supporting anchor. Hexahedrons and pyramids were peeled away from the wafer 
by using a mounting medium as shown in scheme 3.3. The resulting particles in suspension 
were imaged using fluorescence microscopy (figure 3.9).  
 
Scheme 3.3: Peeling of microparticles from silicon wafer 
 
As can be seen from the images of the released particles, successful labelling was achieved 
for each of the particle shapes. Distinct particle shapes can be identified in the fluorescence 
images which correspond to the brightfield images indicating that RBITC is evenly distributed 
across the surface of the particles and that the labelling was not affected by the release of the 





Figure 3.9: Fluorescently labelled particles in suspension. Brightfield and fluorescence images of A) Spheres B) 
Hexahedrons C) Pyramids after immobilisation of AUTES and labelling with RBITC. Spheres were functionalised 
in suspension whereas hexahedrons and pyramids were functionalised on wafer pieces and subsequently released 
into suspension after detachment by peeling.  
 
In order to compare the degree of fluorescent labelling of each particle type, imaging flow 
cytometry was used to measure the median fluorescence intensity (MFI) (n>1000 particles of 
each shape). The obtained values are shown in table 3.3 and fluorescence intensity 
histograms are shown in appendix I S3.4. The values show that each particle type had similar 
MFI indicating a similar degree of labelling. To confirm this, an estimation of the percentage 
of labelled surface amines was made. This was done by comparing the MFI values of each 
particle type with a calibration curve of particles (3μm spheres) that had known percentages 
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of amines labelled with RBITC (Appendix I S3.5). This was achieved by labelling silane 
molecules prior to immobilization on the particles. The results displayed in table 3.3 show that 
all particles had lower than 2% of surface amines labelled with RBITC.  
 
Table 3.3: Particle MFI and estimation of surface labelling 
 
Particle type Particle MFI % amines labelled 
Spheres 21477.46 1.84 
Hexahedrons 22275.59 1.92 
Pyramids 18095.48 1.53 
 
 
It is important to have a similar amount of RBITC on the surface of the particles because 
rhodamine B is a relatively hydrophobic molecule (logP 1.95) 294  and so could therefore can 
promote uptake into cells 108. Juliano et al found that the uptake of dendrimers into HeLa cells 
was enhanced by their conjugation with Oregon green, a fluorescent dye with a similar 
chemical structure to rhodamine B, although the exact mechanism was not deduced 295. 
Additionally, it has been shown that rhodamine B interacts with type BI scavenger receptors 
and so could enhance uptake via specific receptor interactions 296. However, by having a low 
percentage of surface amines labelled with rhodamine, these effects on interaction with the 
cells will be reduced. In a study looking at the required amount of particle surface 
functionalisation to enhance cellular uptake, it was found that at least 4% of the surface 
functional groups (maleimide) needed to be covered with wheat germ agglutinin (WGA) in 
order to significantly increase uptake of PEG-PLA nanoparticles into Calu-3 cells in 





3.3.3.2 Measurement of trypan blue quenching efficiency 
One of the methods to be used to distinguish internalised particle from surface-bound particles 
in this chapter requires the use of fluorescence quenching of surface-bound particles. In order 
for this method to be effective the degree of fluorescence quenching must be known to ensure 
that surface-bound particles are significantly less fluorescent than internalised particles. In 
order to calculate this, the MFI of each particle type was measured before and after quenching 
with trypan blue (n>1000 particles). The results are displayed in table 3.4. In each case the 
MFI was decreased after trypan blue quenching by over 90%. This indicates particles can be 
suitably quenched in order to distinguish internal and surface-bound particles 298.  
 
Table 3.4: Quenching efficiency of trypan blue 
Particle type Particle MFI Quenched particle MFI 
Quenching efficiency 
(%) 
Spheres 21477.46 1921.78 91.05 
Hexahedrons 22275.59 987.17 95.57 
Pyramids 18095.48 1062.05 94.13 
 
 
3.3.4 Particle interaction with RAW 264.7 cells 
3.3.4.1 Qualitative determination of microparticle uptake  
In order to examine if each of the differently shaped microparticles could be internalised by 
RAW 264.7 macrophages, laser scanning confocal microscopy (LSCM) and immunostaining 
was used. Macrophages were incubated with fluorescently labelled particles of each shape 
for 4 hours before being fixed and stained. BDP 630 was used in place of RBITC to 
fluorescently label the particles for this qualitative examination of particle uptake.  
Representative Z-projections are displayed along with their orthogonal views and 3D 
representations in figure 3.10. Cell nuclei, stained with DAPI are shown in blue, actin filaments 
stained with ifluor488 phalloidin are shown in green and particles are displayed in red.  Actin 
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staining with phalloidin shows the cell cytoskeleton, with cells appearing either rounded or in 
some cases spread out with pseudopodia seen protruding from cells. 
Particles appear as hollow shapes in the orthogonal views (figure 3.10 Bi-Di), because they 







Figure 3.10: CLSM images of RAW 264.7 cells with internalised microparticle shapes. i) Z projections and 
orthogonal views, ii) 3D reconstructions of cells treated with A) 1% HEPES in HBSS only B) Spheres C) 
Hexahedrons D) Pyramids. Nuclear staining (BLUE), Actin staining (GREEN), Particles (RED).  
 
In comparison with control cells that had not received any particle treatment, macrophages 
which had been treated with particles displayed similar morphologies and nuclear shapes. The 
actin cytoskeleton staining (green) can be used to determine if the particles have been 
internalised. In the orthogonal views, particles found within the green boundary of the 
cytoskeleton can be considered to have been internalised. These images show that each of 
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the particle shapes had been internalised by RAW 264.7 macrophages. Particles were 
typically found in the perinuclear region of the cell which is in line with the established literature 
which details that upon phagocytosis particles are contained within the phagosome which is 
transported towards the nucleus fusing with lysosomes to become a phagolysosome 299-302. 
 
3.3.4.2 Intracellular localisation of Spheres, hexahedrons, and Pyramids  
Immunostaining was used in order to determine the intracellular localisation of the particles 
after internalisation had taken place. Cells were incubated with particles for 4 hours and then 
fixed and permeabilised. Cell nuclei were stained blue with DAPI and lysosomal-associated 
membrane protein 1 (LAMP-1) antibody stain (green) was applied to stain lysosomes/late 
endosomes. Images of stained cells with each particle shape are displayed in figure 3.11 with 
particles displayed in red. 
In untreated cells (figure 3.11 A) lysosomes/late endosomes were stained and appeared as 
small green dots inside the cell surrounding the nucleus. Lysosomes/late endosomes were 
not stained in all cells, this could be because not all cells contained lysosomes/ late 
endosomes or more likely due to a lack of staining, perhaps resulting from a lack of 
permeabilisation. In cells to which particles had been applied, lysosomes/ late endosomes 
could also be seen as small green dots throughout the cell. However, in cells that had 
internalised particles a green ring was often observed surrounding the particle. This indicates 
that LAMP-1 was present in the membrane surrounding the particle.  
Upon maturation of the phagosome, lysosomes and endosomes fuse with the phagosomal 
membrane to deposit their contents. A ‘Kiss and run’ mechanism has been proposed as a 
major mechanism for this, where complete fusion of the lysosomal/endosomal and 
phagosomal membranes is prevented by fission after some transfer of luminal contents has 
taken place 303. Proteins such as LAMP-1 are left behind in the late 
phagosome/phagolysosome thereby indicating that fusion has taken place 304. The white 
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arrows in figure 3.11 B, C, and D indicate particles that are surrounded by LAMP-1 positive 
membranes and are therefore contained within the late phagosome/phagolysosome.   
Particles that were clearly not internalised by cells displayed no such ring of green 
fluorescence thus demonstrating that the green fluorescence results from the LAMP-1 positive 
membrane rather than an artefact of overlapping fluorescent emission or direct binding of the 
LAMP-1 antibody to the particle. These particles are highlighted with yellow arrows in figure 
3.11 C and D.  
Also present are particles that had been internalised by cells but that did not display a ring of 
fluorescence. It is therefore likely that these particles were inside the phagosome and that 
endosome/lysosome-phagosome fusion had not yet taken place. No difference was seen 
between the different shapes in terms of localisation. As in the case of the actin staining, the 
majority of particles were situated in the perinuclear region of the cell.  
Images of at least 40 cells from each sample were examined and the percentage of particles 
surrounded by LAMP-1 positive membranes calculated. The percentage of spheres and 
pyramids was similar (60.9 and 53.3% respectively), however the percentage of hexahedrons 










Figure 3.11: Intracellular localisation of particles after phagocytosis. Particles treated with A) 1% HEPES in HBSS 
only B) Spheres C) Hexahedrons D) Pyramids. DAPI (BLUE), LAMP-1 (GREEN), Particles (RED). White arrows 





3.3.4.3 Comparison of image analysis and trypan blue (TB) quenching methods 
 
Imaging flow cytometry is a recently developed technique that allows the high-throughput 
imaging of cells and has been used for applications such as  quantifying particle internalisation 
and localisation 305-306.  However, as image analysis is a relatively new technique to quantify 
particle internalisation, and as there have been conflicting reports in the literature about its 
results, it was deemed necessary to compare the results acquired using this method with TB 
quenching, a more established method 273-274.  
RAW 264.7 macrophages were incubated with rhodamine B-labelled particle suspensions at 
particle:cell ratios of 5:1 and 10:1, with or without prior stimulation with LPS and the results 
shown in figure 3.12. Determination of particle uptake was calculated in two ways. Firstly, the 
percentage of cells which had internalised particles was measured by counting the number of 
cells which had a fluorescent intensity above the intensity of untreated cells and dividing by 
the total number of cells (figure 3.12A). Secondly, by fluorescent spot counting of cells with 
internal particles, the mean number of particles internalised per cell was calculated (figure 
3.12B).  
The data in figure 3.12 A showing the percentage of cells with internal particles indicates that 
there was no statistical difference between the two methods. Owing to the way in which the 
image analysis method discriminates internal from external particles (appendix I) it might be 
expected that an over estimate of the percentage of cells with internal particles is observed. 
This is because although surface-bound particles can be discriminated in the X- and Y-planes, 
the depth of field in the Z-plane is not sufficient to distinguish whether particles are internal or 
surface-bound. The TB method does not suffer this drawback and instead relies on adequate 
fluorescence quenching to gate surface-bound particles. Despite this, these results agree with 
the study by Vranic et al. that showed equivalent uptake using quenching and image analysis 
82 
 
274. A possible explanation for the lack of difference between the two methods is that the 
majority of particles are internalised rather than surface-bound and so the overestimation of 
surface-bound particles by the image analysis method is minimised.  
Particle uptake at 4°C was assessed using the image analysis method (figure S3.6) and 
showed a reduction in particle uptake in comparison to 37°C. As Phagocytosis is an energy-
dependent process it is reduced at this temperature, 307 and so this confirmed that the image 
analysis method was able to measure particle internalisation.  
The mean number of particles per cell was calculated and the data presented in figure 3.12 
B. In the majority of cases the image analysis method calculated a higher mean number of 
particles per cell than the trypan blue method. This may result from the fact that surface-bound 
particles in cells that have both internal and external particles are included in the image 





Figure 3.12: Comparison of image analysis and TB quenching methods for quantifying particle internalisation. A) % Cells that had internalised particles. B) Number of particles 
internalised per cell. *, **, ***, **** indicate statistical significance (p < 0.05, 0.01, 0.001, 0.0001 respectively) as calculated by multiple unpaired T-tests. Values are representative 




3.3.4.4 Effect of LPS stimulation on particle uptake   
Macrophages are highly dynamic cells that exhibit phenotypic changes in response to 
environmental cues. Upon stimulation with lipopolysaccharide (LPS), a component of bacterial 
cell membrane, differentiation occurs towards an M1 phenotype. This is characterised by 
changes in regulation of membrane receptors, (increase in expression of TLR2, TLR4, CD16, 
CD32, CD64, CD80, CD86, decrease in expression of Scavenger receptors A/B, CD163, MR, 
CD14, CD23) and changes in cytokine production (Increase in production of IL-12, IL-23, TNF-
α, IL-1, IL-6, Type 1 IFN, decrease in production of Il-10, IL-1 receptor agonist) 70. Therefore, 
the effect of the stimulation of macrophages with LPS on particle uptake was examined.  
RAW 264.7 cells were stimulated with LPS for 24 hours prior to dosing in order to encourage 
differentiation to the M1 phenotype. This was assessed visually by light microscopy as can be 
seen in figure 3.13. Cells that had undergone stimulation with LPS exhibited morphological 
changes as can been seen in figure 3.13 B. In general,  cells appeared larger and displayed 




Figure 3.13: Light microscopy images of RAW 264.7 cells incubated for 24 hours in A) Culture media, B) Culture 







Particle uptake by cells was analysed using both TB quenching and image analysis, the results 
are shown in figure 3.14. Figure 3.14 A shows the effect of LPS stimulation on the percentage 
of cells that had internalised particles. LPS stimulation did not alter significantly the percentage 
of cells taking up particles. The only significant difference was observed in the case of spheres 
that were administered at a dose of 10 particles per cell and analysed using the trypan blue 
quenching method where LPS stimulation resulted in a significantly lower percentage of cells 
with internal particles.  
Similarly, there was very little difference in the average number of particles taken up per cell 
in LPS stimulated and unstimulated cells (figure 3.14 B). The majority of cells internalised 1 or 
2 particles with a much smaller proportion of cells internalising 3 or more particles.  
A study by Rieger et al. using imaging flow cytometry demonstrated that, upon stimulation with 
LPS, RAW 264.7 macrophages association with microparticles increased overall, however the 
cause for the increase in association was not an increase in internalisation but an increase in 
surface binding of zymosan particles 310. If the same was true in the case of the silicon oxide 
particles used in this study, the increased binding of particles to the cell surface would not be 
detected by the TB quenching method as these additional particles would be quenched. The 
image analysis method can quantify this effect by analysing the percentage of cells with 
surface-bound particles as shown in figure 3.15.  Higher surface binding was not observed 
upon stimulation with LPS, instead no statistically significant difference in overall particle 






Figure 3.14: Effect of LPS stimulation on particle uptake. The effect of LPS stimulation on A) % cells with internalised particles B) The number of particles internalised per cell. *, 
**, ***, **** indicate statistical significance (p < 0.05, 0.01, 0.001, 0.0001 respectively) as calculated by multiple unpaired T-tests. Values are representative of three biological 





Figure 3.15: The effect of LPS stimulation on particle association, internalisation, and surface-binding. *, **, ***, **** 
indicate statistical significance (p < 0.05, 0.01, 0.001, 0.0001 respectively) as calculated by multiple unpaired T-
tests. Values are representative of three biological repeats ± SEM (N=3). 
3.3.4.5 Effect of particle shape on uptake by RAW 264.7 macrophages  
Macrophages have previously been shown to display differential uptake of particles depending 
on the particle morphology. As such, it was expected that differences in the internalisation of 
spheres, hexahedrons, and truncated pyramids would be observed. The results from 
analysing differences in internalisation between the different particle shapes using both the 
image analysis and TB quenching method are shown in figure 3.16. Using both analysis 
methods there was an increase in the percentage of cells with internal particles upon 
increasing the dose from 5 to 10 particles per cell figure 3.16 A. This effect was seen in both 
LPS-stimulated and non-stimulated cells. However the mean number of particles internalised 
per cell did not change with increasing dose (figure 3.16 B).  
Using the image analysis method, the data is presented as the percentage of cells associated 
with particles and further distinguishes the percentage of cells with internal and surface-bound 




Figure 3.16: The effect of particle shape on cellular uptake. The effect of particle shape on A) % of cells with internal particles, B) Number of particles internalised per cell. i/ii) 
analysed using image analysis method, iii/iv) analysed using TB quenching method. *, **, ***, **** indicate statistical significance (p < 0.05, 0.01, 0.001, 0.0001 respectively) as 




Using the image analysis method (figure 3.16Ai-ii) no significant differences between spheres 
and hexahedrons in terms of the percentage of cells associated with particles, the percentage 
of cells with internalised particles or the percentage cells with surface-bound particles. This 
was the case for both LPS-stimulated and non-stimulated cells. This was also the case using 
the TB quenching method, with no significant differences seen in internalisation of particles 
between spheres and hexahedrons (figure 3.16 Aiii-iv).  
However, significantly fewer cells internalised truncated pyramids compared to spheres 
indicating that the ability of macrophages to internalise truncated pyramids is lower. This may 
result from the anisotropic nature of these particles which can present to cells in multiple 
orientations as opposed to spherical particles which can only make contact with the cell in one 
orientation. Actin polymerisation must then occur in order to wrap the plasma membrane 
around the particle 311. Differences in the capacity of membrane wrapping, depending on 
particle orientation, could therefore result in reduced uptake.  
Curiously this effect was seen only in cells that had not been stimulated with LPS. There were 
no differences between any of the shapes in LPS-stimulated cells. Filopodia and membrane 
ruffles on the surface of macrophages are dynamic structures which have been shown to 
contribute to macropinocytosis and phagocytosis 312. Upon stimulation with LPS, actin 
polymerisation is increased resulting in more filopodia and membrane ruffles 313-315. This 
change in the macrophage skeletal structure could therefore explain the reduced the effect of 
particle shape seen in LPS-stimulated cells.  
No differences were seen in the number of particles internalised per cell for any particle shape 
(figure 3.16 Bi-iv). The majority of cells that internalised particles only internalised one particle 
regardless of particle shape and this was consistent for both particles doses.  
In a similar study by Sharma et al. which looked at the internalisation of polystyrene spheres, 
oblate ellipsoids, and prolate ellipsoids by RAW 264.7 macrophages, there was no difference 
in internalisation seen between the different shapes with volumes above 24 μm3 (particles 
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stretched from a 3.6 μm sphere) 242. There were, however, significant differences seen 
between the shapes that had volumes up to 0.69 μm3. The volumes of the particles used in 
this chapter were 14.14 μm3 (spheres), 11.6 μm3 (hexahedrons), and 17.2 μm3 (truncated 
pyramids) and so are in-between the volumes of particle groups used by Sharma et al.  
On the other hand, shape effects on internalisation of larger microparticles by macrophages 
has been reported by Doshi et al. who found that hyaluronic acid-coated disk-like 
microparticles (d = 6 μm) were able to avoid uptake by J774 macrophages compared with 
spherical particles (6 μm) of the same surface composition which exhibited high uptake 316. 
Additionally, Champion and Mitragotri have shown that worm-like particles (aspect ratio >20, 




Silicon oxide have been fluorescently labelled on the surface in order to be used for cell 
studies. Non-covalent and covalent labelling methods were explored with covalent methods 
proving to result in a more uniform and stable labelling.  
Image analysis as a method for quantifying particle uptake was compared with the trypan blue 
quenching method and proved to give similar results demonstrating its usefulness as a 
technique which does not rely on specific quenching of fluorophores.  
The effect of particle shape on cellular uptake was evaluated. RAW 264.7 cells could 
phagocytose all particle shapes which were shown to follow the established phagosomal 
maturation pathway. The uptake of particles increased with increasing dose and was not 
significantly altered upon stimulation of macrophages with LPS. Very little difference in particle 
uptake was observed between spheres and hexahedrons both in terms of the percentage of 
cells with internalised particles and the number of particles internalised per cell. However, 
truncated pyramids displayed reduced uptake in comparison with spheres.   
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4. Interaction of polysilicon microparticles with RAW 264.7 
macrophages 
 
4.1 Introduction  
Polycrystalline silicon (polysilicon) microfabrication (Scheme 4.1) offered more versatility in 
terms of varying the size and shape of microparticles than the method for producing the silicon 
oxide particles used in the previous chapter. A wider range of microparticle shapes was 
fabricated with varying lengths, thicknesses and curvatures. The effect of particle shape on 
cellular uptake, metabolic activity, membrane permeability, and lysosomal enzyme release 









4.1.1 Polysilicon and silicon microparticles 
 
Polysilicon microparticles, manufactured by photolithography, have been used by the group 
of Jose A. Plaza for a number of purposes 216, 221-222, 284, 288, 317-322. Their main focus has been 
to fabricate polysilicon barcodes which can be used for the purpose of cellular tracking 
throughout the assisted reproductive process 216, 318-319, 321. More recently, polysilicon micro-
devices were fabricated in order to measure changes in intracellular pressure and to measure 
intracellular mechanical forces 320, 322. These measurements are made possible by the high 
precision with which polysilicon particles can be fabricated. This property is advantageous for 
studies looking at the impact of particle shape on internalisation however, few such studies 
have been undertaken.  
The internalisation of polysilicon particles in THP-1 cells was assessed by Fernandez-Rosas 
et al. 317. Disk-shaped particles with a diameter of 3 μm and a thickness of either 1.5 or 0.5 
μm were used. SEM imaging showed that both particle types were taken up by the THP-1 
monocytes, however a quantitative examination of particle uptake was not performed.  
In a study by Duran et al. hexahedral polysilicon particles (3x3x0.5 μm) were fabricated with 
and without silicon nano wires grown on the top surface and their internalisation into Hela cells 
compared by SEM. The number of particle internalised per cell did not differ between the 
different types of particles, however nanowire coated particles were found to have their 
nanowire face in contact with the cell membrane more frequently than their flat face 323.  
The above studies highlight a difficulty of working with polysilicon particles which is that it is 
very expensive and time-consuming to fabricate the large numbers of particles that are 
required for quantitative uptake studies. As such these studies have used mainly 
qualitative/semi-quantitative techniques such as SEM to assess internalisation into low 
numbers of cells.  
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Similarly to polysilicon microparticles, monocrystalline silicon particles fabricated by a similar 
lithographic process have been assessed for their potential use as a drug delivery system in 
a number of studies by the group of Mauro Ferrari 220. Discoidal silicon microparticles have 
been used as a carrier for nanoparticles which in turn are carriers for the delivery of RNA, and 
chemotherapeutics 324-326. Uptake of discoidal particles with diameters of 1.6 and 3.2 μm by 
HUVECs demonstrated higher uptake of the smaller particles 248. In a study comparing the 
biodistribution of disk-shaped and cylindrical silicon particles in tumour-bearing mice, 
cylindrical particles were more accumulated more in the lungs than disk-shaped particles. 
Additionally, more disk-shaped particles were found in the tumour than cylindrical particles 327.  
The effect of polysilicon microparticle shape on internalisation by macrophages has not been 
studied. In this chapter, polysilicon microparticles serve as a model particle to investigate the 
effect of microparticle shape on interactions with macrophages. Polysilicon particles were 
fabricated and characterised by collaborators at the CNM (figure 4.1). A summary of their 
dimensions is shown in table 4.1. Shapes were designed so that all had at least one dimension 
of 3 μm (with the exception of 4 μm circular disks) as it is was shown in chapter 3 that RAW 
264.7 cells were able to internalise microparticles within these dimensions. The chosen 
particle shapes allow for the effect of factors such as particle length, thickness, and curvature 
on macrophage interaction to be examined. This could provide insight into particle shapes that 
are advantageous as carriers for drug delivery.  The crystal habits of active pharmaceutical 
ingredients (APIs) describe their particle shape depending on their crystalline form 328. APIs 
can form bar, needle, plate, or cuboid shapes and so the particle shapes chosen here are 





Figure 4.1: SEM images of the polysilicon particles used in this chapter. A) 3x3x0.5 μm hexahedrons, B) 3x3x0.05 
μm hexahedrons, C) 3x3x3 μm cubes, D) 3x15x0.5 μm bars, E) 3x15x0.05 μm bars, F) 3x10x0.5 μm bars, G) 
Circular disks diameter 3 μm, thickness 0.5 μm, H) Circular disks diameter 4 μm, thickness 0.5 μm, I) Circular disks 






















4.2 Materials and Methods 
4.2.1 Materials  
 
Rhodamine B isothiocyanate (RBITC, 283924), Triton X-100, Silicon oxide spheres (3 μm), 
LDH assay kit and 4-methyl umbelliferyl-β-D-glucuronide hydrate (MUG) were purchased from 
Sigma-Aldrich. AQueous One solution cell proliferation assay (MTS reagent) was purchased 
from Promega UK. 11-Aminoundecyltriethoxysilane (AUTES, S25045) was purchased from 
Fluorochem (UK). H2SO4 (98%) and NH4OH (20%) were purchased from Fisher Scientific. 
Polysilicon particles were provided by Centro Nacional de Microelectrònica (CNM) 
(Barcelona).  
4.2.2 Methods 
4.2.2.1 Fabrication and Scanning electron microscopy (SEM) characterisation of polysilicon 
particles 
Particles were fabricated and characterised by collaborators at the Centro Nacional de 
Microelectrònica (CNM) in Barcelona. Particles were fabricated according to the procedure in 
ref 330. Briefly, onto a 4 inch P-type silicon wafer, a 1 μm thick silicon oxide layer was grown 
by thermal oxidation. Chemical vapour deposition was then used to deposit a polysilicon layer 
of controlled thickness (3, 0.5, or 0.05 μm). A photoresist layer (HiPR 6512, thickness 1.5 μm) 
was spun onto the wafer and irradiated through a chromium mask. The irradiated areas were 
then removed by reactive ion etching using a Bosh process recipe (Alcatel A601). The 
photoresist was removed by plasma etching using a Tepla 300-E. HF (49%) vapours were 
used to dissolve the underlying oxide layer and release the particles from the underlying wafer. 
Particles were rinsed thoroughly with EtOH before being stored in EtOH. SEM images were 
analysed to measure particle dimensions using imageJ®. Particles were stored and 




4.2.2.2 Labelling of polysilicon particles with AUTES and RBITC 
Surface activation of polysilicon microparticles in suspension 
Polysilicon particles suspended in EtOH (700 μL) in microcentrifuge tubes were centrifuged at 
5700 RPM (6175G) for 10 minutes. Particles were suspended in 700 μL acidic piranha solution 
for 1 hour with shaking to prevent particles from falling out of suspension. Particles were 
centrifuged at 5700 rpm (6175G) for 10 minutes and the acidic piranha solution removed. 
Particles were washed by suspension in 700 μL milliQ water and then centrifuged at 5700 rpm 
(6175G) for 10 minutes. This washing process was repeated 3x and the supernatant removed. 
Particles were suspended in 700 uL basic piranha solution and left shaking for 30 minutes. 
Particles were centrifuged at 5700 rpm (6175G) for 10 minutes and the basic piranha solution 
removed. Particles were washed using the same suspension in 700 μL milliQ water and 
centrifugation steps used to wash the particles after removal of the acidic piranha solution. 
 
Labelling of polysilicon microparticles with AUTES and RBITC 
Initially the method used to label silicon oxide spheres was duplicated exactly as follows. 
Freshly activated polysilicon particles were suspended in 0.1% v/v AUTES in EtOH (700 μL) 
and left to shake for 2 hours. Particles were centrifuged at 5700 RPM (6175 G) for 10 minutes 
and the silane solution removed. Particles were washed by resuspension in 700 μL EtOH and 
centrifugation at 5700 RPM (6175 G) for 10 minutes before removal of the supernatant. This 
washing process was repeated 3x and then the supernatant removed. Particles were 
suspended in RBITC (30 μM) in EtOH (700 μL) and left on a shaker overnight while protected 
from light. Particles were washed with EtOH 3x 700 μL by repeated suspension and 
centrifugation as above. 
Alternative conditions for silane addition were surveyed as follows: 0.1% v/v AUTES in 
Toluene, 0.1% v/v AUTES in Acetone. Reaction with AUTES was carried out for 2 hours and 
the remaining labelling steps were carried out as before. Control particles were incubated with 
RBITC (30 μM) overnight after surface activation but without treatment with AUTES.  
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Labelling of particles was assessed by fluorescence microscopy. Brightfield and fluorescence 
images were acquired using a Nikon Eclipse TiU fluorescence microscope. For fluorescence 
imaging of RBITC labelled samples, exposure time was kept constant (1s) ex = 550 nm and 
em >590 nm. Images were processed using imageJ® to produce fluorescence surface plots 
and measure median fluorescence intensity values. 6 particles were analysed per sample.    
 
 
4.2.2.3 Label free detection of polysilicon particles by light scattering 
Particles were assessed for their ability to scatter the 642 nm laser in an Amnis imagestreamX 
MKII imaging flow cytometer. Polysilicon particles were suspended in 1% HEPES in HBSS 
and scattering intensity histograms of each particle type were compared with the scattering of 
RAW 264.7 cells to see which particles had a sufficiently high scattering to be able to 
discriminate cells without particles from cells with particles.  
 
4.2.2.4 Quantification of polysilicon particle uptake by RAW 264.7 cells by flow cytometry 
 
Preparation of particles 
Particles stored in EtOH in microcentrifuge tubes were centrifuged at 5700 RPM (6175 G) for 
ten minutes. From this point on all work was carried out inside a sterile cell culture hood to 
maintain sterility. The EtOH supernatant was removed and the particles suspended in 1 mL 
buffer comprising 1% HEPES in HBSS. Particles were counted using a haemocytometer and 
required volume of each particle stock containing 300,000 particles transferred to fresh 
microcentrifuge tubes. The volume of each microcentrifuge tube was then made up to 1 mL 
with the required volume of 1% HEPES in HBSS. Particle suspensions were warmed to 37° C 




Preparation of cells  
RAW 264.7 cells were harvested once they reach 60-80% confluency by scraping as 
described in section 2.2.1. 100,000 cells in culture media were seeded per well into a 12 well 
plate and incubated overnight at 37°C, 5% CO2, 95% humidity. Culture media was removed 
by aspiration and the cells washed with 1 mL pre-warmed (37°C) PBS. PBS was removed and 
1 mL pre-warmed particle suspensions applied at a ratio of 3 particles per cell. Cells were 
incubated for 4 hours after which time the particle suspensions were removed and the cells 
washed with 3 x 1 mL warm HBSS. Cells were prepared for flow cytometry. 
Preparation of cells for flow cytometry 
HBSS was removed from each well by aspiration and 250 μL accutase added to each well 
and the cells placed in an incubator for 5 minutes to detach cells. 250 μL HBSS was added to 
each well and the total volume of each well transferred to fresh microcentrifuge tubes. 
Samples were centrifuged at 250 G for 5 minutes and the supernatants removed. The cells 
were suspended in 250 μL 4% formaldehyde in PBS for 20 minutes before being centrifuged 
for 5 minutes (250 G) and the supernatant removed. Fixed cells were suspended in 50 μL 
HBSS and stored at 4°C until analysis by flow cytometry. Samples were always analysed 
within 1 week of sample preparation.  
Flow cytometry 
Flow cytometry was performed using an Amnis imagestreamX MKII imaging flow cytometer in 
standard configuration with 40X magnification. Illumination settings: Brightfield LED 30.75 
mW, 642 nm laser 150 mW, 785 nm laser 1.25 mW. Data was acquired using INSPIRE 
software with a minimum of 500 cells per sample (typically > 1000 per sample). Data was 
analysed using IDEAS software. 
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Quantification of particle internalisation by image analysis 
Single cell populations were first determined by plotting a scatter plot of area against aspect 
ratio. Scattering intensity histograms of single cells were plotted to distinguish particle 
associated and non-associated cells as shown in figure 4.2. Cells with internal particles were 
distinguished from cells with surface-bound particles using the same image analysis method 
as in chapter 3 but instead of fluorescence, light scattering was used to identify the location of 





Figure 4.2: Distinction between polysilicon particle-associated and unassociated cells using scattering intensity. A) 
Scattering of untreated RAW 264.7 macrophages B) Scattering of RAW 264.7 cells treated with polysilicon 





Figure 4.3: Distinction between cells with internal particles and cells with external particles A) Histogram showing 
internalisation score. Brightfield, scattering and overlay images of B) Cell with external particle C) Cells with internal 
particle 
 
4.2.2.5 MTS, LDH and glucuronidase assays 
 
Preparation of particles 
Particles stored in EtOH in microcentrifuge tubes were centrifuged at 5700 RPM (6175 G) for 
ten minutes. From this point on all work was carried out inside a sterile cell culture hood to 
maintain sterility. The EtOH supernatant was removed and the particles suspended in 1 mL 
buffer comprising 1% HEPES in HBSS. Particles were counted using a haemocytometer and 
required volume of each particle stock transferred to fresh microcentrifuge tubes. The volume 
of each microcentrifuge tube was made up to 500 μL with the required volume of 1% HEPES 
in HBSS. Particle suspensions were warmed to 37° C before addition to cells.  
 
Preparation of cells 
RAW 264.7 cells were harvested once they reach 60-80% confluency by scraping as 
described in section 2.2.1. 10,000 cells in 150 μl culture media were seeded per well into a 
clear 96 well plate and incubated overnight at 37°C, 5% CO2, 95% humidity. Culture media 
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was removed by aspiration and the cells washed with 200 μL pre-warmed (37°C) PBS. PBS 
was removed and 150 μL pre-warmed particle suspensions applied to each well. 150 μL 1% 
HEPES in HBSS was applied as a negative control, 0.1% Triton X-100 in PBS was applied as 
a positive control. Cells were incubated for 4 hours after which time 50 μL per well cell-
conditioned buffer was removed and transferred to a fresh clear 96 well plate for LDH assay 
and 50 μL per well cell-conditioned buffer transferred to a fresh black 96-well plate for 
glucuronidase assay. Remaining cell-conditioned buffer was removed by aspiration and the 
cells washed with 3x 150 μL pre-warmed PBS.  
MTS assay 
The MTS assay is a colorimetric assay that measures the metabolic activity of cells. It contains 
a tetrazolium dye ([3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium] (MTS)) and an electron coupling reagent, phenazine 
ethosulphate (PES). The MTS reagent is reduced by metabolically active cells to produce a 
coloured formazan product. The quantity of formazan produced is directly proportional to the 
metabolic activity of cells and can be determined by recording the absorbance at 492 nm. 
The MTS assay was performed according to the manufacturer’s instructions. After removal of 
the cell-conditioned buffer and washings with 3x 150 μL PBS, remaining PBS was aspirated 
and 20 μL MTS reagent in 100 μL culture medium was added to each well. Cells were 
incubated at 37°C, 95% humidity, 5% CO2 for 2 hours after which time the absorbance at 492 
nm of each well was measured using a TECAN spark microplate reader. Relative metabolic 
activity was calculated with respect to the negative control by using the following equation. 
Relative metabolic activity (%) = ((X – positive control) / (negative – positive 
control))*100 




The LDH assay is a colorimetric assay that measures the viability of cells by measuring the 
release of LDH. LDH is an intracellular enzyme located in the cytoplasm that is only released 
from cells when there is damage to the cellular membrane and therefore can be used as a 
measure of cell death relative to healthy cells. Released LDH in culture medium reduces NAD 
to NADH which in turn reduces a tetrazolium reagent to a coloured formazan product. The 
quantity of formazan which is proportional to membrane damage can be determined by 
absorbance at 492nm thus relative LDH release can be calculated. 
The LDH assay was performed according to the manufacturer’s instructions. To the clear 96 
well plate containing 50 μL per well cell-conditioned buffer, 100 μL LDH reagent was added 
and the well plate left for 2 hours at room temperature while protected from light. After this 
time the absorbance at 492 nm was measured using a TECAN spark microplate reader. 
Relative LDH release with respect to the positive control was calculated using the following 
equation. 
Relative LDH release % = ((X – negative control)/(positive – negative control))*100 
Where X = absorbance of the sample well 
Glucuronidase assay 
4-Methylumbelliferyl-β-D-glucuronide hydrate (MUG) is a non-fluorescent substrate for β- 
glucuronidase. Upon cleavage of the O-glycosidic bond, fluorescent 4-methylumbelliferone is 
produced with excitation maximum at 372 nm and emission at 445 nm. The fluorescent signal 
is proportional to the amount of enzyme activity and so can be used to measure the release 
of the lysosomal enzyme β-glucuronidase in to the culture media.  
MUG was dissolved in sodium acetate buffer 0.1M pH 4.5 to a final concentration of 100 µM. 
To the black 96 well plate containing 50 μL per well cell-conditioned buffer, 100 uL per well 
MUG solution was added. The plate was then protected from light and incubated for 2 hours 
at 37°C 95% humidity, 5% CO2. After this time 10 μL per well NH4OH was added to terminate 
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the reaction and increase the fluorescent signal. Fluorescence signal at 460 nm was then 
measured after excitation at 360 nm using a TECAN spark microplate reader. Relative β-
glucuronidase release with respect to the positive control was then calculated using the 
following equation. 
Relative β-Glucuronidase release % = ((X – negative control)/(positive – negative 
control))*100 




4.3 Results  
 
4.3.1 Functionalisation of polysilicon particles with AUTES and RBITC 
In order to be able to detect the presence of polysilicon particles after administration to cells 
by flow cytometry, the particles were labelled using AUTES and RBITC using the same 
procedures as the silicon oxide particles in chapter 3. The particles were then imaged using 
fluorescence microscopy and images of the particle analysed to assess their brightness and 
uniformity of labelling. Hexahedrons of dimensions 3x3x0.5 μm were used to assess particle 
labelling.   
Figure 4.4 shows representative brightfield and fluorescence microscopy images as well as 
fluorescence surface profiles of fluorescently labelled polysilicon microparticles. Ethanol was 
used as the solvent for AUTES self-assembled monolayer (SAM) formation on silicon oxide 
particles in the previous chapter and so it was thought that this would be appropriate to use 
the same protocol for polysilicon particles. The activation by acidic and basic piranha causes 
and oxide layer to form on the surface of silicon which then allows for SAM formation 331. 
However, as can be seen in the fluorescence images and fluorescence surface plots (figure 
4.4A), poor labelling was achieved as particles could barely be distinguished from the non-
fluorescent background and were similar to unmodified control particles (figure 4.4D). Acetone 
(figure 4.4B) and toluene (figure 4.4C) were assessed as alternative solvents for AUTES 
deposition as these have been used in the literature for the deposition of aminosilanes to 
silicon surfaces 332-333. A greater degree of labelling was achieved with both acetone and 
toluene, however labelling was non-uniform. In all cases particles displayed patches of higher 






Figure 4.4: Effect of AUTES deposition solvent on particle labelling with RBITC. Brightfield images, fluorescence images, and fluorescence surface plots of 3x3x0.5 μm polysilicon 




Deposition of silanes onto silicon wafers has been shown to occur faster and result in higher 
silane surface concentration in toluene than ethanol 334. Using polysilicon particles, Penon et 
al. showed that silane layers of the same chain length to those used in this chapter were 
deposited faster in toluene (within 30 minutes) than those in ethanol (overnight) 288. Given this, 
it seems that polysilicon particles may require a longer silanisation step than silicon oxide 
particles used in chapter 3, potentially due to their crystalline nature. This may account for the 
lack of labelling when ethanol was used as the deposition solvent. The lack of labelling 
uniformity could result from partial deposition of the silanes due to insufficient silanisation time. 
Alternatively it could be due to the arrangement of the silanes as they form on the rough 
polycrystalline silicon surface. For example, if the conformation of the silanes is such that the 
amine is not sufficiently exposed to react with the RBITC then a lack of labelling will result. In 
order to determine the molecular arrangement of silanes as they deposit on to the polysilicon 
surface, angle resolved XPS could be used 335. Atomic force microscopy (AFM) would typically 
be used to characterise monolayers on surfaces 336, however this is not possible with 
polysilicon due to its inherent rough surface.  
Additionally, loss of particles (3x3x0.5μm hexahedrons) over the course of the 
functionalisation procedure (loss during the washing steps) was assessed by counting with a 
haemocytometer.  The number of particles was measured at the beginning and end of the 
functionalisation process. On average microcentrifuge tubes contained 1,583,750 particles (± 
65,407) before the functionalisation (as received) and 162,500 particles (± 7071) after 
functionalisation (89.7% of particles lost).  Due to the high loss of particles during the 
functionalisation process, further optimisation of particle labelling was not performed. Instead, 
a label-free method of detecting polysilicon particles was pursued which reduces the need for 
high numbers of washing steps and subsequent loss of particles. In addition, it ensures that, 
as all particles have the same surface chemistry, the effect of surface chemistry on cellular 
interaction between the different particle shapes is negligible 
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4.3.2 Assessment of particle side scattering  
 
As methods to uniformly fluorescently label polysilicon particles were not successful, it was 
necessary to find an alternative method to distinguish cells associated with particles from 
unassociated cells. Particle side scattering has been used by a number of groups to detect 
high refractive index inorganic particles in cells 337. This approach has been used to detect the 
association of cells with Stainless steel, TiO2, ZnO, CuO, Fe3O4, Ag, and Au nanoparticles as 
well as carbon nanotubes338-343. Additionally, Mauro Ferrari and colleagues have used side 
scattering to detect porous silicon microparticles in human umbilical vein endothelial cells 
(HUVECS) 344. Side scatter is heavily dependent on both refractive index and particle shape 
and so each particle shape was assessed and compared with cellular side scatter to ensure 
that the two could be distinguished in a mixed population. The scattering intensity histograms 





Figure 4.5: Scattering intensity histograms of RAW 264.7 cells and each particle shape. A) RAW 264.7 cells, B) 
hexahedrons 3x3x0.5 μm, C) hexahedrons 3x3x0.05 μm, D) cubes 3x3x3 μm, E) Bars 3x15x0.5 μm F) Bars 




RAW 264.7 cells displayed a median scattering intensity (MSI) of 22382 ± 3575 (figure 4.5A) 
and so the MSI of particles needed to be significantly higher than these values in order to 
unambiguously distinguish between particle associated and non-associated cells. Figure 4.6A 
displays the MSI values of each particle shape. The data shows that for the majority of particle 
shapes the scattering intensity was significantly higher than that of RAW 264.7 cells, meaning 
that they could be used in a label-free manner for uptake studies. However, this was not the 
case for 3x3x0.05 μm hexahedrons and 3x0.05 μm circular disks which both had similar MSI 
to that of RAW 264.7 cells. This is likely because of the thickness of the particles (0.05 μm) 
which makes the particles semi-transparent and thus reduces the amount of light scattered. 
These particles were therefore not suitable for use in cell uptake studies using this method. 
Despite having the same thickness, bars with dimensions 3x15x0.05 μm were able to be 
distinguished from cells because of their length, although scattering was significantly reduced 
compared to 3x15x0.5 μm bars.  
In terms of measuring cellular uptake, this method of detection is advantageous because it 
avoids a chance of differences in surface labelling affecting the results. Studies have shown 
that having a higher amount of surface labelling can increase uptake, 295 potentially due to the 
hydrophobicity of the dye molecules and so by maintaining the uniformity of the particle 
surface chemistry across all particle shapes, the chance of erroneous results relating to this 





Figure 4.6: Summary of MSI values for RAW 264.7 cells and each particle shape. Particle MSI values compared 
with RAW 264.7 cells. * indicates statistically significant difference between particle scattering and RAW 264.7 cell 




4.3.3 Polysilicon particle association with RAW 264.7 macrophages 
 
Side scattering intensity of RAW 264.7 cells that had been exposed to polysilicon particles for 
4 hours was measured by imaging flow cytometry. Representative scattering intensity 
histograms for each particle type are shown in figure 4.7. In each case, two clear populations 
of unassociated cells (lower scattering intensity) and cells associated with particles (higher 
scattering intensity) can be clearly distinguished. This was confirmed by visual examination of 
the cell images in each population by looking at images across the intensity range of each 
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population. Cell images from low (minimum), medium (median) and high (maximum) 
scattering intensity for each population for each sample are shown in figure 4.8. As can be 
seen from the images of unassociated cells, high scattering intensity relates to having a more 
granular appearance than those of low scattering. In particle-associated cells, higher 




Figure 4.7: Side scattering intensity histograms of RAW 264.7 cells incubated with polysilicon particles. A) 
Hexahedrons (3x3x0.5 μm), B) Cubes (3x3x3 μm), C) Bars (3x15x0.5 μm), D) Bars (3x15x0.05 μm), E) Bars 





Figure 4.8: Cell images from imaging flow cytometry across the range of scattering intensities for cells unassociated 
and associated with polysilicon particles. A) Hexahedrons (3x3x0.5 μm), B) Cubes (3x3x3 μm), C) Bars (3x15x0.5 
μm), D) Bars (3x15x0.05 μm), E) Bars (3x10x0.5 μm), F) Circular disks (d=4 μm h= 0.5 μm), G) Circular disks (d=3 




The percentage of cells that are associated with particles is shown in figure 4.9A. 3x3x0.5 μm 
hexahedrons had the highest association (24.6%) and was significantly higher than all other 
particle shapes apart from 3x3x3 μm cubes (12.9%). There were no significant differences 
between 3x15x0.5 μm bars (8.1%), 3x15x0.05 μm bars (6.8%), 3x10x0.5 μm bars (10.0%), 4 
μm circular disks (11.45%), and 3 μm circular disks (11.3%).  
Despite having similar dimensions there is a large difference between the association of 
3x3x0.5 μm hexahedrons and 4 and 3 μm circular disks. This may point to a role for particle 
curvature in influencing cellular association.  
Bar-shaped particles showed the lowest association, however as there was no statistical 
difference between the different bar shapes, no effect of bar thickness (0.5 μm against 0.05 
μm) or length (15 μm against 10 μm) was observed.  
Due to the large size of these microparticles it was not clear whether the macrophages would 
internalise the particles or simply spread onto the particle surface in so-called frustrated 
phagocytosis 345. To examine this, the image analysis method used in chapter 3 was applied 
in order to assess the percentage of particles with internal particles and the percentage of 
cells with surface-bound particles. After application of the analysis, images of cells were 
assessed visually to check that internal and surface-bound particles were distinguished 
(appendix II figure S4.1). For bar-shaped particles there were clear instances of particle 
internalisation, whereby the shape of the cell is less circular and appears to have stretched to 
accommodate the presence of the internalised bar. Cells with surface-bound particles could 





Figure 4.9: Cellular association, internalisation and surface binding of polysilicon particles with RAW 264.7 cells. 
A) % cells associated with particles, B) % cells with internalised particles, C) % cells with surface-bound particles. 
Statistical differences analysed by one-way ANOVA with Tukey’s multiple comparisons test (* p<0.05, ** p<0.01, 
*** p<0.001, **** p<0.0001). n=1, N=3 ± SEM 
 
Figure 4.9B shows the percentage of cells that had internal particles. Similarly to the 
association data, 3x3x0.5 μm hexahedrons showed the highest internalisation (20.3%), 
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however this was not significantly different from 3x3x3 μm cubes (11.25%) or 4 μm circular 
disks (9.3%). There were no significant differences in internalisation between 3x15x0.5 μm 
bars (7.8%), 3x15x0.05 μm bars (5.6%), 3x10x0.5 μm bars (8.95%), and 3 μm circular disks 
(8.1%).  
Figure 4.9C shows the percentage of cells that had surface-bound particles. Here, more 
significant differences between the different particle shapes were observed. 3x3x0.5 μm 
hexahedrons showed significantly higher surface binding than all other shapes (3.9%). 3 μm 
and 4 μm circular disks showed statistically equivalent surface binding (3.1% and 2.1% 
respectively). 3x3x3 μm cubes, 3x15x0.5 μm bars, 3x15x0.05 μm bars, and 3x10x0.5 μm bars 
showed the lowest surface binding (1.5%, 0.3%, 1.3%, and 1.0% respectively).  
As the first stage of phagocytosis is binding of the cell membrane to the particle, the higher 
surface binding of hexahedrons tallies well with their increased uptake. Low binding of cells to 
bar-shaped particles could be the reason for lower internalisation. 
The effect of particle volume and surface area on cellular association, internalisation, and 
surface binding was assessed to see if a correlation was present (figure 4.10). For cellular 
association (figure 4.10A) and internalisation (figure 4.10B) there was a poor correlation with 
both particle surface area (R2 = 0.28 and 0.18 respectively) and particle volume (R2 = 0.07 
and 0.02 respectively). This indicates that differences in cellular association and internalisation 
are not dependent on particle surface area or volume when different shapes of particle are 
administered to cells.  
For surface binding (figure 4.10C) there was an inverse correlation with particle surface area 
(R2 = 0.69). A higher proportion of cells had surface bound particles when the particle surface 





Figure 4.10: Particle factors affecting cellular association, internalisation, and surface-binding. Graphs showing the 
effect of particle surface area and volume on A) cellular association, B) particle internalisation, and C) particle 















The number of particles per cell was calculated by dividing the MSI of the cells with internal or 
surface-bound particles by the MSI of the particles, this data is shown in figure 4.11. On 
average between 1 and 1.5 particles was internalised per cell for 3x3x0.5 μm hexahedrons 
(1.34), 3x3x3 μm cubes (1.15), 3x15x0.05 μm bars (1.16), 4 μm circular disks (1.42), and 3 
μm circular disks (1.36) (figure 4.10A). For 3x15x0.5 μm bars and 3x10x0.5 μm bars 0.62 and 
0.82 particles per cell was calculated respectively.  
Similarly for surface-bound particles (figure 4.10B) ~1 surface-bound particle per cell was 
calculated for 3x3x0.5 μm hexahedrons (1.11), 3x3x3 μm cubes (1.15), 3x15x0.05 μm bars 
(1.16), 4 μm circular disks (0.99), and 3 μm circular disks (1.15). For 3x15x0.5 μm bars and 




Figure 4.11: Effect of particle shape on number of internalised (A) and surface-bound (B) particles per cell. 
 
 
The calculated values for 3x15x0.5 μm bars and 3x10x0.5 μm bars are <1 because the 
scattering intensity values for the cells with particles is lower than the MSI value of the particles 
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on their own. The reason for this is not clear, however one possible explanation could be the 
orientation of the particles. When the MSI of the particles alone was measured for 3x15x0.5 
μm bars and 3x10x0.5 bars and particles aligned with the flow and so the MSI of the bars was 
calculated based on a single particle orientation. However, when the bars are present inside 
or on the surface of cells the orientation is more random with respect to the detector and so 
there is a disparity between the MSI of particles alone and the particles with cells.  
After manually reviewing the images of cells that were exposed to 3x15x0.5 μm bars, 91.4% 
(± 3.9%) of cells that had internalised particles had internalised 1 particle and 100% of cells 
that had surface-bound particles had 1 particle bound. For 3x10x0.5 μm bars 75.9% (± 8.1%) 
of cells with internal particles had internalised 1 particle and 93.7% (± 5.4%) of cells with 
surface-bound particles had 1 surface-bound particle. These results therefore suggest that, in 
line with the other particle shapes, the vast majority of cells were associated with 1 particle.  
 
 
4.3.4 Effect of particle shape on metabolic activity, toxicity, and lysosomal enzyme 
release 
 
4.3.4.1 MTS assay 
MTS assay was used to measure the metabolic activity of RAW 264.7 cells upon exposure to 
increasing ratios of polysilicon particles. Upon reduction of the assay compound by 
metabolically active cells producing dehydrogenase, a coloured formazan product is produced 
which can be detected by absorbance measurements 346. As the quantity of formazan 
produced is related to the metabolic activity of cells, it is often used as a measure of toxicity 
346. However, as phagocytosis is an energy-dependent process requiring actin polymerisation 
to rearrange cellular structure, ATP requirement is increased and changes in macrophage 
metabolism, for example an increase in the rate of glycolysis occurs 347-348. Changes in cellular 




Polysilicon hexahedrons (3x3x0.5 μm), cubes (3x3x3 μm), bars (3x15x0.5 μm) and bars 
(3x10x0.5 μm) were applied to RAW 264.7 macrophages and the effect on cellular metabolic 
activity studied (figure 4.12). Silicon oxide particles (spheres, diameter 3 μm) were also 
included as a comparator. Note, due to limited stock of particles, the maximum dose for cubes 
and bars was 30 particles per cell, while for hexahedrons it was 80 particles per cell. Spheres 
were applied up to 320 particles per cell.  
The metabolic activity followed a similar trend for each particle shape. Cellular metabolism 
increased compared to that of cells treated with 1% HEPES in HBSS. However, in the case of 
3 μm spheres (figure 4.12E) where higher doses of particles were administered, the maximum 
at 30 particles per cell (46 μg/mL) was followed by a steady decline in metabolic activity, likely 
indicative of toxicity. The highest dose used was equivalent to 500 μg/mL and metabolic 
activity was ~70% of the control cells, thus the EC50 was not reached. This is comparable to 
dosages found in the literature that elicit toxicity, however, often exposure to particles is 





Figure 4.12: Effect of increasing polysilicon particle dose on RAW 264.7 metabolic activity. A) Hexahedrons 
(3x3x0.5 μm), B) Cubes (3x3x3 μm), C) Bars (3x15x0.5 μm), D) Bars (3x10x0.5 μm), E) Silicon oxide spheres 
(diameter 3 μm). Relative metabolic activity was calculated with respect to cells treated with 1% HEPES in HBSS 





Maximum metabolic activity of cells treated with polysilicon particles was around 140-150% of 
control cells and was achieved at different particle doses. For hexahedrons and cubes this 
occurred at 20 particles per cell (10 μg/mL and 21 μg/mL respectively), for bar shaped particles 
3x15x0.5 μm and 3x10x0.5 μm this occurred at 12 particles per cell (31 μg/mL and 21 μg/mL 
respectively). The increase in metabolic activity could be indicative of the increased energy 
requirement of the cells internalising particles. As seen in the uptake data, between 5 and 20% 
of cells are likely to take up particles, which might explain why the increase in activity is not 
more pronounced at lower doses. The increases in metabolic activity do not match the uptake 
data, for example the largest increase was seen with bar shaped particles which also had the 
lowest uptake. This may indicate that these bar shaped particles required disproportionately 
large increase in metabolic activity upon internalisation.  
 
4.3.4.2 LDH assay  
 
Lactate dehydrogenase (LDH) is an intracellular enzyme which is present in the cytoplasm of 
cells and is only released extracellularly when the cellular membrane is damaged 350. As such, 
the LDH assay can be used to measure the toxicity of nano and microparticles 351. Polysilicon 
particles were applied at increasing doses and the amount of LDH in the supernatant 
measured compared with cells that were treated with 1% HEPES in HBSS (negative control, 
0%) and cells treated with 0.1% Triton X-100 (positive control, 100%). The data is shown in 




Figure 4.13: Effect of increasing polysilicon particle dose on RAW 264.7 LDH release. A) Hexahedrons (3x3x0.5 
μm), B) Cubes (3x3x3 μm), C) Bars (3x15x0.5 μm), D) Bars (3x10x0.5 μm), E) Silicon oxide spheres (diameter 3 
μm). Relative LDH release was calculated with respect to cells treated with 1% HEPES in HBSS (negative control), 




Low levels (5-10%) of LDH were released for each particle type for doses between 3-80 
particles per cell for hexahedrons, 3-30 for cubes, 3-20 for 3x15x0.5 bars, 3-30 for 3x10x0.5 
bars, and 3-80 for spheres. For 3x15x0.5 μm bars this increased to ~17% when the dose was 
increased to 30 particles per cell (78 μg/mL) indicating that at this dose an increasing number 
of cells were damaged by the particles. As in the case of the MTS assay the EC50 value was 
not obtained for polysilicon particles.  
For spherical particles, where higher doses could be applied, LDH release remained fairly 
constant up to 80 particles per cell (124 μg/mL). LDH release then increased and showed an 
EC50 value of ~250 particles per cell (388 μg/mL) thus indicating that membrane damage was 
increasing, causing cell death.  This matches fairly well with the MTS data. Although, the EC50 
was not obtained in that case, this is likely due to the initial increase in metabolic activity upon 
exposure to particles.  
 
4.3.4.3 Release of lysosomal enzyme glucuronidase 
During phagocytosis, actin polymerisation drives the formation of a phagocytic cup 
surrounding the particle, which is subsequently internalised 352. The internalised phagosome 
then matures by undergoing fusion with lysosomes containing an array of digestive enzymes 
353. It has been shown however, that during phagocytosis lysosomes can undergo fusion with 
the cell membrane (exocytosis) in order to contribute to the extra cellular membrane that may 
be required to engulf larger particles and that this process is increased with increasing particle 
size 354-355.  
Additionally, it has been shown that upon damage to the cell membrane, an influx of calcium 
ions causes intracellular vesicles, including lysosomes, to fuse with the cell membrane in order 
to regain plasma membrane integrity 356-357.  
Upon fusion with the cell membrane, the contents of the lysosome are released into the extra 
cellular medium which can then be detected. It was therefore hypothesised that polysilicon 
particles of different shapes would differentially trigger release of the lysosomal enzyme 
glucuronidase. The release of glucuronidase is therefore indicative either of the cells 
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requirement of additional membrane to engulf larger particles or damage to the cell 
membrane. The two can be distinguished by comparing glucuronidase release with LDH 
release which is only indicative of cell membrane permeability 358.  
Glucuronidase release was detected using 4-methyl umbelliferyl-β-D-glucuronide hydrate 
(MUG), a non-fluorescent molecule which becomes fluorescent upon degradation by 





Figure 4.14: Effect of increasing polysilicon particle dose on RAW 264.7 lysosomal glucuronidase release. A) 
Hexahedrons (3x3x0.5 μm), B) Cubes (3x3x3 μm), C) Bars (3x15x0.5 μm), D) Bars (3x10x0.5 μm), E) Silicon oxide 
spheres (diameter 3 μm). Relative glucuronidase release was calculated with respect to cells treated with 1% 
HEPES in HBSS (negative control), and cells treated with 0.1% Triton X-100 (positive control). Data is expressed 




The data for release of lysosomal glucuronidase follows a similar trend to LDH release. Low 
levels (~5% of total glucuronidase) were released from each particle shape across the 
administered dose range. It does not appear from this data that a significant different release 
of lysosomal glucuronidase occurs in response to the different particle shapes used, however, 
the congruency with the LDH data suggests that particles are causing some degree of cell 
membrane damage, which causes the release of both LDH and glucuronidase at low levels. 
In the case of 3 μm spheres, where higher doses were administered, lysosomal glucuronidase 
release increased with increasing dose rising from 13% to 57% of total lysosomal 
glucuronidase when particle dose increased from 160 to 320 particles per cell (250 to 500 
μg/mL).  
 
4.4 Discussion  
 
It is difficult to know if in vitro studies assessing the effects of nano and microparticles reflect 
realistic in vivo scenarios. It has been observed that toxicity can be caused by an overload of 
cells by particles which may not occur in vivo due to lower fractions of the applied dose 
reaching the cells 359. How the doses used in this study relate to realistic, physiological doses 
of particles to macrophages requires numerous assumptions. For example, considering 
particle delivery to the lung by a dry powder inhaler (DPI), only a rough estimate can be made. 
Stone et al. calculated the number of macrophages per surface area of alveolar epithelium to 
be ~1 macrophage per 18000 μm2 360 and it has been calculated that the surface area of 
alveolar epithelium to approximately 140 m2 361 . Using a deposition fraction for 3 μm particles 
in the alveolar region of 0.4 362 and assuming 50% of the total emitted dose makes it to the 
lungs 363, a 500 μg dose would result in 100 μg particles depositing in the alveolar region. 100 
μg particles of density 1.3 g/cm3 364 (spherical, diameter 3 μm) is equivalent to 5.4 x106 
particles and thus dividing by the approximate number of macrophages in the alveoli gives a 
particle per cell ratio of 0.0007. Therefore, realistically a macrophage is unlikely to interact with 
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more than one microparticle, therefore indicating that the doses used in this study are 
significantly above what may be delivered in a single inhalation from a DPI. However, removal 
of particulate material by macrophages is known to take place over a number of weeks, the 
accumulation of multiple doses of insoluble particles over a number of weeks could reach the 
levels of doses used in this study 365. 
Albrecht et al. studied the release of LDH and glucuronidase from alveolar macrophages 90 
days after the intra tracheal instillation of quartz particles (0.4-0.8 μm) in rats 366. The dose 
used (10 mg/kg) was chosen to represent the exposure of a worker to a years’ worth of 
respirable quartz rather than drug delivery, and showed increased release of both LDH and 
glucuronidase compared to a PBS control. However, in rats treated with quartz, the number 
of alveolar macrophages increased which likely contributed to the increase in enzyme release.  
On the other hand, Van Landuyt et al. studied the release of LDH and glucuronidase by 
NR8383 macrophages in vitro after exposure to quartz (of respirable size, but shape not well 
characterised) and showed similar enzyme release to those found in this study at similar 
doses. Enzyme release then increased with increasing dose between 22.5 and 180 μg/mL 367. 
Similarly to quartz particles, the polysilicon particles studied in this chapter are crystalline 
whereas the 3 μm spheres used are amorphous. Costantini et al. showed that amorphous 
particles are equally toxic to macrophages as crystalline particles 368. Moreover, significant 
membrane damage was seen after 4 hours incubation suggesting that the duration of 
experiments in this chapter were sufficient to observe these effects.  
In vitro studies utilising microparticles of different shapes have tended to focus on inhaled 
fibres with macrophage responses studied to assess potential toxicity predominantly by LDH 
release. For example, the effect of macrophage exposure to glass fibres of different lengths 
(3, 4, 7, 17, 33 μm, width 0.5 μm) was studied by Blake et al. at doses of 50-500 μg/mL. In 
congruence with this study, low levels of LDH release were seen upon exposure to particles 
at comparable doses, and very few differences were seen in LDH release by the different 
length particles. The one exception was a marked increase in LDH release by fibres with 
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length 17 μm which the authors attributed to frustrated phagocytosis of these longer fibres. 
However, there is no explanation for why this effect was not seen in fibres with length 33 μm. 
The 3x15x0.5 μm bars used in this study were similar in length, and elicited lower LDH release 
at the same dose which is not suggestive of frustrated phagocytosis.  
Watanabe et al. studied the effect of titanium dioxide fibres (5 μm x 0.2 μm) and particles 
(diameter ~2 μm) on LDH release by macrophages between 20 and 60 μg/mL 369. Particles of 
this size did not exhibit any increase in LDH release upon increasing dose, however the fibres 
elicited a dose dependent increase in LDH release. It was theorised that the narrow diameter 
of the fibres caused puncturing of the cell membrane which was the cause of LDH release, 
however, this was not proven definitively. It is unlikely that the particles used in this chapter 
would cause a puncturing of the cell membrane in this manner as the dimensions are greater 
than those used by Watanabe.  
The mechanism by which silicon toxicity occurs is not clearly defined. The predominant theory 
is that of free radical generation leading to DNA damage and subsequent apoptosis 370. On 
the other hand it has been suggested that toxicity can arise from lysosomal disruption caused 
by a failure of the lysosomal environment to break down the particle 371. The release of 
cathepsin D and subsequent sphingomyelinase activation leads to mitochondrial membrane 
depolarisation and the activation of caspase 3 and 9.  These two theories are likely not 
mutually exclusive and what they have in common is the requirement of particles to be 
internalised before events leading to toxicity take place. In other words, direct disruption of the 
cellular membrane by contact with particles is not thought to be the cause of toxicity. In this 
chapter it was shown that ~10-20% of cells internalised particles of each shape over the 
course of the experiment.  Thibodeau et al. looked at the time course of silica toxicity and 
showed that ~15% cells had lost membrane integrity within 6 hours, which then increased to 
~60% within 24 hours 372. This may therefore indicate that the assays in this chapter depict 
the early stages of toxicity due to the increased metabolic activity and the release of low levels 
of intracellular enzymes within 4 hours.  
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There are few studies focusing on the shape of microparticles and their uptake by 
macrophages. Mathaes et al. looked at the difference in uptake of PLGA micro particles with 
spherical (diameter 2 μm) compared with equivalent particles stretched to decrease the aspect 
ratio to 0.2 373. It was shown that spherical particles were internalised to a greater extent than 
the stretched particles. Additionally, Champion and Mitragotri demonstrated that macrophages 
are less able to internalise high aspect ratio microparticles (length ~20μm) than spherical 
particles (3 μm particles) 241. The phenomena was explained by low attachment of 
macrophages to the major axis of the particles (the tips of the particles). Given the results of 
these studies it would be anticipated that the bar shaped particles (3x15x0.5 μm, 3x15x0.05 
μm and 3x10x0.5 μm) would therefore show drastically reduced uptake relative to particles 
with a lower aspect ratio. While this was the case compared with hexahedrons it did not hold 
true for disks and cubes. The above-mentioned studies used polymer particles which are 
known to have a degree of deformability and indeed macrophages were observed exerting 
enough mechanical force to bend the particles in the study by Champion and Mitragotri 241.  
A number of studies suggest that macrophages are less capable of internalising soft particles 
than those that are more rigid 374-376. Alexander et al. studied the effect of both mechanical 
properties and shape on phagocytosis by J774A.1 macrophages by comparing core-shell and 
shell only particles of spherical and cubic shape (diameters 2-3 μm) 377. There was no effect 
of particle shape on uptake, however macrophages showed significantly reduced uptake of 
shell only particles with lower Young’s moduli.  Young’s modulus is affected not only by the 
material properties but also by the shape of the material 378. This is therefore a confounding 
factor in such particle uptake studies as is difficult to separate from shape alone. 
No deformation of the majority of polysilicon particles used in this chapter was observed and 
so the effect of mechanical stiffness may be low. The exception to this is the 3x15x0.05 μm 
bars which were observed to bend slightly, most likely due to their thickness. In comparison, 
the deformation of polymer particles used by Champion and Mitragotri was far more extensive. 
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Hexahedrons (3x3x0.5 μm) were associated with, and internalised by significantly more 
macrophages than circular disks (diameter 3 μm). Given the similarity between these two 
particle sizes, similar binding and uptake characteristics would be expected. No published 
studies have compared the phagocytosis of these two shapes, however the phagocytosis of 
circular disk shaped microparticles have been compared with spherical particles 316. It was 
shown that macrophages attached to, but did not internalise circular disk-shaped particles, 
whereas spherical particles were internalised. Other studies have made use of hitchhiking 
particles of this disk shape to enable particles to be carried by macrophages to the site of 
action 374, 379-380.There is therefore a precedent for the reduced uptake of disk-shaped particles 
but no studies comparing the uptake of hexahedral disks. Because hexahedrons have corners, 
there are points of high curvature compared to circular disks that may influence macrophage 
binding and internalisation. Receptor clustering, drives particle internalisation during 
phagocytosis 381. If the initial point of contact between particle and cell is at a point of high 
curvature receptor clustering could be more efficient and so drive more efficient phagocytosis. 
Further investigation of this is warranted by monitoring individual particle cell interactions.  
 
4.5 Conclusions 
The shape of polysilicon particles had only small effects on their interactions with 
macrophages. In terms of particle uptake, it was shown that 3x3x0.5μm hexahedrons 
displayed the highest cellular association and uptake, therefore this particle shape may have 
benefits for targeted delivery to macrophages compared to the other shapes used in this study. 
On the other hand, similarly sized circular disks and bar-shaped particles displayed lower 
uptake and so may be beneficial for the avoidance of macrophage uptake. Uptake studies 
could only be done using a single concentration due to limitations on the available number of 
particles. Therefore, in future it would be beneficial to expand on this work using a range of 




As in the case of particle uptake, polysilicon particles of different shapes did not elicit major 
changes in cellular metabolism, LDH release, or release of lysosomal glucuronidase. In 
response to particles, macrophages increased their metabolic activity, and released low levels 
of intracellular enzymes which could indicate the early stages of toxicity. Increasing the particle 
dose did appear to increase the metabolic activity of the cells although it had no effect on 




5. Effect of silicon oxide particle size and surface modification 




Altering particle size and surface chemistry are potential methods for modulating the uptake 
of particles by macrophages. In a study looking at the effect of microparticle size it has been 
shown that particle internalisation was highest at a particle size of 1.9 μm when compared 
against 450 nm and 4.8 μm particles 107. Another study showed a peak in uptake at a particle 
size of 2-3 μm when particles of diameter 1-6 μm were compared 106. A study by Catelas et 
al. found very little difference in uptake in particles sized between 1-5 μm whereas particles 
<1μm in size showed significantly less uptake 105.  
Targeting macrophages by altering the surface chemistry of particles has been used for a 
number of particle types. Liposomes, modified to display mannose on their surface, displayed 
3.6 fold increase in uptake by alveolar macrophages compared to those without the 
modification 382. It has also been shown that folate decorated PLGA nanoparticles exhibit 
enhanced uptake 383.  On the other hand, a great deal of work has focussed on modifying 
particle surface chemistry to decrease particle uptake by macrophages. The most studied of 
these is polyethylene glycol (PEG) which has been used successfully by a number of groups 
to reduce particle uptake 384-387. However, it is important to note that the chemical identity on 
the surface of the particle after administration is altered by the formation of a biological corona. 
The underlying surface chemistry (and other factors such as size, charge etc.) will affect the 
composition of this corona, as well as the components of the biological medium which in turn 
can modulate uptake by macrophages 388. 
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Recently, the application of zwitterionic surface chemistries and their effect on cellular uptake 
has been studied. Zwitterionic molecules contribute to the formation of a hydrophilic surface 
which has been shown to affect protein adsorption and cellular uptake. For example, Liu et al. 
coated gold nanoparticles with a mixed monolayer containing both quaternary amine (+ve 
charge) and sulphate groups (-ve charge). The study found that this zwitterionic coating 
considerably reduced particle uptake by RAW 264.7 macrophages compared with particles 
that had monolayers of only quaternary amines or only sulphates 389. In another such study, 
Zhao et al. showed that zwitterionic phosphorylcholine-coated micelles exhibited reduced 
particle uptake by mouse peritoneal macrophages 390.  
The majority of studies seem to suggest a reduction in cellular uptake of particles with 
zwitterionic surface chemistries 391-393. However, studies have mainly focused on particles in 
the nano-size range. As such, it is necessary to see what the effects of zwitterionic coatings 
on cellular uptake are in micron-sized particles.  
In this chapter the effect of particle size and zwitterionic coating on cellular uptake by 
macrophages is assessed. Three sizes of silicon oxide particles (0.5 μm, 1 μm, and 3 μm) 
were modified with either AUTES surface chemistry (positively charged) or further modified 
with zwitterionic N-(3-sulfopropyl)-N-methacroyloxyethyl-N,N-dimethylammonium betaine 
(MDSA). Modified particles are characterised using X-ray photoelectron spectroscopy (XPS), 
Zeta potential, water contact angle, and fluorescence microscopy. Particle uptake is assessed 
using imaging flow cytometry in undifferentiated RAW 264.7 cells, LPS stimulated RAW 264.7 
cells, and in the presence of phospholipid dipalmitoylphosphatidylcholine (DPPC). 255 
During different stages of respiratory disease states, particularly in infections such as 
tuberculosis and pneumonia, macrophages have been shown to differentiate towards an M1 
phenotype 394-395. This phenotype can be replicated in vitro by stimulation with LPS and 
therefore can be used to represent the macrophage activation state in these cases 396.  
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Furthermore the effect of including DPPC in the media was examined. In the alveoli, lung 
surfactant is present in order to prevent the alveolar structures from collapsing 397. 
Phospholipids, including DPPC, form the majority of this surfactant and so are likely to interact 
with inhaled particles, potentially altering their interactions with macrophages 398.  
Particle uptake studies are common in the literature and typical experiments involve the 
administration of particle suspension to cells in a well plate for a defined period of time, 
removal of the suspension and subsequent rinsing of the cells 272. The cells are then analysed 
for fluorescence by flow cytometry or elemental concentrations by ICP-MS. In order to 
compare, for example, the effect of nanoparticle surface chemistry, typically an equivalent 
mass of particles is applied to each well, however some studies have included the use of 
multiple dose metrics 35, 107. 
When comparing the uptake of different sized particles it is particularly important to bear in 
mind the effect of dose metric, as administering an equivalent particle mass results in non-
equivalent particle number and surface area applied. In this study, three dose metrics were 
chosen for the purpose of examining how this affects the uptake of differently sized particles. 
Particles were administered according to equivalent mass (10 μg per well), number (10 
particles per cell), and total surface area (10,000,000 μm2) and quantified in terms of the 
percentage of cells internalising particles, the number of particles internalised per cell, and the 








5.2 Materials and Methods  
 
5.2.1 Materials 
Rhodamine B isothiocyanate (RBITC, 283924), N-(3-sulfopropyl)-N-methacroyloxyethyl-N,N-
dimethylammonium betaine (MDSA, 537284), NaCl, and Silicon oxide spheres (diameter 0.5, 
1, 3 μm) were purchased from Sigma-Aldrich. H2SO4 (98%) and NH4OH (20%) were 
purchased from Fisher Scientific. 11-aminoundecyltriethoxysilane (AUTES, S25045) was 
purchased from Fluorochem (UK). H2O2 (35%), and dimethylsulfoxide (DMSO) were 
purchased from VWR. DPPC was purchased from Avanti polar lipids Inc.  
 
5.2.2 Methods  
 
5.2.2.1 Modification of silicon oxide spheres with AUTES, RBITC, and MDSA 
Activation of silicon oxide spheres  
Silicon oxide spheres 1 mg (20 μL)  in suspension (stock concentration 5% w/v) were 
transferred to a 1.5 mL microcentrifuge tube and centrifuged at 5700 RPM (6175G) for 10 
minutes and the supernatant removed. Particles were suspended in 700 μL acidic piranha 
solution for 1 hour with shaking to prevent particles from falling out of suspension. Particles 
were centrifuged at 5700 rpm (6175G) for 10 minutes and the acidic piranha solution removed. 
Particles were washed by resuspension in 700 μL milliQ water and then centrifuged at 5700 
rpm (6175G) for 10 minutes. This washing process was repeated 3x and then the supernatant 
removed. Particles were suspended in 700 uL basic piranha solution and left shaking for 30 
minutes. Particles were centrifuged at 5700 rpm (6175G) for 10 minutes and the basic piranha 
solution removed. Particles were washed using the same resuspension in 700 μL milliQ water 
and centrifugation steps used to wash the particles after removal of the acidic piranha solution. 
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Modification of silicon oxide particles surface with AUTES and RBITC 
AUTES (5 mg, 0.015 mmol) was mixed with RBITC solution (10 μM, 15 mL) in EtOH to give a 
final AUTES concentration of 1mM. The AUTES:RBITC molar ratio was 100:1 so as to result 
in 1% of the particle surface being labelled. This solution was stirred for 2 hours and then 
added to microcentrifuge tubes containing 1 mg freshly activated silicon oxide particles (700 
μL per tube). Particles were suspended and left on a shaker for 2 hours while protected from 
light. Particles were washed 3x by centrifugation at 5700 RPM (6175 G) and replacement of 
the supernatant with 700 μL EtOH.  
 
Addition of MDSA to particles 
Silicon oxide particles modified as above were suspended in MDSA 1mM in DMSO 700 μL 
with triethylamine (30μM) and left shaking overnight while protected from light. Particles were 
washed 3x by centrifugation and rinsing with DMSO 700 μL Particles were stored in EtOH 700 
μL at 4°C.  
 
5.2.2.2 XPS characterisation of modified particles 
Preparation of XPS samples  
1 mg particles were washed by centrifugation and resuspension 3x with 700 μL MilliQ water 
and flash frozen by dipping the microcentrifuge tubes in liquid nitrogen. Particles were freeze-
dried overnight. Microcentrifuge tubes containing freeze-dried particles were stored at 4°C 
until analysis by XPS.  
 
XPS analysis 
XPS measurements were performed using a Kratos AXIS Ultra DLD instrument. Freeze-dried 
microparticles were mounted using double-sided tape onto a standard Kratos sample bar 
which were inserted into the airlock and left overnight until the vacuum reached 3 x 10-7 Torr. 
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Wide energy survey scans were collected using a pass energy of 80 eV in hybrid slot lens 
mode with a step size of 0.5 eV. High resolution spectra were obtained at a pass energy of 20 
eV over energy ranges suitable for each peak with a step size of 0.1 eV. The charge neutraliser 
filament was used to prevent sample charging over the irradiated area. The X-ray source was 
a mono-chromated Al k alpha emission, run at 10 mA and 12 kV (120 W). The data were 
captured using Kratos VISIONII software and exported into vms format for data processing 
with CASAXPS. Three sample positions were set up and data collected for these was 
quantified from the wide scan data using the standard kratos RSF library. The high-resolution 
data was charge corrected to C 1s at 285 eV. 
5.2.2.3 Zeta potential measurements 
Zeta potential measurements were performed using a Malvern zetasizer Nano. Particles were 
suspended in 10 mM NaCl at a concentration of 0.1 mg/mL. Each sample was then transferred 
to a DTS 1070 zeta cell for measurement.  
 
5.2.2.4 Water contact angle measurements 
30 μL particle suspension (1 mg/mL) in EtOH was pipetted drop wise onto a glass coverslip 
and the EtOH allowed to evaporate. After drying the particles were visible as a semi-
transparent film on the coverslip. The water contact angle was measured 3 times for each 
sample using a KSV CAM 200 optical contact meter.  
 
5.2.2.5 Acquisition of brightfield and fluorescent images 
Brightfield and fluorescence images were acquired using a Nikon Eclipse TiU fluorescence 
microscope. Images of particles in suspension were acquired by pipetting 15 μL particle 
suspension (0.5 μg/mL for 0.5 μm particles, 1 μg/mL 1 μm particles, 10 μg/mL for 3 μm 
particles in NaCL 10 mM) onto a glass slide and then covering with a coverslip. For 
fluorescence imaging of RBITC-labelled samples λex = 550 nm and λem = 590 nm. Images 
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were processed using imageJ®. The threshold function was used to identify individual 
particles and create corresponding regions of interest (ROIs). The multi measure tool was then 
used to acquire the median fluorescence intensity (MFI) of each ROI across multiple images 
for each sample (~100 particles per sample).  
 
5.2.2.6 Quantitative uptake of silicon oxide spheres by RAW 264.7 cells 
 
Preparation of particles 
Modified particles were freeze dried in microcentrifuge tubes of known mass in order to 
calculate the exact mass of particles in each tube. Particle stock suspensions were prepared 
in sterile conditions by adding 1% HEPES in HBSS 1 mL to each tube. Stock suspensions 
were diluted to the desired concentration by removal of the required volume of stock 
suspension and addition of 1% HEPES in HBSS. Particle suspensions were warmed to 37°C 
prior to addition to cells. In experiments where particles were administered in the presence of 
DPPC, the required volume of stock solution was diluted with 1% HEPES in HBSS containing 
DPPC 0.25 mg/mL freshly prepared on the day of the experiment.  
The mass of freeze-dried particles was used to calculate the particle number and surface area 
using a density of 2.2 g/cm3, particle volumes of 0.065, 0.52, and 14.14 μm3, and particle 
surface areas of 0.79, 3.14, and 28.27 μm2 for 0.5, 1, and 3 μm diameter particles respectively.  
Preparation of RAW 264.7 cells 
RAW 264.7 cells were harvested once they reach 60-80% confluency by scraping. 100,000 
cells in culture media were seeded per well into a 12 well plate and incubated overnight at 
37°C, 5% CO2, 95% humidity. In experiments where RAW 264.7 cells were stimulated with 
LPS, culture media was used without 1% penicillin/streptomycin and was supplemented with 
100 ng per mL LPS.  
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Culture media was removed by aspiration and the cells washed with 1 mL pre-warmed (37°C) 
PBS. PBS was removed and 1 mL pre-warmed particle suspensions applied at different 
concentrations based on particle mass, number, and surface area. Cells were incubated for 4 
hours after which time the particle suspensions were removed and the cells washed with 3 x 
1 mL warm HBSS. Cells were prepared for flow cytometry. 
Preparation of fixed cells for flow cytometry  
HBSS was removed from each well by aspiration and 250 μL accutase added to each well 
and the cells placed in an incubator for 5 minutes to detach cells. 250 μL HBSS was then 
added to each well and the total volume of each well transferred to fresh microcentrifuge tubes. 
Samples were centrifuged at 250 G for 5 minutes and the supernatants removed. The cells 
were suspended in 250 μL 4% formaldehyde in PBS for 20 minutes before being centrifuged 
for 5 minutes (250 G) and the supernatant removed. Fixed cells were suspended in 50 μL 
HBSS and stored at 4°C until analysis by flow cytometry. Samples were always analysed 
within 1 week of sample preparation.  
Flow cytometry 
Flow cytometry was performed using an Amnis imagestreamX MKII imaging flow cytometer in 
standard configuration with 40X magnification. Illumination settings: Brightfield LED 32.01 
mW, 561 nm laser 200 mW, 785 nm laser 2 mW. Data was acquired using INSPIRE software 
with a minimum of 500 cells per sample (typically > 1000 cells per sample). Data was analysed 
using IDEAS software. Gatings for cells with particles were set above the fluorescence of 
control cells (cells not exposed to particles) for each condition. The percentage of cells 
internalising particles was determined using IDEAS software’s internalisation feature. The 
number of particles per cell was calculated using the following formula: (MFI of cells 
internalising particles – MFI of control cells)/ MFI of particles. The % dose internalised was 
calculated by multiplying the proportion of cells internalising particles by the number of 




5.3 Results and Discussion 
 
5.3.1 Characterisation of modified silicon oxide particles 
Spherical silicon oxide particles of 0.5 μm, 1 μm, and 3 μm diameter were purchased and 
surface chemistry modified with AUTES (labelled with 1% RBITC). Further modification then 
took place with zwitterionic MDSA (Scheme 5.1) and the particles characterised at each stage 
by XPS, zeta potential, contact angle, and fluorescence microscopy.  
 
 




5.3.1.1 XPS characterisation  
XPS was performed on 0.5 μm, 1μm, and 3μm particles without any modification, after 
modification with AUTES, and after further modification with MDSA, the data is shown in figure 
5.1 and table 5.1. 
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The results obtained for unmodified particles showed the presence of O (533 eV), C (285 eV), 
and Si (103 eV) at concentrations ~50%, ~20%, and ~30% respectively. The presence of 
carbon here results from adventitious carbon that results from exposure of the sample to air, 
this is a ubiquitous phenomenon during XPS analysis 399.  
Upon modification with AUTES the results were consistent between each particle size. There 
was a sharp increase in the % Carbon as determined by the peak at 285 eV which is indicative 
of the carbon chain in AUTES. A decrease in O (533 eV) and Si (103 eV) peaks resulting from 
silicon oxide is observed due to the surface being covered by the AUTES layer. Additionally 
the appearance of a Nitrogen peak at 400 eV resulting from the amine groups in AUTES 
confirmed deposition of AUTES on the surface of the particles 400. Upon further modification 
with MDSA an appearance of a sulphur peak at 168.9 eV was observed. High resolution scans 
of MDSA modified particles compared with scans of pure MDSA powder confirmed that this 
peak comes from the zwitterion on the particle surface (Appendix III figure S5.1). High 
resolution scans of Nitrogen peaks of AUTES modified particles showed two peaks at 399 and 
401 eV representing C-NH2 and C-NH3+ groups (Appendix III figure S5.2) 401. Upon 
modification with MDSA, a third nitrogen peak was found at 402 eV which results from the 
NR4+ group 402 and thus confirmed the presence of the zwitterion.  
Table 5.1 shows the relative atomic concentrations for each particle size and modification. 
Only one other study has examined the deposition of AUTES on silicon oxide, and the results 
showed a close agreement with those of this chapter for both unmodified silicon oxide and 
AUTES-modified silicon oxide 403. Specifically, the study showed after deposition of AUTES 
atomic concentrations of Carbon, Nitrogen, Oxygen, and Silicon to be 62.6 (± 0.3), 2.1% (± 
0.8), 21.8, and 13.5 (± 0.3) respectively. The deposition of a similar silane aminopropyl 
triethoxy silane (APTES) on to silicon oxide surfaces has been more extensively studied and 
nitrogen concentrations of between 2.0-9.8% after APTES deposition have been reported 194, 
404-406. A higher nitrogen concentration is expected than for AUTES because of the relative 
chain lengths (AUTES has 11 carbons, APTES has 3 carbons).  
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In order to estimate the % conversion of the AUTES primary amine to secondary amine upon 
conjugation with MDSA, the ratio of nitrogen:sulphur (N:S) was considered (Table 5.1). 
Theoretically if a complete conversion of all surface amines were to take place the result would 
be a N:S ratio of 2:1 with one nitrogen coming from the AUTES and one nitrogen and one 
sulphur coming from the MDSA molecule. The results showed that the N:S ratio was 3.49, 
3.51, and 2.97 for 0.5 μm, 1μm, and 3μm particles respectively. This equates to a 40% 
conversion of the surface amines by MDSA for 0.5 μm and 1 μm particles and 50% conversion 










Figure 5.1: Widescan XPS spectra of silicon oxide particles with modified surface chemistry. A) 0.5μm, B) 1μm, C) 









Table 5.1: Surface composition (Atomic %) of silicon oxide particles with modified surface chemistry 
Particle type Atomic % 
0.5um  O C Si N S N/S* 
Blank particles  51.10 ± 13.38 18.61 ± 9.45 23.52 ± 5.37 - - - 
AUTES 
particles 28.58 ± 2.21 55.14 ± 2.21 15.28 ± 1.84 1.00 ± 0.27 - - 
MDSA particles 32.97 ± 1.41 47.44 ± 3.09 17.83 ± 1.30 1.36 ± 0.25 0.39 ± 0.16 3.49 
       
       
1um  O C Si N S N/S* 
Blank particles  54.01 ± 0.66 17.66 ± 0.71 28.1 ± 0.18 - - - 
AUTES 
particles 28.11 ± 0.67 52.69 ± 1.73 16.63 ± 1.14 2.43 ± 0.10 - - 
MDSA particles 25.16 ± 1.22 62.12 ± 1.2 10.52 ± 0.02 1.72 ± 0.07 0.49 ± 0.11 3.51 
       
       
3um  O C Si N S N/S* 
Blank particles  55.45 ± 1.67 16.64 ± 3.60 27.7 ± 2.14 - - - 
AUTES 
particles 21.02 ± 1.61 65.74 ± 4.01 9.72 ± 3.29 1.52 ± 0.82 - - 
MDSA particles 24.16 ± 1.33 60.45 ± 2.47 12.35 ± 0.84 2.29 ± 0.14 0.77 ± 0.16 2.97 
              
* N/S is the ratio of Nitrogen to Sulfur 
 
5.3.1.2 Zeta potential measurements 
Zeta potential measurements were taken of each particle size before modification of the 
particle surface (unmodified), after modification of the surface with AUTES (including 1% 
labelling with RBITC), and after modification the MDSA in 10mM NaCl. The data is shown in 
figure 5.2. Unmodified particles showed zeta potential values of -37.3 mV (0.5 μm), -44.4 mV 
(1 μm), and -25.5 mV (3 μm). Silicon oxide particles have a negative zeta potential at neutral 
pH owing to surface hydroxyl groups, as pH decreases the zeta potential becomes less 
negative until it reaches the isoelectric point at pH 2 407-408.  
Here negative zeta potential values were obtained for all particle sizes, but smaller particles 
exhibited a more negative zeta potential. From the XPS data it is known that the different 
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particle sizes have identical surface chemistry and so the reason for the disparity is due to 
another factor. The measurement of zeta potential is dependent on a number of other factors 
including pH, ionic strength, applied voltage, particle concentration, and particle size 409. The 
differences could therefore be explained due to particle size differences, particularly as the 
large size of these particles means that some degree of sedimentation takes place. 
Additionally, although the mass concentration of particles was kept the same for each sample, 




Figure 5.2: Zeta potential measurements of silicon oxide particles with different surface chemistry in 10mM NaCl. 
Unmodified particles (blue bars), AUTES-modified particles (red bars), MDSA-modified particles (green bars).  
 
After modification with AUTES the zeta potential values were +10.6 mV (0.5 μm), +21.0 mV 
(1 μm), and +41.5 mV (3 μm) resulting from the primary amines on the particle surface 410. In 
aqueous conditions, surface amines are protonated and so a net positive zeta potential results 
unless the pH is very high 411. Zeta potential values of similarly modified silicon oxide particles 
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Upon modification with MDSA the zeta potential values were -17.9 mV (0.5 μm), -24.2 mV 
(1μm), and -8.6 mV (3μm). These results are in agreement with literature values for silicon 
oxide particles modified with sulfobetaine silanes. Knowles et al. reported zeta potential values 
between -25 mV and -40 mV 417-418. The results for MDSA particles were slightly less negative 
than these values, however this can be attributed to the presence of unreacted amines as 
indicated by the XPS data. Affonso de Oliveira et al. reported zeta potential of silicon oxide 
particles with both amino and sulfobetaine groups on their surface, similar to the particles used 
in this chapter 419. They measured the zeta potential of particles with different ratios of amine 
to sulfobetaine and found that in the absence of sulfobetaine, particles had a positive zeta 
potential (+10 mV), however when the sulfobetaine was present (amine to sulfobetaine ratios 
of 3:1, 1:3, and 0:1) the zeta potential was negative (between -20 mV and -40 mV).  
The above studies have examined zwitterionic monolayers on silica particles, however Dong 
et al. reported silica particles coated with an MDSA-based polymer which had a zeta potential 
value of – 5mV 420. Other studies utilising the similar polymer coatings have reported zeta 
potential values of between -30mV and -50mV 421-423.  
The zeta potential measurements here concur with the XPS results for each step of the 
functionalisation procedure, however it can also give an indication of colloidal stability. 
Colloidal particles with zeta potential values of ± 0-10, ± 10-20, ± 20-30, and ± 30 mV are 
unstable, relatively stable, moderately stable, and highly stable respectively 424. According to 
this, the majority of particles here fall into the relatively stable category, except for 3μm MDSA 
particles which would be unstable. Nonetheless, other factors such as particle hydrophilicity 
play a role in colloidal stability, and it has been shown that zwitterionic particles with low zeta 
potential can be stable due to their high hydrophilicity 425-426.  
 




Water contact angle measurements provide a measure of the hydrophilicity of the surface of 
the particle 427. This is therefore useful in indicating the effects that changes in the surface 
chemistry have and can be used to compare with values in the literature of particles with 
similar modifications.  
Static water contact angles were measured for particles modified with AUTES and after 
modification with MDSA, the data is shown in figure 5.3. AUTES modified particles displayed 
a hydrophobic character in all particles sizes with 0.5 μm, 1 μm, and 3 μm particles displaying 
water contact angles of 53.9°, 56.2°, and 61.9° respectively. This is to be expected due to the 
length of the hydrocarbon chain 293.  
After modification with MDSA the particles became more hydrophilic due to the presence of 
the zwitterion resulting in contact angles of 28.9°, 32.4°, and 22.8° respectively for 0.5 μm, 1 
μm, and 3 μm particles. However, it was expected that contact angles for MDSA particles 
would be lower, as values for sulfobetaine-modified silicon oxide surfaces in the literature can 
be as low as <10° 428-429. The values here are likely higher because of the unreacted AUTES 
molecules which contribute some hydrophobicity. This is in agreement with the zeta potential 





Figure 5.3: Water contact angle measurements of modified particles. A) AUTES modified particles, B) MDSA 
modified particles. i) 0.5 μm, ii) 1 μm, iii) 3 μm 
 
5.3.1.4 Fluorescence of modified particles 
Brightfield and fluorescence images were acquired of each particle size and representative 
images are shown in figure 5.4. Images were subsequently analysed using imageJ® to assess 
the fluorescence intensity values (approx. 100 particles analysed per sample) and are 
presented in table 5.2 along with a summary of water contact angle and zeta potential 
measurements. This confirmed fluorescent labelling of the particles and showed increasing 




Figure 5.4: Representative brightfield and fluorescence images of silicon oxide particles. A) 0.5μm B) 1μm C) 3μm, 
i) AUTES modified particles, ii) MDSA modified particles. Scale bars are 10 μm for images A and B, and 20 μm for 
images in C.  
 
 








(mV) MFI (a.u) 
0.5 AUTES 53.9 ± 3 10.7 ± 1.3 257.6 ± 16 
0.5 MDSA 28.9 ± 7 -17.9 ± 1.5 235.6 ± 10 
1.0 AUTES 56.2 ± 4 21.0 ± 3.7 393.9 ± 59 
1.0 MDSA 32.4 ± 7 -24.3 ± 1.6 328.9 ± 51 
3.0 AUTES 61.9 ± 2 41.5 ± 3.4 1208.4 ± 279 





5.3.2 Uptake of silicon oxide particles by RAW 264.7 macrophages 
 
Particle uptake was examined using imaging flow cytometry with particles being administered 
to cells based on equivalent mass, number, and surface area. Table 5.3 shows the applied 
doses and their equivalent doses by other metrics for comparative purposes, for example 
when an equivalent mass of particles (10 μg) was administered, this equates to 699, 87, and 
3 particles per cell for 0.5, 1, and 3 μm particles respectively.  
 
Table 5.3: Applied particle doses and equivalent doses by other metrics 
Particle size 






applied per cell 
Total surface 
area of applied 
particles (μm2) 
0.5 
Mass 10.00 699 55244755 
Number 0.14 10 790000 
Surface area  1.81 127 10000000 
1 
Mass 10.00 87 2744755 
Number 1.14 10 3140000 
Surface area  3.64 32 10000000 
3 
Mass 10.00 3 9087694 
Number 31.10 10 28270000 
Surface area  9.98 3 10000000 
 
5.3.2.1 Effect of particle size on uptake 
 
Effect of particle size on the percentage of cells internalising particles  
The data for particle uptake, as measured by the percentage of cells that internalised particles, 
is shown in figure 5.5. When administered according to equivalent mass of particles (figure 
5.5 Ai), 0.5 μm and 1 μm particles showed significantly higher uptake than 3 μm particles. The 
number of 3 μm particles administered in this case (3.21 x105) was significantly lower than the 
number of 0.5 μm particles (6.9 x 107) and 1 μm particles (8.7 x 106). It could therefore be 
154 
 
speculated that with an abundance of particles in the medium there was a higher probability 
of particles coming into contact with, and being internalised by the cells.   
However, there was no significant difference between 0.5 μm and 1 μm particles with AUTES 
surface modification and in the case of particles coated with MDSA, a higher proportion of 
cells internalised 1 μm particles. 
 
Figure 5.5: Effect of particle size on the percentage of cells with internalised particles. Particles were administered 
in A) 1% HEPES in HBSS buffer, B) 1% HEPES in HBSS buffer (cells were first stimulated with LPS), C) 1% 
HEPES in HBSS containing 250 μg/mL DPPC. Particles were administered according to i) equivalent mass (10ug 
per well), ii) equivalent number (106 particles per well), iii) equivalent surface area (107μm2 per well). Data represent 
mean ± SEM (N=3). *, **, ***, **** indicate statistical significance p < 0.05, 0.01, 0.001, 0.0001 respectively as 




When particles were administered according to equivalent number (10 particles per cell) the 
opposite trend was observed, 3 μm particles were taken up by a higher proportion of cells 
(figure 5.5 Aii). With the same number of particles it would be expected that the cells would 
have an equal probability of interacting with the particles and therefore resulting differences in 
the proportion of cells taking up particles are due to differences in the capability of cells to 
internalise particles. This would indicate that RAW 264.7 macrophages are better able to 
phagocytose 3 μm particles than 0.5 μm and 1 μm particles. However, it was also considered 
that the rate of sedimentation of these particles would be different due to their difference in 
mass. This was examined by assessing the amount of time for each particle size to completely 
sediment in HBSS (1 mL). It was found that 3 μm particles underwent complete sedimentation 
within 2 hours, whereas 1 μm and 0.5 μm particles took 19 hours and 64 hours respectively. 
With 3 μm particles being the only particle size undergoing complete sedimentation within the 
time course of the experiment (4 hours) it is therefore likely that, as in the case of 
administration by mass, these results show that having a higher number of particles to interact 
with was the key driver of the percentage of cells that internalise particles.    
In the case of administration by equivalent surface area (figure 5.5 Aiii) there were no 
significant differences observed between the different particle sizes. Given the higher numbers 
of 0.5 μm and 1 μm particles used in this experiment (1.27 x 107 and 3.18 x 106 respectively) 
sedimentation of particles is less likely to play a significant role. It is therefore interesting that 
despite there being far fewer 3 μm particles (3.5 x 105) available in the media for the cells to 
interact with, the percentage of cells internalising particles was not significantly less than for 
smaller particles. This could suggest that the RAW 264.7 macrophages were more able to 
bind and internalise 3 μm particles. 
This data shows a clear relationship between the dose/dose metric used and the effect of 
particle size on the percentage of cells internalising particles. The highest particle uptake for 
each particle size was observed using the metric with the highest particle dose (by mass for 
0.5 and 1 μm, by number for 3μm) and the lowest uptake was observed using the metric that 
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had the lowest particle dose (by number for 0.5 and 1 μm, by mass for 3 μm). In summary, 
these data showed that comparison of uptake between different particle sizes, using the 
percentage of cells internalizing particles as a measure, gives different results depending on 
the dose metric used. Moreover, it is further complicated by differences in sedimentation rate 
of different size particles. The administration of particles by equivalent surface area resulted 
in similar levels of uptake across particle sizes and therefore this dose metric may be most 
appropriate for comparing other effects (e.g. effects of surface chemistry) across different 
particle sizes.  
Upon stimulation with LPS the effect of particle size followed the same pattern as in 
unstimulated cells (figure 5.5 Bi-iii). This suggests that there is no change in the proportion of 
macrophages that undergo phagocytosis upon stimulation with LPS. This is in line with 
published studies which have shown an equivalent ability of macrophages to engulf 
microparticles regardless of activation state 430. It does not rule out that activated macrophages 
may be internalising more particles however, this is discussed later on. 
Particles were administered in the presence of 250 μg/mL DPPC as a simple model to better 
simulate the environment in the alveoli where pulmonary surfactant is present (figure 5.5 Ci-
iii) 431-432. When particles were administered in the presence of DPPC according to equivalent 
particle mass, there were no significant differences in the number of cells internalising particles 
for AUTES modified particles and in the case of MDSA modified particles there was more 
uptake of 1 μm and 3 μm particles than 0.5 μm particles (figure 5.5Ci).  
When administered by particle number, the results were consistent with those seen upon 
administration without DPPC (figure 5.5Cii). 3 μm particles were taken up by a higher 
percentage of cells than 0.5 μm and 1 μm particles. As previously mentioned, it is likely that 
sedimentation of particles is the most important factor in determining the percentage of cells 
taking up particles in this case.  
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In contrast, particles administered by equivalent surface area showed different results to those 
administered without DPPC. 3 μm particles were taken up by a higher percentage of cells than 
both 0.5 μm and 1 μm particles and in the case of MDSA modified particles, 1 μm particles 
were taken up by a higher percentage of cells than 0.5 μm particles. 
 
Figure 5.6 compares the percentage of cells internalising particles with and without DPPC. 
For particles administered according to equivalent mass and surface area there is a large 
reduction in the percentage of cells internalising 0.5 μm and 1 μm particles, however the 
percentage of cells internalising 3 μm particles increases when administered by equivalent 
mass and remains the same when administered by equivalent surface area (figure 5.6Ai/ Bi, 
Aiii/Biii). This result is in agreement with a study published by Vranic et al. who studied the 
uptake of 50 nm and 100 nm silicon oxide particles by murine alveolar macrophages in the 
presence of lung surfactant substitute Curosurf® 433. The reduction in particle uptake was 
attributed to the reduction in sedimentation of particles due to the presence of lung surfactant, 
which lead to less interaction of particles with the macrophages. This explanation could 
account for the results seen in this study for 0.5 μm and 1 μm particles, however 3 μm particles 
were seemingly unaffected by this due to their mass and even showed a slightly increased 






Figure 5.6: Effect of DPPC on the % of cells with internalised particles. A) AUTES-modified particles B) MDSA-
modified particles. Particles were administered according to i) equivalent mass (10ug per well), ii) equivalent 
number (106 particles per well), iii) equivalent surface area (107μm2 per well). Data represent mean ± SEM (N=3). 
*, **, ***, **** indicate statistical significance p < 0.05, 0.01, 0.001, 0.0001 respectively as calculated by multiple 
unpaired T-tests.  
 
Effect of particle size on the number of particles internalised 
The second measure of particle uptake used is the number of particles internalised per cell. 
Here the number of particles internalised per cell has been calculated only for cells that were 
identified as having internalised particles by the analysis software and as such is independent 
of the percentage of cells taking up particles. The data is presented in figure 5.7.  
When administered by equivalent particle mass (figure 5.7 Ai) the data shows that 4-6 particles 
were internalised per cell for both 0.5 μm and 1 μm particles whereas for 3 μm particles 1-2 
particles was internalised on average. On the other hand, when particles were administered 
according to equivalent particle number, 3-4 particles were internalised for 0.5 μm and 1 μm 
particles and 1-2 particles were internalised for 3 μm particles. Upon administration by 
equivalent particle surface area 2-3 particles per cell was internalised for 0.5 μm and 1 μm 
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particles and 1-2 particles were internalised for 3 μm particles. Therefore, the number of 
particles internalised per cell seems to be less sensitive to changes in dose/dose metric than 
the percentage of cells internalising particles.  
Upon stimulation with LPS (Figure 5.7B) the results were similar to unstimulated cells. It would 
be expected that, after LPS stimulation, the cells would alter receptor density on the plasma 
membrane. Receptors such as TLR-2/4 are upregulated whereas a decrease in the 
expression of scavenger receptors is seen 70. Silicon oxide particles with amines present on 
their surface are thought to be internalised by scavenger receptors 434, and so it is expected 
that a reduction in the number of particles per cell would be observed. However, this was not 
the case, possibly because the number of internalised particles per cell was fairly low even in 
the absence of LPS stimulation. Similarly the number of particles taken up when administered 
in the presence of DPPC did not change drastically, suggesting there is no change in the 





Figure 5.7: Effect of particle size on the number of internalised particles per cell that internalised particles. Particles 
were administered in A) 1% HEPES in HBSS buffer, B) 1% HEPES in HBSS buffer (cells were first stimulated with 
LPS), C) 1% HEPES in HBSS containing 250 μg/mL DPPC. Particles were administered according to i) equivalent 
mass (10ug per well), ii) equivalent number (106 particles per well), iii) equivalent surface area (107μm2 per well). 
Data represent mean ± SEM (N=3). *, **, ***, **** indicate statistical significance p < 0.05, 0.01, 0.001, 0.0001 
respectively as calculated by 2 way ANOVA with Tukey’s multiple comparisons test. 
 
Considering these data together, the number of particles internalised per cell taking up 
particles did not fluctuate a great deal. Only in the presence of a large excess of particles per 
cell did an increase occur, however in real terms this was only a difference of 1-2 particles per 
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cell when the number of particles administered per cell was 699.3 and 87.4 for 0.5 μm and 1 
μm particles respectively.  
From a drug delivery perspective, the mass of particles taken up by each cell is relevant if the 
majority of the particle mass is comprised of the therapeutic molecule. Given the mass of the 
particles increases by a factor of n3 when the particle diameter is increased, the differences in 
particle size result in large differences in the mass of particles internalised. The mass of one 
3 μm particle is equivalent to the mass of twenty seven 1 μm particles and two hundred and 
sixteen 0.5 μm particles. These results therefore show that in terms of mass, in all cases 3 μm 
particles were taken up most efficiently.  
On the other hand, if the therapeutic molecule does not make up the majority of particle mass 
but is instead attached to the surface of a carrier particle, the surface area of particles 
internalised is relevant. The surface area of spherical particles increases by a factor of n2 when 
the particle diameter is increased. The surface area of one x 3 μm particle is equivalent to nine 
1 μm particles and thirty six 0.5 μm particles. This implies that, in terms of surface area, 3 μm 
particles were taken up most efficiently. However, this would not apply to porous particles 
which would have a much higher surface area than a non-porous particle of equivalent size.  
Effect of particle size on percentage of dose taken up by cells 
Considering the internalisation of particles in terms of the percentage of dose taken up by the 
cells is useful to understand what particle size is taken up most efficiently as it combines both 
the percentage of cells internalising particles and the number of particles taken up per cell. 
These values are presented in figure 5.8. Across each of the conditions tested, the results 
were mostly consistent. The highest percentage of dose taken up was in the case of 3 μm 
particles followed by 1 μm and 0.5 μm particles. Similarly to these results, Khanbeigi et al. 
examined the delivered dose of different sized (diameter 0.05, 0.1, 0.2, 0.7, 1 μm) polystyrene 
particles to J774A.1 macrophages and found 1 μm particles exhibited the most efficient 
delivery 435. The effect of particle sedimentation was also considered to be a contributing 
factor, with larger particles exhibiting more sedimentation. It seems therefore, that larger 
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particles are more efficiently delivered to macrophages in part due to their higher 
sedimentation, however, this effect will reach a limit at 2-3 μm above which macrophages are 
less able to internalise particles 103.  
 
Figure 5.8: Effect of particle size on the % dose internalised. Particles were administered in A) 1% HEPES in HBSS 
buffer, B) 1% HEPES in HBSS buffer (cells were first stimulated with LPS), C) 1% HEPES in HBSS containing 250 
μg/mL DPPC. Particles were administered according to i) equivalent mass (10ug per well), ii) equivalent number 
(106 particles per well), iii) equivalent surface area (107μm2 per well). Data represent mean ± SEM (N=3). *, **, ***, 
**** indicate statistical significance p < 0.05, 0.01, 0.001, 0.0001 respectively as calculated by 2 way ANOVA with 






5.3.2.2 Effect of zwitterion surface chemistry on particle uptake 
 
Effect of zwitterion surface chemistry on percentage of cells internalising particles 
The data for the percentage of cells internalising particles is shown in figure 5.9. For all particle 
sizes, the percentage of cells internalising particles showed a clear dependence on the dose 
applied. In the case of 0.5 μm particles (figure 5.9 Ai) it was only at the highest concentration 
(10 μg, 699 particles per cell) that there was a difference in uptake between the two surface 
chemistries, whereby MDSA modified particles were internalised by ~50 % fewer cells. This 
was also the case when administered to LPS activated cells (figure 5.9 Bi) and in the presence 
of DPPC (figure 5.9 Ci).  
For 1 μm particles (figure 5.9 Bi), as in the case of 0.5 μm particles, there was a significant 
difference between uptake of the two particle surface chemistries at the highest dose (10 μg, 
87 particles per cell). However, there was also a difference seen at the lowest dose (1.14 μg, 
10 particles per cell). In contrast, there was no difference in uptake between the two surface 
chemistries at any particle dose when administered to LPS activated cells (figure 5.9 Bii) or in 
the presence of DPPC (figure 5.9 Cii).  
In the case of 3 μm particles (figure 5.9 Ci-iii) there were no differences seen in uptake 
between the two surface chemistries at either dose (10 μg, 3.21 particles per cell or 31.1 μg, 




Figure 5.9: Effect of zwitterion surface chemistry on the % of cells with internalised particles. Particles were 
administered in A) 1% HEPES in HBSS buffer, B) 1% HEPES in HBSS buffer (cells were first stimulated with LPS), 
C) 1% HEPES in HBSS containing 250 μg/mL DPPC. i) 0.5 μm ii) 1 μm iii) 3 μm. Data represent mean ± SEM 
(N=3). *, **, ***, **** indicate statistical significance p < 0.05, 0.01, 0.001, 0.0001 respectively as calculated by 





In section 5.3.1, it was demonstrated that MDSA modified particles had a hydrophilic surface 
and negative zeta potential in comparison with AUTES modified particles which had a more 
hydrophobic surface with a positive zeta potential. As such, it would expected that differences 
in particle uptake would be observed 108, 436. However, this was only observed in a few cases, 
and only in 0.5 μm and 1 μm particles. In a recent study that looked at the effect of PEGylation 
of polystyrene particles of different sizes, it was shown that PEGylation only reduced the 
uptake of particles in particles <0.5 μm and that the effect of PEGylation decreased with 
increasing particle size. Particles of 2.6 μm showed no difference in internalisation despite 
having the same surface charge and density of PEG molecules on the surface as smaller 
particles 437. The results presented here are consistent with this finding, but also suggests that 
a high dose of particles might be necessary to see these effects. On the other hand, 
PEGylation of PLGA microparticles (diameter 5 μm) has been shown to reduce macrophage 
uptake, 438 which indicates that a reduction in uptake as a result of surface chemistry 
modifications can take place in larger particles.  
In the presence of DPPC, it is expected that adsorption of DPPC could take place onto the 
particle surface and thereby the underlying surface chemistry is masked by the cells 439. 
Despite this however, a reduction in uptake of MDSA modified particles was seen for 0.5 μm 
particles at the highest dose (10 μg, 699 particles per cell), however, in all other cases there 
was no difference in uptake between the two surface chemistries.  
 
 
Effect of zwitterion surface chemistry on number of particles internalised  
 
Data in figure 5.10 shows the effect of zwitterion surface chemistry on the number of particles 
internalised per cell that internalised particles. For 0.5 μm and 1 μm particles the number of 
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particles internalised increased with the highest particle dose (figure 5.10 Ai/Aii). However, 
this was not the case for 3 μm particles (figure 5.10 Aiii).   
MDSA surface chemistry had very little effect on the number of particles internalised in each 
case. Although in the case of 0.5 μm particles, a slight increase was observed for lower doses 
in cells stimulated by LPS, this effect is small (figure 5.10 Bi).  
Previous studies looking at the effect of zwitterionic surface chemistries on uptake by 
macrophages have mostly used comparisons of median fluorescence intensity (MFI) as a 
measure of uptake 391-392, 440. This is influenced both by the number of particles per cell, and 
the percentage of cells taking up particles and so it is difficult to compare these data. It is not 
clear if reductions in uptake of zwitterion modified particles in the literature result from fewer 
cells internalising particles, individual cells internalising fewer particles, or both.  
It is thought that a reduction of recognition of zwitterionic particles by macrophages could stem 
from their hydrophilicity which influences the interaction with proteins in the biological milieu 
441. As the present work did not include protein in the media, this potentially explains the reason 




Figure 5.10: Effect of zwitterion surface chemistry on the number of internalised particles per cell that internalised 
particles. Particles were administered in A) 1% HEPES in HBSS buffer, B) 1% HEPES in HBSS buffer (cells were 
first stimulated with LPS), C) 1% HEPES in HBSS containing 250 μg/mL DPPC. i) 0.5 μm ii) 1 μm iii) 3 μm. Data 
represent mean ± SEM (N=3). *, **, ***, **** indicate statistical significance p < 0.05, 0.01, 0.001, 0.0001 





In the previous section it was shown that in some cases, zwitterion modified particles showed 
reduced uptake compared with AUTES modified particles. This did not translate to fewer 
particles being internalised per cell which suggests that a smaller proportion of cells was able 
to bind and internalise particles, but the cells that came into contact with MDSA particles did 
so to the same extent as cells that came into contact with AUTES modified particles.  
 
Effect of zwitterion surface chemistry on the percentage dose internalised 
 
The data for percentage dose internalised is shown in figure 5.11 and shows very little effect 
of surface modification on the percentage dose internalised in all cases. This is reflective of 
the lack difference in uptake seen between the two surface chemistries as measured by 
percentage of cells internalising particles and the number of particles internalised per cell. This 
data shows that the zwitterionic surface chemistry used here is not effective in modulating 
particle uptake. As mentioned previously this may result from the size of these particles being 
large enough so that the effect of surface chemistry on uptake is negligible or alternatively, 
the lack of protein in the media. 
A third explanation could be, as the characterisation of the particles showed, unreacted 
amines are present on the surface of MDSA-modified particles which could be triggering 
internalisation by macrophages 434. Although particles were more hydrophilic and showed a 
negative zeta potential, the amine groups may still be able to interact with the scavenger 
receptors and thus facilitate particle internalisation. More studies are needed, whereby the 





Figure 5.11: Effect of zwitterion surface chemistry on the % dose internalised. Particles were administered in A) 
1% HEPES in HBSS buffer, B) 1% HEPES in HBSS buffer (cells were first stimulated with LPS), C) 1% HEPES in 
HBSS containing 250 μg/mL DPPC. i) 0.5 μm ii) 1 μm iii) 3 μm. Data represent mean ± SEM (N=3). *, **, ***, **** 








The work described in this chapter has examined the effect of particle size and zwitterionic 
surface chemistry on particle uptake by macrophages. Three measures of particle uptake were 
used, percentage of cells internalising particles, the number of particles per cell, and 
percentage of dose internalised. Also studied, was the impact of the dose metric used when 
comparing particles of different sizes.  
By examining the percentage of cells internalising particles, it was clear that this measure of 
uptake was heavily influenced by the particle dose. For all particle sizes, the more particles 
that were present in the medium, the higher the probability of an interaction with a cell, which 
leads to a higher probability of uptake. In this regard, considering a scenario in which 
macrophage uptake is to be desired, it would be advantageous to make use of a larger number 
of smaller particles. This would allow for an equivalent mass of drug to be administered and 
result in more interactions with macrophages and therefore more uptake. However, in the 
presence of DPPC, likely due to a lack of sedimentation, the percentage of cells internalising 
0.5 μm and 1 μm particles reduces to the point where larger particles are more likely to come 
into contact with cells and be taken up. Therefore, where lung surfactant is present, it may be 
beneficial to use larger particles to increase sedimentation and macrophage uptake.  
The number of particles internalised per cell was less sensitive to changes in dose compared 
with percentage of cells internalising particles. As a measure, it is most relevant when 
considering the particle mass and surface area that each cell takes up. The data showed that 
more particle mass and surface area is taken up per cell when larger particles are 
administered. Therefore, where the highest particle dose per cell is required it is advantageous 
to use larger particles.  
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The percentage of dose internalised combines the above two measures and considers the 
efficiency of uptake overall. This data showed that if particle uptake by macrophages is 
desired, 3 μm particles were most efficient as the highest percentage of dose was internalised. 
0.5 μm and 1 μm particles were taken up least efficiently and so, for avoidance of uptake, 
would be advantageous over 3 μm particles.  
Comparing the effect of zwitterionic surface chemistry, it was demonstrated that this had far 
less significant effect on particle uptake across all three measures than particle size. For 3 μm 
particles there was virtually no difference in uptake between zwitterionic and positively 
charged particles. For 0.5 μm and 1 μm particles a reduction in particle uptake was observed 
in a few circumstances but this effect was not seen consistently. Further study is needed to 
ascertain the reasons for the lack of difference in particle uptake between the two surface 
chemistries, however, from this study, it can be concluded that altering particle size was a 





6. General discussion and Future work  
 
This project sought to investigate the effect of several key particle properties on interaction 
with macrophages with a particular emphasis on the role of particle shape. Polysilicon and 
silicon oxide microparticles were selected for this work owing to a collaboration with the CNM 
who have expertise in fabricating highly uniform populations of microparticles of different 
morphologies. In addition, silicon-based particles have been widely explored for their use in 
drug delivery 442, with drug molecules either being physically entrapped or covalently bound 
through modification of particle surface chemistry. This meant that, as well as being a model 
particle, there exists potential for real-world applications of these particles for drug delivery to 
the lung.  
Particle uptake by the RES, in particular macrophages, is thought to be one of the main 
challenges to particulate delivery for both systemic and pulmonary routes of administration 443. 
On the other hand, targeting of macrophages is particularly desirable in certain disease states, 
for example in the case of infection, where infected macrophages serve as a reservoir for 
microorganisms leading to persistent reinfection 444-446. Therefore an in vitro macrophage cell 
line, RAW 264.7, which has been used as a model for alveolar macrophages was chosen 447-
449. The RAW 264.7 cell line is derived from BALB/c mice and has been used as a macrophage 
model owing to their ability to perform phagocytosis and to undergo phenotypic changes in 
response to LPS stimulation e.g. increased nitric oxide production 261. Indeed, RAW 264.7 
cells have been used by a number of groups to study the uptake of different particle shapes 
and accordingly have shown to be sensitive to different particle shapes 237, 242, 450.  
Particular attention was paid to ensuring that particle uptake was measured, rather than 
cellular association. Imaging flow cytometry was used for this purpose and, as it is a relatively 
new technique, this was compared with a well-established method that uses trypan blue to 
quench extracellular florescence 298, 451-455 in chapter 3. The two methods yielded comparable 
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results which confirmed the suitability of imaging flow cytometry for the project. This method 
offers advantages over traditional quenching methods, which require specific fluorescent 
molecules and their quenchers limiting options for choosing fluorophores and also requires 
the quencher to be in close proximity to the fluorophore making it tough to achieve efficient 
quenching with encapsulated dyes. Moreover, in the course of this work it was found that fixed 
samples (with 4% formaldehyde or 4% paraformaldehyde) became permeable to trypan blue 
and so the quenching method could only be performed on live cells.  
In chapter 3 the functionalisation of silicon oxide particles with an imidazolium surfactant 
(1.2Br) in order to enable labelling with porphyrins (TCPP and ATPP) was explored. Although 
the presence of the surfactant did enable the immobilisation of ATPP onto the particle surface, 
the retention of ATPP on the particle in PBS was inferior to conjugation of RBITC using 
covalent silane linker AUTES. The release of dye molecule into PBS meant that this non-
covalent labelling method was not suitable for cellular uptake work however, there is potential 
to explore this method to enable the binding and release of drug molecules. For example, Lu 
et al. immobilised the anti-cancer drug camptothecin onto the surface of mesoporous silica 
nanoparticles using hydrophobic interactions 456. On the other hand, electrostatic interactions 
have been used to enhance the loading of curcumin on to iron oxide nanoparticles 457. The 
use of imidazolium surfactant molecules such as 1.2Br offers the opportunity for both 
electrostatic and hydrophobic interactions with drug molecules and has recently been explored 
by our group for the immobilization of piroxicam on gold nanoparticles 458. 
It was originally thought that the method that was chosen to label silicon oxide particles using 
the aminosilane AUTES in chapter 3 could be used to label the polysilicon particles used in 
chapter 4, however this was not found to be the case. It seemed from the results that, with 
further optimisation, an improvement in the uniformity of particle functionalisation could be 
achieved for use in other studies. The surface modification of polysilicon with silane linkers 
has been shown to take place on polysilicon surfaces 459, however vertical polycondensation 
of hydrolysed silanes and deposition of silane aggregates owing to the presence of water can 
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occur 460-462. Left over water from the activation steps could therefore be the reason for the 
uneven labelling observed when acetone and toluene were used as solvents and thus a step 
for removal of left over water from the samples could be implemented to improve uniformity of 
labelling. The reason why labelling occurred in silicon oxide particles using ethanol as the 
solvent but not in polysilicon particles is not clear and further investigation is required to 
ascertain why.  
The effect of particle shape on uptake by macrophages was studied in chapters 3 and 4 in 
terms of percentage of cells taking up particles and the number of particles internalised per 
cell. The results of both of these chapters suggested that, for the most part, particle shape had 
an effect on cellular uptake as determined by percentage of cells taking up particles but no 
effect on the number of particles internalised per cell.  
In chapter 3, the uptake of truncated pyramids was reduced in comparison to spherical 
particles. When the particles first come into contact with the cell, spherical particles are unique 
in the fact that, regardless of orientation, the presentation of the particle to the cell is the same. 
In the case of hexahedrons and truncated pyramids, the particles can come into contact with 
the cell with different sides or at corners which, according to Champion and Mitragotri, will in-
turn affect whether or not particle internalization occurs 240.  In this thesis, individual particle-
cell interactions were not studied and so it is not known if a particular orientation dominated 
for each particle type but it could suggest that truncated pyramids present to cells in a way 
that is less favourable for uptake.  
Actin remodelling is required to cause extension of the plasma membrane in order for particle 
internalisation to occur 311. It has been suggested that shapes that require more actin 
remodelling will require more time and energy for internalisation to occur 242. Therefore, 
another potential explanation for the lower internalisation of truncated pyramids relative to 
spheres is that actin remodelling to accommodate truncated pyramids is less efficient and so 
results in less particle uptake overall. On the other hand, hexahedrons were internalised to 
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the same extent as spheres which could suggest a similar level of actin modelling is required 
for internalisation.  
A wider range of particle shapes was studied in chapter 4 including hexahedrons, cubes, bars, 
and circular disks each with one dimension 3 μm in length. Considering their internalisation in 
terms of actin rearrangement, large bar-shaped particles (length 10 and 15 μm) would require 
extensively more actin rearrangement than smaller hexahedrons. This is reflected in the 
internalisation data for these shapes, however, the internalisation of circular disks (diameter 3 
μm) was similar to that of bar-shaped particles but would be expected to require similar actin 
rearrangement to hexahedrons and so differences in actin rearrangement can only partially 
explain differences between shapes. The effect of particle high local curvature at the contact 
point between particle and cell has been suggested to result in more efficient phagocytosis 
463-464. This could therefore suggest that the high curvature of the corners of hexahedral 
particles is sufficient to increase their uptake with respect to circular disks. Further work 
examining these effects over a wider range of doses, longer periods of time and including the 
study of individual particle:cell interactions, for example by visualising actin rearrangement 
during uptake, would be beneficial to more fully elucidate the cause of these shape effects.  
Published studies examining the effect of microparticle shape on uptake have described 
differences in internalisation rate and the ability of cells to attach and take up microparticles 
240, 465. However, the results of these studies that examined individual microparticle-cell 
interactions, did not necessarily translate to significant differences in overall microparticle 
uptake when methods such as flow cytometry were used 242-243. According to the results in 
chapters 3 and 4, microparticle shape did have an effect on overall cellular uptake.  
Although differences in the uptake of different shapes were observed, the significance of these 
results as they pertain to realistic in vivo scenarios is difficult to examine. For example, in 
chapter 3 the truncated pyramids showed ~30-40% reduction in cellular uptake in comparison 
to spheres with a similar volume. From a theoretical perspective, this reduction in uptake could 
be particularly advantageous, allowing for a longer residence time in the body for drug release 
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to occur, and thus reducing dosing frequency. However, further in vitro studies should include 
the effect of microparticle shapes on cytokine production to gauge the effect on inflammatory 
response. For example, if reduced uptake results from a lower ability to internalise a particle 
as a result of its shape, it is possible that this will cause frustrated phagocytosis and 
downstream toxicity resulting from the production of inflammatory mediators such as TNF-α 
466-467. In chapter 4 the effect of microparticle shape on metabolic activity, LDH release, and 
glucuronidase release showed no differences between shapes and suggests that frustrated 
phagocytosis did not occur. Further work assessing the effect of particle shape on TNF-α, IL-
10, and ROS and NOS generation as well as increasing the amount of time cells are exposed 
to particles would build on this work to confirm if differences in uptake of different particle 
shapes cause downstream effects which would limit their usefulness in drug delivery.   
In chapter 5 the uptake of different sized silicon oxide spheres (diameter 0.5,1, 3 μm) showed 
a large dependence on the dose and the dose metric used and agreed with the findings of 
published studies showing that more cells take up larger particles (3 μm) than smaller particles 
(0.5, 1 μm) when equivalent particle numbers are administered 103, 105, 468. However, because 
0.5 and 1 μm diameter particles do not sediment at the same rate as 3 μm particles it was not 
clear if this is the cause of differences in uptake or if differences in the macrophages ability to 
phagocytose particles of different sizes is responsible. Champion et al. explained the 
phenomenon of particle internalisation being most efficient for particles with a diameter 2.8 
μm in terms of the measured distance between membrane ruffles (1.9 μm) 106. Particles with 
diameters smaller than this will be able to fit in-between ruffles without contact and this makes 
their internalisation less likely, while particles with diameters larger than this will make contact 
with multiple ruffles and are therefore more likely to be internalised.  However, in contrast to 
this, the number of particles internalised per cell when administered at equivalent particle 
numbers was higher for smaller particles (0.5 and 1 μm).   
When particles were administered according to equivalent mass, both a higher percentage of 
cells taking up particles and a higher number of particles per cell was observed for 0.5 and 1 
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μm particles than for 3 μm particles. This is reflective of the abundance of 0.5 and 1 μm 
particles in the media and demonstrates that the probability of particle internalisation is 
increased when more particles are in the media for the cells to come into contact with.  
Administering particles by equivalent surface area showed that similar numbers of cells 
internalised particles for each particle type and is therefore perhaps the best dose metric to 
compare the effects of surface chemistry across different particle sizes. The number of 
particles internalised per cell was higher for 0.5 and 1 μm particles however, 3 μm particles 
were more efficiently internalised if the volume and surface area of internalised particles is 
considered.  
Irrespective of dose/dose metric the percentage of dose internalised was highest with 3 μm 
particles. The nominal dose was used to calculate this and so it does not account for the 
effects of particle sedimentation. The actual dose for 0.5 μm and 1 μm particles (i.e. the 
particles that came into contact with cells) was likely a lot lower than the nominal dose. In 
future experiments, it may be worth attempting to measure how much of the particle 
suspension reaches the cell layer and then using this to calculate the percentage of 
internalised dose as a proportion of the dose that reaches the cell layer. Khanbeigi et al. 
attempted to predict how sedimentation would affect uptake using a model of in vitro 
sedimentation, diffusion and dosimetry (ISDD), however the model was not a good predictor 
of the dose that reached cells 435. On the other hand, in some in vivo scenarios, for example 
in pulmonary delivery, particle sedimentation plays a role so correcting for the presence of 
sedimentation effects may not be desirable.  
The modification of silica spheres with zwitterionic surface chemistry did not have a large 
impact on their uptake by macrophages despite these particles having a negative zeta 
potential and a more hydrophilic surface than particles coated with AUTES which have a 
positive zeta potential and a relatively more hydrophobic surface. As discussed in chapter 1 
the hydrophilic, negatively charged particles would be expected to exhibit reduced uptake in 
comparison to hydrophobic, positively charged particles, however this was not found to be the 
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case. Although the two particle types are different in respect of hydrophobicity and zeta 
potential, both have free primary amines on their surface which may explain the similarity of 
their uptake if their presence dominated cell interaction over the presence of the zwitterion. 
Further work should focus on increasing the amount of zwitterion on the surface of the particles 
or blocking free amine groups in order to see if this was the case.   
In this work, changing particle size seemed to play a more significant role in affecting cellular 
uptake than altering surface chemistry, however the two parameters also showed some 
interplay whereby smaller particles (0.5, 1 μm) modified with zwitterion surface chemistry 
administered at higher doses showed reduced uptake compared to particles with AUTES 
surface chemistry. This finding is in agreement with a few published studies of the effect of 
polymeric particle size and surface chemistry on cellular uptake, which suggest that surface 
chemistry is less important for larger particles 437, 469. The zwitterionic surface chemistry used 
in this chapter could therefore be further explored in particles of smaller size to ascertain if 
greater effects on uptake take place. Additionally, this would allow the study of cell types which 
are not specialised phagocytic cells and the effects of this surface chemistry on endocytic 
pathways to be established.  
The use of the phospholipid DPPC served as a simple model to represent the presence of 
lung surfactant and showed to reduce uptake of particles in comparison with buffer alone 
(HBSS). This highlights the importance of using more bio-relevant media for uptake studies. 
In future, a better model of lung surfactant would include a more complex mixture of lung 
surfactant components which includes surfactant proteins A-D and other phospholipids such 
as phosphatidylglycerol and phosphatidylinositol 470. Upon exposure of particles to this 
complex media, adsorption of proteins and surfactants is expected to take place which would 
be determined both by media composition and particle surface chemistry. This gives the 
particles a new biological identity which in turn influences its interactions with cells. The 
composition of this new biological identity should be determined so as to identify the exact 
nature of cellular interaction.  
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Comparing data from each of the chapters 3-5, microparticle uptake by macrophages was 
dependent on applied dose, particle shape, and size, but the dependence on hydrophobicity, 
surface charge, and surface chemistry presented a more complex picture which requires more 
work to fully elucidate. Larger and more elongated particle shapes demonstrated the potential 
for macrophage avoidance whereas particles possessing high curvature features may be 
useful in promoting particle uptake. This work supports earlier work in this field by Mitragotri 
and colleagues and provides impetus to further develop understanding of the properties 
affecting cellular uptake of microparticles. In particular, the study of parameters which govern 
the internalisation of different microparticle shapes and how they can be manipulated to tune 
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Appendix I – Supporting information from chapter 3 
 
 




Figure S3.2: 1H NMR of 1.2Br 
 
Figure S3.3: Brightfield, fluorescence, and surface plots of surfaces washed with water instead of DMSO after 




Figure S3.4: Fluorescence intensity histograms of RBITC labelled particles before and after trypan blue quenching. 
A) Spheres B) Spheres + trypan blue C) Hexahedrons D) Hexahedrons + trypan blue E) Pyramids F) Pyramids + 




Figure S3.5: Calibration of particle labelling.  3 μm silicon oxide spheres were modified using AUTES pre-labelled 
with different concentrations of RBITC so that the percentage of surface labelling was known. MFI was then 















Figure S3.6: Effect of temperature on phagocytosis. Cells were incubated at 4°C for 30 minutes before 
administration of pre-chilled particles and for the duration of the experiment (4 hours). Cellular uptake was 































































Quantification of particle internalisation by Image analysis   
 
Single cell populations were determined by plotting cell area against cell aspect ratio as shown 
in figure S3.7. Each dot on the scatter plot is linked with an image and so gating can be 
checked visually and different populations distinguished to remove unwanted images from the 
analysis. The population of single cells is then analysed to select a population of cells that are 
in focus. This is done by creating a histogram using the gradient RMS feature as shown in 
figure S3.8. This feature ranks images based on their focus, images that have higher scores 
are more in-focus. By visually checking cells in each bin a minimum focus can be designated 
(GRMS >50) which is then used for all further analyses.  
 






Figure S3.8 Gating of in-focus cell population 
 
In order to quantify particle uptake using image analysis it was first necessary to distinguish 
populations of cells which were associated with particles. This was achieved by plotting a 
histogram of fluorescence intensity as shown in figure S3.9. In order to adequately distinguish 
populations, a control sample of cells that had not been exposed to particles was analysed 
and a region spanning the fluorescence range of these cells designated as non-associated 
cells (figure S3.9A). A region with a fluorescence intensity above this gate was then 
designated as being associated with particles. By analysing a sample of cells which had been 
exposed to fluorescent particles it was demonstrated that a distinct population appears within 
the associated region (figureS3.9B). Further confirmation of the cells association with particles 
was performed by selecting images from each of the regions examples of which are shown in 





Figure S3.9: Gating of cells associated with particles. A) Histogram of untreated cells B) Histogram of cells treated 
with RBITC-labelled silicon oxide spheres C) Images of cells from non-associated and associated populations 
 
In order to distinguish surface bound particles from internalised particles a cell mask was 
created as shown in figure S3.10A (blue region). This mask was eroded to exclude the cell 
membrane using the adaptive erode feature with an adaptive erode coefficient of 80 as shown 
in figure S3.10B. This defines an area specific to each cell outside of which particles are 
considered surface bound by considering the ratio of fluorescence intensity inside the mask 
to the intensity of the entire cell. This analysis gives each image an internalisation score where 
a positive score indicates the particle is inside the cell and a negative score indicates the 
particle is surface bound. A histogram displaying the internalisation scores is produced and 






Figure S3.10: Cell masks used to identify cells with internal and surface-bound particles. A) General cell mask B) 
Eroded cell mask 
 
 
Figure S3.11: Histogram of internalisation score defining whether particles are internalised or surface-bound 
 
Quantification of particle internalisation by trypan blue quenching 
 
The trypan blue quenching method distinguishes internalised particles from those which are 
surface bound by quenching the fluorescence of the surface-bound particles. Trypan blue is a 
cell-impermeable dye that only enters the cell when the membrane is damaged and is 
therefore normally used to distinguish live and dead cells. Trypan blue has an absorption 
maximum at 580 nm which is the same wavelength of the emission of rhodamine B and so it 
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quenches fluorescence when in close contact with the fluorophore by absorbing emitted light. 
As such, only those particles which it can come into close contact with i.e. surface bound 
particles are quenched.  
After following the initial analysis step to isolate single cell populations as in figure S3.7, a plot 
of intensity in brightfield channel-Ch09 (X-axis) against intensity of fluorescence channel-Ch03 
(Y-axis) is used to distinguish cell populations. The brightfield channel intensity relates to the 
degree of trypan blue staining, dead cells appear darker and so this can be used to distinguish 
live from dead cells (figure 3.12). 
 
Figure S3.12: Distinction between trypan blue stained and unstained cells 
 
When particles are applied to the cells, a third population that contains live cells that have 
internalised particles is present (figure S3.13A). This population contains cells which have 
internal particles (figure S3.13B) and cells that have both internal and external particles, 
however external particles are no longer fluorescent (figure S3.13C). Cells that have external 
particles and no internal particles are present in the live cells only region (figure S3.13D) as 
the fluorescence from their particles has been quenched. The number of live cells with internal 
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particles is divided by the number of live cells + the number of live cells with internal particles 
to give the percentage of cells with internal particles. 
 
Figure S3.13: Distinction between cells with surface-bound and internalised particles using the trypan blue 
quenching method. A) B) Brightfield and fluorescence images of a live cell with internal particles  only C) Brightfield 
and fluorescence images of a live cell with both an internal and external particle D) Brightfield and fluorescence 
images of a live cell with a quenched surface-bound particle 
 
Using spot count analysis to calculate the number of particles per cell 
 
Populations of cells with internal particles (as determined using both the image analysis 
method and the trypan blue quenching method) were subsequently analysed using the IDEAS 












Figure S4.1: Cell images from imaging flow cytometry of cells with internal and external particles. A) Hexahedrons 
(3x3x0.5 μm), B) Cubes (3x3x3 μm), C) Bars (3x15x0.5 μm), D) Bars (3x15x0.05 μm), E) Bars (3x10x0.5 μm), F) 
















Appendix III – Supporting information for chapter 5 
 
 








Figure S5.2: High resolution XPS spectra of Nitrogen peaks for silicon oxide particles. A) 0.5μm, B) 1μm, C) 3μm 
D) MDSA powder. i) Particles modified with AUTES ii) Particles modified with AUTES and MDSA.  
 
